{"meta":{"query_hash":"fb0a2cfeb5a7","filters":{"venue":"Journal of Child and Adolescent Psychopharmacology"},"cohort_total":151,"direct_labels_cover":1,"predictions_cover":151,"exported":151,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/fb0a2cfeb5a7","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Child+and+Adolescent+Psychopharmacology"},"results":[{"id":"W1142757792","doi":"10.1089/cap.2015.0024","title":"Risperidone and Risk of Gynecomastia in Young Men","year":2015,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Male Breast Health Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Gynecomastia; Risperidone; Medicine; Cohort; Pediatrics; Cohort study; Internal medicine; Psychiatry; Schizophrenia (object-oriented programming)","score_opus":0.014813927721246012,"score_gpt":0.320449214920325,"score_spread":0.305635287199079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1142757792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99696416,0.0021867042,0.00013615775,0.000035819816,0.000008479763,0.0000063318357,0.00030442807,0.0000102742415,0.00034774537],"genre_scores_gemma":[0.99903774,0.00047818627,0.00015239869,0.000015414504,0.000013581746,0.0000027700908,0.00013518421,0.0000013476264,0.00016333845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973065,0.00007130837,0.000027425262,0.00006892843,0.00007659894,0.000025008734],"domain_scores_gemma":[0.99865985,0.00022944815,0.000910619,0.000043093944,0.000063072555,0.00009386981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037999553,0.00018067838,0.00018137971,0.00071802357,0.00014317219,0.0003354753,0.00014505035,0.00017599527,0.0011474284],"category_scores_gemma":[0.0014491474,0.0001359291,0.0004077499,0.00043702166,0.00012220629,0.00012630332,0.00017576317,0.00019457756,0.00016082422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010347365,0.00001350351,0.9967644,0.000015971864,0.000085185675,0.00015352515,0.000040158473,0.00003325148,0.00029444476,0.000016499685,0.00004902473,0.0024304707],"study_design_scores_gemma":[0.0000048010656,0.000108740634,0.99851435,0.000010711405,0.000047739155,0.0008225339,0.000026545642,0.00010565619,0.0001324931,0.0000145021795,0.00021021662,0.0000017489024],"about_ca_topic_score_codex":0.0019705654,"about_ca_topic_score_gemma":0.0021900367,"teacher_disagreement_score":0.0019705654,"about_ca_system_score_codex":0.00016099145,"about_ca_system_score_gemma":0.00014332205,"threshold_uncertainty_score":0.0039182305},"labels":[],"label_agreement":null},{"id":"W1481180959","doi":"10.1089/cap.2014.0106","title":"Psychotropic Medication Use Among Adolescents and Young Adults with an Autism Spectrum Disorder: Parent Views About Medication Use and Healthcare Services","year":2015,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Autism Spectrum Disorder Research","field":"Neuroscience","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Autism spectrum disorder; Psychiatry; Young adult; Autism; Mental health; Health care; Medicine; Psychotropic medication; Clinical psychology; Psychology; Gerontology","score_opus":0.03132283092867226,"score_gpt":0.3324478125775178,"score_spread":0.30112498164884555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1481180959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99901676,0.0002667326,0.000022988383,0.00021193702,0.0000051457805,0.0000033345614,0.000048242437,6.9518074e-7,0.0004242121],"genre_scores_gemma":[0.9991685,0.00045900463,0.00006469,0.00011672296,0.000005373128,0.000007071869,0.00005219905,6.40991e-7,0.00012590094],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9995808,0.00016442337,0.000060468832,0.00003775694,0.000111277346,0.00004536999],"domain_scores_gemma":[0.9967235,0.0011462771,0.0014143002,0.00004847867,0.0003275487,0.0003399118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011364991,0.00009705856,0.00018619683,0.00041979997,0.0005178958,0.00067317893,0.00013638039,0.00029569116,0.0017358499],"category_scores_gemma":[0.0041903583,0.00018521091,0.0002713535,0.00029278215,0.0003069572,0.00071026146,0.00052782596,0.0004715212,0.000111186455],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031336094,0.000032443575,0.9785469,0.00003724843,0.000026954496,0.00030944461,0.015094623,0.000014855635,0.00019417678,0.000042963253,0.0003021726,0.005366977],"study_design_scores_gemma":[0.0000066710427,0.00013019227,0.9329419,0.00013153061,0.00003414836,0.0011644996,0.06416689,0.000090049296,0.000132375,0.000031697124,0.0011627662,0.0000072564744],"about_ca_topic_score_codex":0.008401834,"about_ca_topic_score_gemma":0.012978228,"teacher_disagreement_score":0.008401834,"about_ca_system_score_codex":0.00047935868,"about_ca_system_score_gemma":0.00055651675,"threshold_uncertainty_score":0.01670587},"labels":[],"label_agreement":null},{"id":"W1502285643","doi":"10.1089/104454603321666162","title":"Methodological Issues and Controversies in Clinical Trials with Child and Adolescent Patients with Bipolar Disorder: Report of a Consensus Conference","year":2003,"lang":"en","type":"review","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Bipolar disorder; Psychiatry; Clinical trial; Psychology; Interim; Protocol (science); Medicine; Clinical psychology; Alternative medicine; Cognition; Political science","score_opus":0.13347477971578078,"score_gpt":0.4602372830150016,"score_spread":0.32676250329922085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1502285643","genre_codex":"commentary","genre_gemma":"review","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0070950296,0.10591821,0.06169269,0.76051015,0.0405183,0.01930066,0.00040733983,0.00025138882,0.0043061855],"genre_scores_gemma":[0.11631444,0.049402695,0.41835064,0.3206302,0.017391639,0.073415376,0.0008666945,0.000536977,0.003091341],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.15000612,0.60611117,0.16403651,0.014182903,0.05959047,0.006072825],"domain_scores_gemma":[0.12681246,0.633432,0.04658005,0.025343372,0.15561043,0.012221777],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.8077229,0.0026157608,0.0068294676,0.008947311,0.011660301,0.021618728,0.018676303,0.040921237,0.0020879265],"category_scores_gemma":[0.7695376,0.0053181825,0.013503922,0.008932081,0.01330584,0.018496385,0.020500563,0.05316596,0.0011637466],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026368538,0.0009850201,0.0050321994,0.085733145,0.0077563557,0.0023038506,0.08550591,0.0049933842,0.005373211,0.0693779,0.19261143,0.53769076],"study_design_scores_gemma":[0.0036896751,0.0010575836,0.004933058,0.1949729,0.004300884,0.001862806,0.032634724,0.007927994,0.0049553486,0.14763889,0.59498197,0.0010441286],"about_ca_topic_score_codex":0.0051611946,"about_ca_topic_score_gemma":0.0049943733,"teacher_disagreement_score":0.19227707,"about_ca_system_score_codex":0.029637683,"about_ca_system_score_gemma":0.09486895,"threshold_uncertainty_score":0.23711193},"labels":[],"label_agreement":null},{"id":"W1817601989","doi":"10.1089/cap.2014.0002","title":"Medication Persistence in Turkish Children and Adolescents with Attention-Deficit/Hyperactivity Disorder","year":2014,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child, Adolescent and Family Mental Health","funders":"Sakarya Üniversitesi","keywords":"Persistence (discontinuity); Impulsivity; Attention deficit hyperactivity disorder; Methylphenidate; Psychiatry; Comorbidity; Rating scale; Turkish; Psychology; Medicine; Clinical psychology; Pediatrics","score_opus":0.010585015579317646,"score_gpt":0.2880479875840953,"score_spread":0.27746297200477765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1817601989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992925,0.00045356146,0.0000132591995,0.000022080872,0.0000029752039,0.0000033751082,0.0001085095,9.3017246e-7,0.000102791375],"genre_scores_gemma":[0.99932396,0.00030535943,0.00005356529,0.00001717469,0.0000061501087,0.000006505921,0.00023133135,8.5340827e-7,0.000055062672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996019,0.000059231163,0.00007204236,0.00007246648,0.000105387844,0.00008894475],"domain_scores_gemma":[0.99887174,0.0001234588,0.0007398851,0.000025480782,0.00012350838,0.00011589157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034029357,0.00025192118,0.0004089228,0.0009597305,0.00043136624,0.00046182194,0.00032061327,0.0003517032,0.0010081149],"category_scores_gemma":[0.001343772,0.00016273315,0.00054230535,0.00085890514,0.0002545694,0.00032645944,0.00033388872,0.0004521419,0.00011413632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025202657,0.00002287212,0.9978775,0.000013924429,0.000014595418,0.00015528232,0.0001824376,0.000011517278,0.0000641056,0.000005576173,0.000040925588,0.0015860971],"study_design_scores_gemma":[0.0000022927984,0.000061075465,0.9985147,0.000010730834,0.000014607092,0.0007457746,0.00046889452,0.000041515177,0.00003235494,0.000004576852,0.00010150285,0.0000018845249],"about_ca_topic_score_codex":0.013859731,"about_ca_topic_score_gemma":0.016559808,"teacher_disagreement_score":0.013859731,"about_ca_system_score_codex":0.00047854788,"about_ca_system_score_gemma":0.00055334665,"threshold_uncertainty_score":0.027558088},"labels":[],"label_agreement":null},{"id":"W1922244853","doi":"10.1089/1044546041649020","title":"Risperidone Effects in the Presence/Absence of Psychostimulant Medicine in Children with ADHD, Other Disruptive Behavior Disorders, and Subaverage IQ","year":2004,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Risperidone; Stimulant; Placebo; Psychology; Attention deficit hyperactivity disorder; Somnolence; Psychiatry; Concomitant; Adverse effect; Randomized controlled trial; Internal medicine; Clinical psychology; Medicine; Schizophrenia (object-oriented programming)","score_opus":0.011594938305294941,"score_gpt":0.3266258061027143,"score_spread":0.31503086779741934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1922244853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951814,0.004184576,0.000065386994,0.000029714744,0.0000133892945,0.000035915262,0.00009565755,0.000006992201,0.00038693254],"genre_scores_gemma":[0.99884254,0.00072031893,0.00020243337,0.000039762665,0.000019592906,0.000017038385,0.000097559336,0.0000014106824,0.000059449612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998743,0.0006355608,0.0002032878,0.00011848414,0.0002346494,0.00006502607],"domain_scores_gemma":[0.9968004,0.0012798259,0.0014361775,0.00012051349,0.00014762804,0.00021549354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014450729,0.00036546527,0.0010189824,0.00047204358,0.00016915685,0.00036022085,0.00022048903,0.00030955186,0.00092608924],"category_scores_gemma":[0.0026604661,0.00020814134,0.0010745868,0.00030102732,0.000335245,0.00025110296,0.0002544226,0.0005408422,0.000091850925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22254214,0.0038467264,0.6081352,0.0016127337,0.007897408,0.0011996231,0.0005258202,0.0013541806,0.023085851,0.00011685456,0.00048554884,0.12919794],"study_design_scores_gemma":[0.012699653,0.082026176,0.8905073,0.00015013463,0.0043247994,0.0019524943,0.00020836716,0.00091774244,0.005781547,0.000069497495,0.0013372819,0.000025074922],"about_ca_topic_score_codex":0.0010298599,"about_ca_topic_score_gemma":0.003074991,"teacher_disagreement_score":0.0014450729,"about_ca_system_score_codex":0.00032408314,"about_ca_system_score_gemma":0.00042950828,"threshold_uncertainty_score":0.0076423287},"labels":[],"label_agreement":null},{"id":"W1933358293","doi":"10.1089/cap.2013.0120","title":"Clinical Characteristics Associated with Lithium Use among Adolescents with Bipolar Disorder","year":2014,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Bipolar disorder; Lithium (medication); Schedule for Affective Disorders and Schizophrenia; Psychology; Psychiatry; Clinical psychology; Mood; Mania; Mood disorders; Schizophrenia (object-oriented programming); Impulsivity; Depression (economics); Family history; Not Otherwise Specified; Medicine; Internal medicine; Anxiety","score_opus":0.01226244295537265,"score_gpt":0.29409240093326694,"score_spread":0.2818299579778943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1933358293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991424,0.00026563468,0.000021357651,0.000057032546,0.000003668038,0.000009498592,0.00016090935,0.0000024754772,0.00033695975],"genre_scores_gemma":[0.9995652,0.000106968524,0.00004841391,0.000033041688,0.00000603008,0.000008628675,0.00017376487,0.0000010075689,0.000056883902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996673,0.00007928512,0.00006391831,0.000043233875,0.000102014725,0.000044312263],"domain_scores_gemma":[0.9983271,0.00024483106,0.0010696792,0.000021909593,0.000115327195,0.00022120902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031606393,0.00014494362,0.00023030989,0.0005594738,0.0003327311,0.00049667654,0.00018945421,0.00034602772,0.0013191213],"category_scores_gemma":[0.0021362975,0.00014299742,0.00025827123,0.00064308103,0.00020490077,0.00027759394,0.00024718855,0.000524971,0.00012744818],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002262714,0.000020300622,0.9993081,0.0000045790957,0.00000825806,0.00003959377,0.000026225474,0.0000071604277,0.00004951124,0.000003179218,0.00003420254,0.00047621602],"study_design_scores_gemma":[0.0000039095507,0.000060765797,0.9992367,0.0000073275696,0.0000081760545,0.00037487366,0.0001536833,0.00005608444,0.000025910645,0.000005551104,0.00006585179,0.0000012108046],"about_ca_topic_score_codex":0.003265231,"about_ca_topic_score_gemma":0.0076135183,"teacher_disagreement_score":0.003265231,"about_ca_system_score_codex":0.0002878804,"about_ca_system_score_gemma":0.0003203108,"threshold_uncertainty_score":0.006492436},"labels":[],"label_agreement":null},{"id":"W1967557107","doi":"10.1089/1044546041649002","title":"The Kutcher Generalized Social Anxiety Disorder Scale for Adolescents: Assessment of its Evaluative Properties Over the Course of a 16-Week Pediatric Psychopharmacotherapy Trial","year":2004,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Anxiety; Social anxiety; Psychology; Clinical psychology; Generalized anxiety disorder; Psychiatry; Psychotherapist; Medicine","score_opus":0.03360595246240872,"score_gpt":0.3960359753673885,"score_spread":0.3624300229049798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967557107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970028,0.0018539189,0.000101604535,0.00008079287,0.00004064342,0.00046837275,0.00017671174,0.0000142478475,0.00026092224],"genre_scores_gemma":[0.9958627,0.001510238,0.0005698701,0.00013131778,0.00013856449,0.0011232002,0.0003428049,0.000005233011,0.0003160185],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9985545,0.00086975226,0.00012671262,0.00014227907,0.00021993004,0.00008675078],"domain_scores_gemma":[0.99770373,0.00066233886,0.00096472533,0.00014871014,0.00016610412,0.0003543649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023709282,0.0006810721,0.0019703347,0.000349341,0.0002371308,0.00040920704,0.00054021704,0.0007912815,0.0013701734],"category_scores_gemma":[0.0035777926,0.0003283807,0.0009559637,0.0003573365,0.00048288933,0.0004919858,0.0002830051,0.0013008595,0.00017718672],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83339405,0.016359864,0.038897086,0.001257223,0.0046217917,0.00009675673,0.0002602597,0.00080628734,0.0029101276,0.00007668291,0.0008592326,0.10046063],"study_design_scores_gemma":[0.59502095,0.23832521,0.16103196,0.00013486783,0.0018802718,0.00018596608,0.0000896239,0.0014473349,0.0008692767,0.00007367539,0.0009055652,0.000035379173],"about_ca_topic_score_codex":0.0007850953,"about_ca_topic_score_gemma":0.0016576706,"teacher_disagreement_score":0.0023709282,"about_ca_system_score_codex":0.00053170574,"about_ca_system_score_gemma":0.0006671167,"threshold_uncertainty_score":0.012538791},"labels":[],"label_agreement":null},{"id":"W1968275141","doi":"10.1089/cap.2006.0076","title":"Citalopram to Treat Depression in Pediatric Oncology","year":2007,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital","funders":"","keywords":"Citalopram; Fluoxetine; Discontinuation; Antidepressant; Serotonin reuptake inhibitor; Medicine; Depression (economics); Oncology; Population; Reuptake inhibitor; Psychiatry; Internal medicine; Serotonin; Anxiety","score_opus":0.01829518789596144,"score_gpt":0.373533031385793,"score_spread":0.35523784348983156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968275141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87408155,0.104752265,0.002209805,0.004992035,0.00047585226,0.0004445899,0.00032103813,0.0000880915,0.012634752],"genre_scores_gemma":[0.9575828,0.033410016,0.0038568026,0.0025358745,0.00042990016,0.00024130121,0.0002639594,0.000021183525,0.0016581756],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99980754,0.00007099357,0.000032010328,0.000022054617,0.000039484796,0.000027890816],"domain_scores_gemma":[0.99939466,0.00023837482,0.00021515951,0.000036089023,0.000028844825,0.00008685184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028569056,0.00020763549,0.00039748015,0.00028294412,0.00023053156,0.00021836715,0.00024478906,0.0006127143,0.00096952746],"category_scores_gemma":[0.0014997649,0.00008255382,0.00033559639,0.0003156297,0.00024298021,0.00016552537,0.00022339636,0.0012818628,0.00027835427],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043370747,0.0016195069,0.100816384,0.0022641944,0.0004510547,0.07801502,0.0013407764,0.00067862956,0.047706034,0.002308932,0.009364352,0.751098],"study_design_scores_gemma":[0.006526098,0.044174865,0.31292757,0.0010924381,0.0008345566,0.39037153,0.00094203866,0.0013549945,0.03920075,0.0019508944,0.20055352,0.00007077456],"about_ca_topic_score_codex":0.0004919933,"about_ca_topic_score_gemma":0.002251677,"teacher_disagreement_score":0.00096952746,"about_ca_system_score_codex":0.000299431,"about_ca_system_score_gemma":0.00033121672,"threshold_uncertainty_score":0.0032433867},"labels":[],"label_agreement":null},{"id":"W1969119626","doi":"10.1089/cap.2006.0051","title":"Preliminary Evidence of Beneficial Effects of Methylphenidate on Listening Comprehension in Children with Attention-Deficit/Hyperactivity Disorder","year":2007,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Ontario Brain Institute; Institute for Work & Health; University of Windsor","funders":"","keywords":"Methylphenidate; Psychology; Working memory; Comprehension; Attention deficit hyperactivity disorder; Active listening; Placebo; Audiology; Developmental psychology; Cognition; Clinical psychology; Cognitive psychology; Psychiatry; Medicine; Psychotherapist","score_opus":0.015128660360513746,"score_gpt":0.3305798086066191,"score_spread":0.3154511482461054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969119626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99771935,0.0015645125,0.000058121674,0.0000987539,0.00000815267,0.000022363987,0.00008943854,0.000011279356,0.0004279593],"genre_scores_gemma":[0.9978083,0.0013607946,0.00038011745,0.00007956068,0.000020266461,0.00002538154,0.00013729483,0.000003648229,0.00018477858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99976355,0.00008356834,0.000036170513,0.00002830567,0.00006349018,0.000024967378],"domain_scores_gemma":[0.9990651,0.00048589066,0.00023812833,0.00002463815,0.000078352095,0.00010788836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000451813,0.00037001568,0.00055243337,0.00015881527,0.00018439947,0.00017201022,0.00020273397,0.00038418072,0.0016058573],"category_scores_gemma":[0.0025306263,0.00011613442,0.00019329056,0.00012961007,0.00028679968,0.0001776755,0.00017078272,0.0004459979,0.00010981854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050151214,0.0059568393,0.4709818,0.0036100817,0.0015009457,0.002221222,0.0016984984,0.0006356686,0.15440899,0.000068171015,0.0013057896,0.30746076],"study_design_scores_gemma":[0.0015387867,0.023086064,0.96126515,0.00009511901,0.0005655463,0.0016243523,0.00027931927,0.000242821,0.0100042485,0.00002994434,0.0012591718,0.000009542278],"about_ca_topic_score_codex":0.0022334103,"about_ca_topic_score_gemma":0.0056664036,"teacher_disagreement_score":0.0022334103,"about_ca_system_score_codex":0.00015419861,"about_ca_system_score_gemma":0.00025033468,"threshold_uncertainty_score":0.0053721666},"labels":[],"label_agreement":null},{"id":"W1970017774","doi":"10.1089/104454601750284027","title":"Update and Recommendations for the Use of Antipsychotics in Early-Onset Psychoses","year":2001,"lang":"en","type":"review","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Quetiapine; Olanzapine; Risperidone; Tolerability; Extrapyramidal symptoms; Antipsychotic; Clozapine; Psychiatry; Medicine; Adverse effect; Psychosis; Psychology; Randomized controlled trial; Atypical antipsychotic; Pediatrics; Schizophrenia (object-oriented programming); Internal medicine","score_opus":0.10700697862653562,"score_gpt":0.4251984175103004,"score_spread":0.3181914388837648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970017774","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003033835,0.95457417,0.0012162034,0.03199547,0.008999105,0.00014724156,0.00032403416,0.00009921778,0.002341101],"genre_scores_gemma":[0.0016715296,0.9689396,0.011301656,0.012463785,0.0027839718,0.0002713084,0.0005247779,0.000023319126,0.0020200636],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.991848,0.0023252477,0.0029934293,0.00047348588,0.0021173963,0.0002425051],"domain_scores_gemma":[0.9651267,0.014467693,0.0044723134,0.00071434624,0.014042429,0.0011764702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014109938,0.0018621845,0.00519971,0.010436632,0.0008567407,0.0032660505,0.0051484057,0.0065023936,0.0059815263],"category_scores_gemma":[0.02486031,0.001243571,0.0037464595,0.008363514,0.0011753422,0.0057361885,0.0019388057,0.006368161,0.003910557],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002507682,0.00013562474,0.0006337014,0.064417884,0.00053064903,0.0006122275,0.00036758106,0.00043345234,0.0007511537,0.00330415,0.250246,0.6783169],"study_design_scores_gemma":[0.000117680574,0.00014265842,0.0020995082,0.076853074,0.0012468457,0.0012038234,0.00042245566,0.00021116005,0.00017087742,0.0034754481,0.9140011,0.00005539214],"about_ca_topic_score_codex":0.005782469,"about_ca_topic_score_gemma":0.013056798,"teacher_disagreement_score":0.014109938,"about_ca_system_score_codex":0.0030610438,"about_ca_system_score_gemma":0.010884848,"threshold_uncertainty_score":0.07462138},"labels":[],"label_agreement":null},{"id":"W1970044726","doi":"10.1089/cap.2013.0054","title":"Atomoxetine Improved Attention in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Dyslexia in a 16 Week, Acute, Randomized, Double-Blind Trial","year":2013,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"","keywords":"Atomoxetine; Attention deficit hyperactivity disorder; Psychology; Dyslexia; Placebo; Randomized controlled trial; Atomoxetine hydrochloride; Rating scale; Psychiatry; Clinical psychology; Audiology; Developmental psychology; Medicine; Methylphenidate; Internal medicine; Reading (process)","score_opus":0.012772536047385845,"score_gpt":0.3070292810484709,"score_spread":0.29425674500108506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970044726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904818,0.0035728174,0.00030513637,0.00029788204,0.00034722534,0.0032792068,0.0006803333,0.00014614711,0.00088948326],"genre_scores_gemma":[0.98232365,0.0048584063,0.0021818392,0.0007879747,0.00045436536,0.005489067,0.00090007385,0.000023058947,0.0029815848],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99952316,0.00021044306,0.000059005382,0.000081313505,0.000049024362,0.0000771686],"domain_scores_gemma":[0.9994684,0.00014830352,0.00012710018,0.000046694397,0.000041627136,0.00016794143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093416474,0.00091205264,0.003244759,0.00043600323,0.0004311136,0.00059141655,0.0010831093,0.001518044,0.004546073],"category_scores_gemma":[0.0010592656,0.0006371238,0.0011598974,0.00039648256,0.0008091966,0.0006346433,0.00035832013,0.0018991649,0.00069247704],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9391193,0.015625438,0.0014620649,0.001588142,0.0012451598,0.00010078997,0.000089369845,0.00023391967,0.0060281027,0.00007713366,0.0009070595,0.03352359],"study_design_scores_gemma":[0.93623704,0.05860408,0.0036356568,0.000045464694,0.00027012275,0.000039955357,0.000020957294,0.00020372328,0.00041975794,0.000026671807,0.0004867234,0.000009872297],"about_ca_topic_score_codex":0.0015971913,"about_ca_topic_score_gemma":0.005254807,"teacher_disagreement_score":0.004546073,"about_ca_system_score_codex":0.0006665403,"about_ca_system_score_gemma":0.00097390974,"threshold_uncertainty_score":0.015208125},"labels":[],"label_agreement":null},{"id":"W1974273367","doi":"10.1089/104454603322572679","title":"The Kutcher Adolescent Depression Scale: Assessment of Its Evaluative Properties over the Course of an 8-Week Pediatric Pharmacotherapy Trial","year":2003,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Child and Adolescent Psychosocial and Emotional Development","field":"Psychology","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Clinical Global Impression; Paroxetine; Depression (economics); Global Assessment of Functioning; Rating scale; Placebo; Psychology; Severity of illness; Physical therapy; Clinical trial; Clinical psychology; Medicine; Psychiatry; Internal medicine; Anxiety; Developmental psychology","score_opus":0.029608027650535412,"score_gpt":0.36920382892299,"score_spread":0.3395958012724546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974273367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99524754,0.0024999608,0.00023068715,0.00012218527,0.000048836304,0.00096277444,0.00033003718,0.000031725067,0.0005262825],"genre_scores_gemma":[0.9930876,0.0022966596,0.0010478749,0.00017231805,0.00016717573,0.0021557792,0.0005096129,0.000008671346,0.0005542875],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9988732,0.0006816274,0.000082866994,0.00013475935,0.0001561147,0.000071401555],"domain_scores_gemma":[0.99860877,0.00030815828,0.00061723444,0.00009540574,0.00012371088,0.00024672138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020861777,0.00074692885,0.0019131419,0.00035964113,0.0002504863,0.0004016284,0.0005599868,0.00084550364,0.0017266169],"category_scores_gemma":[0.002179039,0.00037104127,0.0008617538,0.00037414805,0.00045981322,0.000519389,0.00028296543,0.0014332503,0.00022211649],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8653559,0.019212646,0.021240752,0.0011167175,0.0028735395,0.00008997787,0.00016129136,0.00074853597,0.0037239753,0.00010278402,0.0009658162,0.084408],"study_design_scores_gemma":[0.6331566,0.26123288,0.09951368,0.00012525814,0.0016031796,0.00022146781,0.00005621655,0.0016224774,0.0011357837,0.0000740956,0.0012272251,0.00003111847],"about_ca_topic_score_codex":0.00071697845,"about_ca_topic_score_gemma":0.001349122,"teacher_disagreement_score":0.0020861777,"about_ca_system_score_codex":0.00040956572,"about_ca_system_score_gemma":0.00054814003,"threshold_uncertainty_score":0.011032879},"labels":[],"label_agreement":null},{"id":"W1974610592","doi":"10.1089/cap.2008.040","title":"Activation Adverse Events Induced by the Selective Serotonin Reuptake Inhibitor Fluvoxamine in Children and Adolescents","year":2009,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Mental Health; York University; Johns Hopkins University","keywords":"Fluvoxamine; Adverse effect; Placebo; Anxiety; Reuptake inhibitor; Serotonin reuptake inhibitor; Schedule for Affective Disorders and Schizophrenia; Medicine; Psychiatry; Internal medicine; Psychology; Anesthesia; Serotonin; Antidepressant; Fluoxetine","score_opus":0.01152711408685222,"score_gpt":0.306988158405287,"score_spread":0.2954610443184348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974610592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980247,0.0014971931,0.000050348874,0.000024095943,0.000004131031,0.000016020222,0.00009440756,0.0000033163171,0.0002858062],"genre_scores_gemma":[0.9990663,0.0006090061,0.000111087356,0.000027094013,0.00000848386,0.000009939641,0.00009538831,9.915645e-7,0.00007170027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938047,0.00024564186,0.000075183576,0.00007013797,0.00016843704,0.000060106147],"domain_scores_gemma":[0.9978684,0.00046752664,0.0013340994,0.000038165308,0.0001676595,0.00012412868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006484208,0.00015854019,0.0004395912,0.000292905,0.00014535981,0.00023546,0.0001179868,0.00018481488,0.00069898134],"category_scores_gemma":[0.0021671257,0.00010788514,0.00035535375,0.00027767784,0.00013973837,0.00016400006,0.00013939063,0.00031121788,0.000054973243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007500446,0.00010022693,0.98112124,0.00013096812,0.000140478,0.00031878304,0.00015187323,0.000055272336,0.0016610388,0.000019159588,0.0001149138,0.015435907],"study_design_scores_gemma":[0.000030302755,0.0007005074,0.9975561,0.00002171207,0.000051781153,0.0010177859,0.00009311465,0.00005011455,0.00027590487,0.000005507469,0.00019548842,0.0000017154014],"about_ca_topic_score_codex":0.0016041381,"about_ca_topic_score_gemma":0.0026614368,"teacher_disagreement_score":0.0016041381,"about_ca_system_score_codex":0.00023215299,"about_ca_system_score_gemma":0.00021030656,"threshold_uncertainty_score":0.003429234},"labels":[],"label_agreement":null},{"id":"W1977108072","doi":"10.1089/cap.2011.0142","title":"Safety Methodology in Pediatric Psychopharmacology Trials","year":2013,"lang":"en","type":"review","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Clinical trial; Psychopharmacology; Medicine; Population; Vulnerability (computing); Psychiatry; Computer science; Computer security; Environmental health; Pathology","score_opus":0.2599124592733824,"score_gpt":0.5239947025197178,"score_spread":0.2640822432463354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977108072","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00084053684,0.98150015,0.009870292,0.0028177572,0.0005660847,0.001307721,0.00018765737,0.000044440185,0.0028653534],"genre_scores_gemma":[0.02793277,0.925047,0.035635397,0.0044882842,0.0012491693,0.004231203,0.0004087101,0.000049050075,0.0009584668],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.7890071,0.16440956,0.026543912,0.0040601646,0.015475283,0.0005039104],"domain_scores_gemma":[0.5149196,0.40697894,0.0475925,0.010679059,0.018997693,0.0008322701],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.15964498,0.0012930022,0.0027696614,0.0048714285,0.0005690495,0.00339007,0.002800197,0.0032148,0.0042295423],"category_scores_gemma":[0.2446056,0.00085967965,0.002520628,0.006304735,0.0022935607,0.0035278192,0.00208143,0.003140799,0.0010832183],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004997992,0.00011101296,0.0022221573,0.16824758,0.0010022746,0.00019901905,0.0010623133,0.00092839624,0.0006229844,0.009315141,0.009918464,0.8058709],"study_design_scores_gemma":[0.0009814282,0.0015467342,0.01133999,0.39530283,0.0033182614,0.0026818847,0.0012393419,0.001550027,0.0035897852,0.025604088,0.5526611,0.00018448087],"about_ca_topic_score_codex":0.0013500943,"about_ca_topic_score_gemma":0.001576041,"teacher_disagreement_score":0.84035504,"about_ca_system_score_codex":0.0032592986,"about_ca_system_score_gemma":0.00975015,"threshold_uncertainty_score":0.8442934},"labels":[],"label_agreement":null},{"id":"W1977218757","doi":"10.1089/cap.2010.0010","title":"The Use of <i>Pro Re Nata</i> or <i>Statim</i> Medications for Behavioral Control: A Summary of Experience at a Tertiary Care Children's Mental Health Center","year":2011,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Child and Adolescent Psychosocial and Emotional Development","field":"Psychology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Pro re nata; Olanzapine; Tertiary care; Mental health; Psychiatry; Medicine; Lorazepam; Psychology; Pediatrics; Family medicine; Schizophrenia (object-oriented programming); Internal medicine","score_opus":0.04326028440270974,"score_gpt":0.34428883283809725,"score_spread":0.3010285484353875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977218757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99897826,0.00029995808,0.000028209788,0.00011495305,0.0000032584646,0.000009495365,0.00011133252,0.0000036712954,0.00045088422],"genre_scores_gemma":[0.99883026,0.0006864993,0.00008721111,0.000078386285,0.000009061859,0.000008906305,0.0001403992,0.0000036666088,0.0001556648],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991417,0.00020153803,0.00010834868,0.00008569606,0.00018491189,0.00027785474],"domain_scores_gemma":[0.9970535,0.00041919982,0.0015462065,0.00006212764,0.00025638178,0.0006625381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006785583,0.00028808083,0.0003217898,0.0008307544,0.0012964729,0.001087705,0.00055776525,0.0004003009,0.0010909183],"category_scores_gemma":[0.002676993,0.00034424238,0.00032426236,0.0011193602,0.00068853656,0.0008285456,0.0011905675,0.0011012008,0.00014693424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057012723,0.00015715646,0.9805683,0.00006733955,0.000028937644,0.00095281,0.008132479,0.00006031968,0.0004277041,0.00004567547,0.0005355651,0.008966736],"study_design_scores_gemma":[0.0000039169263,0.00022462642,0.9845366,0.000041621555,0.000016767977,0.0024283936,0.011870669,0.00008691528,0.00022115129,0.000010863451,0.0005469498,0.000011583819],"about_ca_topic_score_codex":0.03437601,"about_ca_topic_score_gemma":0.10526747,"teacher_disagreement_score":0.03437601,"about_ca_system_score_codex":0.0021389255,"about_ca_system_score_gemma":0.0016526012,"threshold_uncertainty_score":0.068351865},"labels":[],"label_agreement":null},{"id":"W1978186711","doi":"10.1089/104454601750284090","title":"Amotivational Syndrome Associated with Selective Serotonin Reuptake Inhibitors in Children and Adolescents","year":2001,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Hallucinations in medical conditions","field":"Neuroscience","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Disinhibition; Apathy; Serotonin; Psychiatry; Psychology; Serotonin Uptake Inhibitors; Medicine; Clinical psychology; Pediatrics; Internal medicine; Fluoxetine; Cognition","score_opus":0.009550664928721312,"score_gpt":0.2740204834066244,"score_spread":0.2644698184779031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978186711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968201,0.00081926334,0.00015353417,0.00014724769,0.0000145163385,0.000018584024,0.000061158105,0.000016435213,0.0019491498],"genre_scores_gemma":[0.9991843,0.0004434246,0.00010893882,0.00006299233,0.000013442613,0.000008600196,0.000044989705,0.0000028906916,0.00013045693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997191,0.000048406215,0.00003593065,0.000033721808,0.000069394206,0.000093500414],"domain_scores_gemma":[0.99900985,0.00020706633,0.00044250092,0.00002841584,0.00007276411,0.0002393067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018997736,0.00050983764,0.00043251933,0.0009121847,0.00067168643,0.0004180133,0.00019041277,0.0006339832,0.0012292097],"category_scores_gemma":[0.002013494,0.00034185208,0.00026929937,0.00055744767,0.0007654684,0.00045899142,0.00045599742,0.00082092895,0.00019745501],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020274059,0.00015944248,0.5993676,0.00018073026,0.00006907209,0.3760365,0.0025103127,0.00017369658,0.006266623,0.00060624327,0.0014362668,0.012990708],"study_design_scores_gemma":[0.00003385484,0.00027633272,0.34459683,0.000053897085,0.000030915242,0.652382,0.0010278493,0.00013046175,0.0005372108,0.00015228325,0.0007649629,0.000013439546],"about_ca_topic_score_codex":0.003347651,"about_ca_topic_score_gemma":0.005582368,"teacher_disagreement_score":0.003347651,"about_ca_system_score_codex":0.00050370995,"about_ca_system_score_gemma":0.0005726178,"threshold_uncertainty_score":0.0066563487},"labels":[],"label_agreement":null},{"id":"W1978533952","doi":"10.1089/cap.2010.0037","title":"Informed Consent and Stimulant Medication: Adolescents' and Parents' Ability to Understand Information About Benefits and Risks of Stimulant Medication for the Treatment of Attention-Deficit/Hyperactivity Disorder","year":2011,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research","keywords":"Stimulant; Informed consent; Attention deficit hyperactivity disorder; Psychology; Recall; Clinical psychology; Parental consent; Cognition; Psychological intervention; Psychiatry; Developmental psychology; Medicine; Alternative medicine","score_opus":0.07431557337611301,"score_gpt":0.37270889338860846,"score_spread":0.29839332001249547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978533952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99899286,0.00014350348,0.0000942787,0.00006621188,0.0000023843286,0.000016801006,0.000021502654,0.0000012595362,0.00066123274],"genre_scores_gemma":[0.9994584,0.000103632854,0.0001642517,0.00003254919,0.0000024483843,0.000018641475,0.00004357237,6.8892103e-7,0.00017587435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997776,0.0012542699,0.00020207725,0.00010119181,0.0005046204,0.00016195854],"domain_scores_gemma":[0.9838808,0.008571201,0.005546402,0.000526921,0.0008782238,0.00059646554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038349635,0.000174307,0.00017775784,0.00041556585,0.0003093657,0.000622996,0.00016387686,0.00038341788,0.0030235786],"category_scores_gemma":[0.023936706,0.00013765096,0.00020967428,0.00015387783,0.00057907694,0.000653339,0.00046992116,0.000556979,0.00015411453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041631403,0.0003329655,0.9599784,0.0000719179,0.000042523803,0.00048314672,0.011216723,0.0000800226,0.0010852452,0.00017789211,0.00029691512,0.025817879],"study_design_scores_gemma":[0.00002630544,0.0011700783,0.9876936,0.00010005814,0.000041260017,0.0019995186,0.0057012723,0.00033305958,0.0012396388,0.00021641002,0.0014636102,0.000015185964],"about_ca_topic_score_codex":0.0016755508,"about_ca_topic_score_gemma":0.0018777703,"teacher_disagreement_score":0.0038349635,"about_ca_system_score_codex":0.00027724163,"about_ca_system_score_gemma":0.00059416017,"threshold_uncertainty_score":0.020281494},"labels":[],"label_agreement":null},{"id":"W1978860923","doi":"10.1089/cap.2011.0131","title":"Clozapine-Induced Neuroleptic Malignant Syndrome in an Adolescent","year":2012,"lang":"en","type":"letter","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Electroconvulsive Therapy Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Nova scotia; Child and adolescent psychiatry; Psychiatry; Amisulpride; Neuroleptic malignant syndrome; Medicine; Library science; Humanities; Psychology; Pediatrics; Clozapine; Schizophrenia (object-oriented programming); Art; History","score_opus":0.022698641243294664,"score_gpt":0.31767342627318085,"score_spread":0.29497478502988617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978860923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95194113,0.0053560217,0.0004070118,0.02506793,0.0011017689,0.000108735076,0.0002599474,0.00006069931,0.015696837],"genre_scores_gemma":[0.985603,0.0028949326,0.00044410003,0.007036021,0.0015034289,0.000029279701,0.00010411291,0.000017595814,0.0023674348],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99963367,0.00006780444,0.00006959691,0.000053390155,0.000077756704,0.00009772259],"domain_scores_gemma":[0.99827826,0.0007027927,0.00038562386,0.000038196282,0.000114763105,0.00048050465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022356275,0.00091819355,0.00082004495,0.0012855056,0.0017256989,0.00091091014,0.0008008659,0.004531659,0.002300898],"category_scores_gemma":[0.003372712,0.00052735145,0.0007784557,0.0007773012,0.00084693485,0.0009545625,0.00051028247,0.0034409708,0.000395691],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008073375,0.00010319279,0.02993091,0.00005004274,0.000020106127,0.96618193,0.00019737156,0.000034459666,0.0005320346,0.00029852506,0.0010336579,0.0015369253],"study_design_scores_gemma":[0.00009266856,0.00030466937,0.045728814,0.000096631346,0.00009539651,0.94966084,0.00050215784,0.0003451634,0.00040518583,0.0002050205,0.002545738,0.000017716591],"about_ca_topic_score_codex":0.00786391,"about_ca_topic_score_gemma":0.013744434,"teacher_disagreement_score":0.00786391,"about_ca_system_score_codex":0.0013160281,"about_ca_system_score_gemma":0.001533452,"threshold_uncertainty_score":0.015636265},"labels":[],"label_agreement":null},{"id":"W1981452601","doi":"10.1089/cap.2006.0081","title":"Electrophysiological Effects of Stimulant Treatment on Inhibitory Control in Children with Attention-Deficit/Hyperactivity Disorder","year":2007,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"Vedecká Grantová Agentúra MŠVVaŠ SR a SAV; National Institute of Mental Health; Shire","keywords":"Stimulant; Inhibitory control; Electrophysiology; Attention deficit hyperactivity disorder; Psychology; Neuroscience; Inhibitory postsynaptic potential; Methylphenidate; Psychiatry; Audiology; Medicine; Cognition","score_opus":0.007730958311313755,"score_gpt":0.2968554111598234,"score_spread":0.2891244528485096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981452601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990357,0.00044723222,0.000062902705,0.000037706028,0.0000029741811,0.000007643302,0.00004103362,0.0000051665907,0.00035961744],"genre_scores_gemma":[0.9989832,0.00047177254,0.00028450426,0.000036779667,0.0000061303654,0.000011842592,0.000080973594,0.0000027198143,0.00012207527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998603,0.00004579361,0.000014528183,0.000015902795,0.00004131296,0.000022054202],"domain_scores_gemma":[0.99929476,0.00030216685,0.00024861612,0.000013074931,0.00006372155,0.00007759258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022255763,0.00029604346,0.00024587158,0.00021768076,0.000107465705,0.00012909375,0.00010936301,0.00023418716,0.000790413],"category_scores_gemma":[0.0020472314,0.00008697996,0.00011666208,0.00012504242,0.00019620359,0.00013282745,0.000107238564,0.0002767784,0.000072017974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006329087,0.0016253106,0.8174997,0.0005168373,0.00033447263,0.0022301248,0.0005927945,0.0005281535,0.0765474,0.00007468389,0.00044379628,0.09327761],"study_design_scores_gemma":[0.000085484564,0.0019940368,0.99251467,0.000016825592,0.000078597055,0.0013112772,0.00014319793,0.00012601852,0.0034597667,0.000018807035,0.00024736935,0.000003955802],"about_ca_topic_score_codex":0.0023476856,"about_ca_topic_score_gemma":0.0038622208,"teacher_disagreement_score":0.0023476856,"about_ca_system_score_codex":0.00020361794,"about_ca_system_score_gemma":0.0001509567,"threshold_uncertainty_score":0.004668057},"labels":[],"label_agreement":null},{"id":"W1984520790","doi":"10.1089/cap.2006.16.404","title":"Placebo-Controlled Study Examining Effects of Selegiline in Children with Attention-Deficit/Hyperactivity Disorder","year":2006,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Selegiline; Methylphenidate; Impulsivity; Attention deficit hyperactivity disorder; Placebo; Psychology; Dopamine; Randomized controlled trial; Monoamine oxidase; Rating scale; Psychiatry; Monoamine oxidase inhibitor; Medicine; Internal medicine; Neuroscience; Developmental psychology","score_opus":0.008553950234931853,"score_gpt":0.2933430160110895,"score_spread":0.28478906577615765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984520790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987578,0.0035736738,0.0004377515,0.00027527925,0.000441662,0.0053031472,0.0008894899,0.000072966235,0.0014279061],"genre_scores_gemma":[0.9856834,0.0022830595,0.0017827926,0.00051470293,0.00042453158,0.0065151677,0.0008292448,0.0000136556455,0.0019535031],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981951,0.000979236,0.00022102878,0.0002933785,0.00015202738,0.00015923659],"domain_scores_gemma":[0.9974056,0.0010680936,0.00047658573,0.00019968845,0.00023665807,0.0006134265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026945986,0.0016661477,0.0036442152,0.0007353612,0.00076707016,0.0005894916,0.0007472923,0.0022596763,0.006379797],"category_scores_gemma":[0.0034821767,0.0006546664,0.0016116565,0.0004666952,0.0016887818,0.0007625602,0.00040855046,0.0026395256,0.00056030235],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9389202,0.036930803,0.0021972354,0.0009819403,0.0012132297,0.00018847053,0.00013615422,0.00013779779,0.004831559,0.000084136635,0.00040221424,0.013976226],"study_design_scores_gemma":[0.6526479,0.33483577,0.009601429,0.000036865775,0.0006923179,0.000057928242,0.00005330313,0.00015157116,0.0010527436,0.00007487034,0.0007798648,0.00001537882],"about_ca_topic_score_codex":0.0012642028,"about_ca_topic_score_gemma":0.0023787154,"teacher_disagreement_score":0.006379797,"about_ca_system_score_codex":0.0005475015,"about_ca_system_score_gemma":0.0011668035,"threshold_uncertainty_score":0.021342516},"labels":[],"label_agreement":null},{"id":"W1992761247","doi":"10.1089/cap.2000.10.277","title":"Effects of Subchronic Methylphenidate Hydrochloride Administration on the Locomotor and Exploratory Behavior of Prepubertal Mice","year":2000,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Pharmacological Effects and Assays","field":"Agricultural and Biological Sciences","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Nova Scotia Hospital","funders":"National Science Council","keywords":"Open field; Elevated plus maze; Saline; Anxiety; Methylphenidate; Morris water navigation task; Water maze; Psychology; Anesthesia; Locomotor activity; Pharmacology; Medicine; Attention deficit hyperactivity disorder; Psychiatry; Hippocampus; Neuroscience","score_opus":0.008368179461298399,"score_gpt":0.24880251987292573,"score_spread":0.24043434041162734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992761247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99676704,0.0006733861,0.0003622196,0.000106590174,0.000030105966,0.00005151892,0.0010568209,0.00008874031,0.00086358585],"genre_scores_gemma":[0.9880102,0.0015487182,0.0021797293,0.00018169027,0.000024524981,0.00024139059,0.0017848645,0.000050680028,0.0059781144],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99971443,0.000033860313,0.00002489549,0.00006253415,0.000068241716,0.00009597878],"domain_scores_gemma":[0.99950635,0.000055258013,0.00014046734,0.000047745223,0.00004274123,0.00020742863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017345232,0.000672857,0.00040106254,0.00072996056,0.00027300467,0.00023752586,0.0003375032,0.0005591913,0.0013423222],"category_scores_gemma":[0.00021878898,0.00033938087,0.0004320728,0.00020093135,0.00048185384,0.00022563762,0.0002183072,0.0015909577,0.00032281945],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010362117,0.00030105902,0.000705705,0.00003616474,0.000011340564,0.0001723723,0.0000681876,0.00004985796,0.99550277,0.000060708993,0.000080932085,0.001974642],"study_design_scores_gemma":[0.0001221579,0.00627833,0.030649604,0.000021515647,0.000053729775,0.00039397686,0.00012691286,0.00037298596,0.9603203,0.0000562723,0.0015843009,0.000019901321],"about_ca_topic_score_codex":0.0030589437,"about_ca_topic_score_gemma":0.0069618705,"teacher_disagreement_score":0.0030589437,"about_ca_system_score_codex":0.00043906755,"about_ca_system_score_gemma":0.0004762968,"threshold_uncertainty_score":0.0060822964},"labels":[],"label_agreement":null},{"id":"W1996904910","doi":"10.1089/cap.2007.0058","title":"Effectiveness of Methylphenidate in the 10-Month Continuation Phase of the Preschoolers with ADHD Treatment Study (PATS)","year":2007,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institute of Mental Health","keywords":"Methylphenidate; Adverse effect; Attention deficit hyperactivity disorder; Rating scale; Clinical Global Impression; Psychology; Pediatrics; Medicine; Psychiatry; Internal medicine; Developmental psychology","score_opus":0.028963752397620238,"score_gpt":0.385119061331984,"score_spread":0.35615530893436376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996904910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986922,0.0006242516,0.000030025662,0.000029500592,0.0000113617725,0.00010824398,0.00029699708,0.000013547831,0.0001939025],"genre_scores_gemma":[0.9972119,0.00048820314,0.0003510965,0.000049410537,0.000028799592,0.00019893788,0.0011074551,0.0000037752386,0.00056054606],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99946386,0.00020863693,0.000060529146,0.00008212226,0.00011996115,0.00006487435],"domain_scores_gemma":[0.999094,0.00012049993,0.00033364576,0.000054285712,0.00011910719,0.00027856868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011847713,0.00044148767,0.0009700648,0.00023878815,0.00039254592,0.00035276634,0.0004227786,0.000428738,0.0016913314],"category_scores_gemma":[0.001684484,0.0002387285,0.0005382523,0.0002662087,0.00015022753,0.00026243442,0.00031289877,0.00077361154,0.00025356025],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23855768,0.01918144,0.38233224,0.0010581401,0.0023180156,0.0005661971,0.0006992418,0.000612883,0.012979217,0.0000442111,0.0024866352,0.33916402],"study_design_scores_gemma":[0.017630547,0.09376228,0.8838552,0.00009688825,0.00070622214,0.00043729946,0.00012046237,0.00037135714,0.001752916,0.000016971668,0.0012310967,0.000018812849],"about_ca_topic_score_codex":0.0038574296,"about_ca_topic_score_gemma":0.009538,"teacher_disagreement_score":0.0038574296,"about_ca_system_score_codex":0.0004810732,"about_ca_system_score_gemma":0.0007671049,"threshold_uncertainty_score":0.0076699853},"labels":[],"label_agreement":null},{"id":"W1999193891","doi":"10.1089/104454602762599871","title":"Glutamatergic Changes with Treatment in Attention Deficit Hyperactivity Disorder: A Preliminary Case Series","year":2002,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Institute for Biodiagnostics; Dalhousie University","funders":"Eli Lilly Canada","keywords":"Neurochemical; Methylphenidate; Atomoxetine; Attention deficit hyperactivity disorder; Prefrontal cortex; Ventral striatum; Creatine; Psychology; Glutamatergic; Atomoxetine hydrochloride; Striatum; Neuroimaging; Magnetic resonance imaging; Psychiatry; Neuroscience; Glutamate receptor; Medicine; Internal medicine; Dopamine; Cognition","score_opus":0.02070552396048282,"score_gpt":0.2979394776282015,"score_spread":0.2772339536677187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999193891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98924834,0.002043607,0.00069678505,0.0011468177,0.00012159479,0.00014276398,0.00012959607,0.00004947144,0.0064210687],"genre_scores_gemma":[0.9962612,0.0011173849,0.0005415294,0.0005038749,0.00024635252,0.00005056264,0.000105299005,0.00001567882,0.0011582064],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.999203,0.00011926409,0.000087877874,0.00014080876,0.00013745343,0.0003115651],"domain_scores_gemma":[0.9987872,0.00034506936,0.00027287577,0.0001394939,0.000098782984,0.00035647934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003727661,0.0017435023,0.00073482457,0.0015534976,0.0029547138,0.001253612,0.0013201595,0.00422202,0.0023805231],"category_scores_gemma":[0.0032237894,0.00093450653,0.0009790672,0.0011792667,0.0021589715,0.0011484366,0.0013446119,0.0023470973,0.0008417503],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061677645,0.00021081115,0.029255122,0.000037218753,0.00002274961,0.96589047,0.00063512946,0.000066710236,0.0005407393,0.0000812561,0.00032435558,0.0028736587],"study_design_scores_gemma":[0.00003261497,0.0001799773,0.013782675,0.0000125931765,0.000023489622,0.98469454,0.0003295331,0.00010564983,0.00031532676,0.00006237075,0.0004467838,0.000014447156],"about_ca_topic_score_codex":0.007486999,"about_ca_topic_score_gemma":0.01261489,"teacher_disagreement_score":0.007486999,"about_ca_system_score_codex":0.0016549573,"about_ca_system_score_gemma":0.0011488557,"threshold_uncertainty_score":0.014886856},"labels":[],"label_agreement":null},{"id":"W2000594322","doi":"10.1089/cap.2007.0060","title":"Parent versus Teacher Ratings of Attention-Deficit/Hyperactivity Disorder Symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)","year":2007,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institute of Mental Health","keywords":"Concordance; Attention deficit hyperactivity disorder; Psychology; Kappa; Clinical psychology; Attention deficit; Developmental psychology; Psychiatry; Medicine","score_opus":0.02231479657999531,"score_gpt":0.338956409806501,"score_spread":0.3166416132265057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000594322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99923265,0.000106724896,0.00007513884,0.00002796331,0.0000059390504,0.000018985233,0.00025429326,0.000008515682,0.00026971428],"genre_scores_gemma":[0.99871695,0.00011179583,0.00017096502,0.000019833753,0.0000070212063,0.0000355706,0.00068016147,0.0000054389593,0.0002522428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981592,0.00082638266,0.00027160475,0.00023868942,0.00038196336,0.00012212811],"domain_scores_gemma":[0.9905804,0.002929475,0.0040348754,0.00041042198,0.0014157174,0.00062911294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003875242,0.00035553792,0.0006392115,0.0011381209,0.0005158045,0.0006914796,0.0003395639,0.00049793895,0.0019942163],"category_scores_gemma":[0.011490615,0.0004438859,0.00039189844,0.0005470145,0.00049848383,0.00047615173,0.00067745533,0.000795072,0.0004398488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014946207,0.00004809894,0.9963626,0.000020551593,0.0000602028,0.000061538085,0.0012307529,0.000026258076,0.0002616687,0.000004566909,0.00018694396,0.0015873675],"study_design_scores_gemma":[0.00001529511,0.00014954478,0.9986507,0.000008327196,0.000017918157,0.00018727288,0.000737152,0.000055157452,0.000096285876,0.0000047186027,0.00007501649,0.0000025428917],"about_ca_topic_score_codex":0.0080210185,"about_ca_topic_score_gemma":0.012924335,"teacher_disagreement_score":0.0080210185,"about_ca_system_score_codex":0.00049605535,"about_ca_system_score_gemma":0.00030642093,"threshold_uncertainty_score":0.020494461},"labels":[],"label_agreement":null},{"id":"W2004716659","doi":"10.1089/cap.2006.0101","title":"Once-Daily Multilayer-Release Methylphenidate in a Double-Blind, Crossover Comparison to Immediate-Release Methylphenidate in Children with Attention-Deficit/Hyperactivity Disorder","year":2007,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Technical University of Nova Scotia; Purdue Pharma (Canada); Centre for Addiction and Mental Health; Royal University Hospital; The Scarborough Hospital; Montreal Children's Hospital; Children's & Women's Health Centre of British Columbia","funders":"","keywords":"Methylphenidate; Attention deficit hyperactivity disorder; Crossover study; Adverse effect; Extended release; Rating scale; Clinical trial; Randomized controlled trial; Psychology; Medicine; Pediatrics; Internal medicine; Psychiatry; Placebo; Pharmacology","score_opus":0.02520444314284859,"score_gpt":0.362684442351774,"score_spread":0.3374799992089254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004716659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994825,0.0031063783,0.0003370111,0.00008837656,0.00027502648,0.0007729423,0.0002367634,0.000047512673,0.00031101695],"genre_scores_gemma":[0.992396,0.0028760366,0.0016458282,0.00021036847,0.00039886593,0.0012177975,0.00036943727,0.000016523754,0.0008690785],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991203,0.00041629808,0.00012638327,0.00014918539,0.000121451,0.00006636725],"domain_scores_gemma":[0.9989066,0.0003287502,0.0003494925,0.00008901369,0.000075110525,0.0002510307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014241704,0.0009596751,0.0030965141,0.00032939628,0.00028031223,0.0005818429,0.00087545393,0.0009941221,0.003524542],"category_scores_gemma":[0.0015006434,0.00064807304,0.0012006412,0.00027865486,0.00061396585,0.00083546276,0.0003372507,0.0015480091,0.00049303554],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9483498,0.013743589,0.001188651,0.0009268017,0.001161056,0.000044876437,0.00008207298,0.00021530155,0.009428721,0.00004897591,0.0002000676,0.02461002],"study_design_scores_gemma":[0.7126644,0.2762911,0.00741284,0.00005666303,0.0008100914,0.00009053414,0.00004275164,0.0005047601,0.0015986781,0.00005003858,0.000457562,0.000020641111],"about_ca_topic_score_codex":0.0005208126,"about_ca_topic_score_gemma":0.0011408558,"teacher_disagreement_score":0.003524542,"about_ca_system_score_codex":0.00033818523,"about_ca_system_score_gemma":0.00069555757,"threshold_uncertainty_score":0.011790752},"labels":[],"label_agreement":null},{"id":"W2008693468","doi":"10.1089/104454604773840454","title":"Pharmacological Treatment of Adolescent Major Depression","year":2004,"lang":"en","type":"review","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Child and Adolescent Psychosocial and Emotional Development","field":"Psychology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Sertraline; Fluoxetine; Paroxetine; Antidepressant; Tricyclic; Depression (economics); Serotonin reuptake inhibitor; Psychiatry; Psychology; Tricyclic antidepressant; Clinical trial; Medicine; Serotonin; Pharmacology; Internal medicine; Anxiety","score_opus":0.040539901161484655,"score_gpt":0.37622641633241466,"score_spread":0.33568651517093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008693468","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00040251014,0.99852896,0.00007039981,0.00013126401,0.00008196067,0.000010365341,0.0000102027525,0.0000060687817,0.00075826835],"genre_scores_gemma":[0.0024042944,0.996775,0.00016275293,0.00012825479,0.00011551492,0.000011555067,0.000017980838,8.2004175e-7,0.0003839431],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997677,0.00005426898,0.00003847961,0.000034838304,0.00008544153,0.000019185907],"domain_scores_gemma":[0.9998136,0.00007784616,0.000049865466,0.0000071698323,0.00003335753,0.000018250268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046774896,0.00067126215,0.0014120351,0.0015235702,0.00023661497,0.00044362343,0.00067872944,0.0007657486,0.0024437795],"category_scores_gemma":[0.00058828766,0.00017382468,0.0004416405,0.0011509988,0.00024076289,0.0003767684,0.00037795628,0.0008911127,0.0012803992],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060378796,0.00010768541,0.00044885767,0.014105633,0.00013999853,0.00035455232,0.000050709186,0.00009600665,0.0012332954,0.0005197741,0.010138463,0.9727446],"study_design_scores_gemma":[0.0002286524,0.0006262737,0.018344373,0.017064871,0.0006598828,0.014728533,0.00024994905,0.00019861705,0.0016864741,0.0016716646,0.94450915,0.000031466778],"about_ca_topic_score_codex":0.0013142313,"about_ca_topic_score_gemma":0.0026537487,"teacher_disagreement_score":0.0024437795,"about_ca_system_score_codex":0.00031626137,"about_ca_system_score_gemma":0.0005843499,"threshold_uncertainty_score":0.0081753135},"labels":[],"label_agreement":null},{"id":"W2009084234","doi":"10.1089/cap.2008.021","title":"Stimulant Treatment in Children with Attention-Deficit/Hyperactivity Disorder Moderates Adolescent Academic Outcome","year":2008,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"National Institute of Mental Health","keywords":"Stimulant; Attention deficit hyperactivity disorder; Psychology; Clinical psychology; Psychiatry; Attention deficit disorder","score_opus":0.031670564549447756,"score_gpt":0.34361216802366573,"score_spread":0.31194160347421795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009084234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99929535,0.00029009447,0.0000067296382,0.00005499314,0.0000058409314,0.000004147675,0.00004780439,0.00000229772,0.00029268302],"genre_scores_gemma":[0.99956197,0.00017490285,0.000025294097,0.000018275769,0.000009026487,0.0000040626937,0.00010941456,0.0000013972477,0.00009556458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995414,0.000118110365,0.000052645202,0.000056289915,0.00013537871,0.000096250886],"domain_scores_gemma":[0.9974962,0.00031848077,0.001517927,0.000056902696,0.00014738465,0.00046323217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005797883,0.00024848702,0.00039530452,0.00059140864,0.00050705357,0.000753445,0.00038143605,0.00039407695,0.00087362574],"category_scores_gemma":[0.003389806,0.00020897413,0.00053631933,0.00052039226,0.00030892654,0.00040050322,0.00047018664,0.0007846446,0.00013487852],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008149796,0.000081116385,0.9981828,0.0000068776794,0.000029818919,0.00012017965,0.000083478306,0.000012261023,0.00013857798,0.000010549522,0.0000516041,0.0012012458],"study_design_scores_gemma":[0.0000037359646,0.000064789594,0.9995307,0.0000057522184,0.000016473241,0.00014562109,0.00011689084,0.000040972285,0.000028889417,0.000007460661,0.000037769452,9.498291e-7],"about_ca_topic_score_codex":0.013999098,"about_ca_topic_score_gemma":0.02680071,"teacher_disagreement_score":0.013999098,"about_ca_system_score_codex":0.0006452107,"about_ca_system_score_gemma":0.00071129814,"threshold_uncertainty_score":0.02783525},"labels":[],"label_agreement":null},{"id":"W2014140219","doi":"10.1089/1044546041648959","title":"Olanzapine in the Treatment of Aggression and Tics in Children with Tourette's Syndrome—A Pilot Study","year":2004,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Obsessive-Compulsive Spectrum Disorders","field":"Psychology","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Rehabilitation Institute; Toronto Western Hospital; University Health Network","funders":"","keywords":"Olanzapine; Tics; Tourette syndrome; CBCL; Psychology; Placebo; Adverse effect; Aggression; Dopamine antagonist; Psychiatry; Medicine; Pediatrics; Internal medicine; Haloperidol; Schizophrenia (object-oriented programming)","score_opus":0.011020017300138402,"score_gpt":0.3050210761790378,"score_spread":0.2940010588788994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014140219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979473,0.0012543332,0.0000852001,0.00008330839,0.000020140204,0.0002281676,0.0000974246,0.000016141585,0.00026804788],"genre_scores_gemma":[0.99612963,0.00196605,0.000666965,0.00012601553,0.00007265466,0.00032141653,0.00027090826,0.000007959636,0.0004384652],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99958307,0.00020885335,0.000052958956,0.00003628427,0.000054111224,0.000064802065],"domain_scores_gemma":[0.99919754,0.00022184911,0.00015910946,0.000035735076,0.000075308955,0.00031046744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009114206,0.00084058975,0.0013799105,0.00022451374,0.0003208845,0.00039644158,0.0005343902,0.0005713585,0.0015636948],"category_scores_gemma":[0.0008001061,0.00026321976,0.0007622645,0.00025004416,0.00057530496,0.0003589547,0.00024372057,0.0012346432,0.00025013284],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5393972,0.07713915,0.039365742,0.00340383,0.0026548193,0.006320626,0.001767422,0.002054277,0.10855127,0.00020748907,0.0017236287,0.21741451],"study_design_scores_gemma":[0.14677702,0.73065233,0.10776568,0.00010964404,0.00088337244,0.0028253659,0.00044496323,0.0009815843,0.0066928146,0.000061258754,0.0027522154,0.00005383788],"about_ca_topic_score_codex":0.0038659996,"about_ca_topic_score_gemma":0.00977161,"teacher_disagreement_score":0.0038659996,"about_ca_system_score_codex":0.0006662526,"about_ca_system_score_gemma":0.001225498,"threshold_uncertainty_score":0.0076869726},"labels":[],"label_agreement":null},{"id":"W2015032082","doi":"10.1089/cap.2008.0143","title":"Treatment Response in Depressed Adolescents With and Without Co-Morbid Attention-Deficit/Hyperactivity Disorder in the Treatment for Adolescents with Depression Study","year":2009,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Duke Clinical Research Institute; Eli Lilly and Company; York University; Baystate Health; University of Oregon; University of Texas Southwestern Medical Center; Johns Hopkins University; Case Western Reserve University; Wayne State University; Cincinnati Children's Hospital Medical Center; National Institute of Mental Health; Northwestern University; Children's Hospital of Philadelphia","keywords":"Major depressive disorder; Fluoxetine; Attention deficit hyperactivity disorder; Psychology; Depression (economics); Psychiatry; Randomized controlled trial; Clinical psychology; Cognitive behavioral therapy; Placebo; Cognition; Medicine; Internal medicine","score_opus":0.022118407700634123,"score_gpt":0.35992646294818154,"score_spread":0.3378080552475474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015032082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99448365,0.0019310361,0.00009839778,0.00021973245,0.00006302678,0.0005299061,0.0020913198,0.000010362151,0.0005724413],"genre_scores_gemma":[0.99551183,0.00085659674,0.00026876456,0.00017441141,0.00006751249,0.00062226335,0.002124297,0.0000051005663,0.00036915133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983215,0.0009067235,0.0002103896,0.00022725186,0.00023029667,0.00010388623],"domain_scores_gemma":[0.9982135,0.00033684834,0.000691642,0.00010354387,0.00015341323,0.00050113705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002098765,0.0004922274,0.0022639483,0.00038552683,0.0003234698,0.0006878131,0.0006135672,0.00094251457,0.0014146529],"category_scores_gemma":[0.0037614556,0.00039715858,0.0024290748,0.000571858,0.00017880705,0.00036724575,0.0004466137,0.0012160775,0.00019570118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22285041,0.004646867,0.7296957,0.00094439834,0.011428688,0.0001174819,0.00026959705,0.000448552,0.0012339222,0.00010591451,0.0021936225,0.026064899],"study_design_scores_gemma":[0.051723044,0.010895582,0.9310798,0.00013872398,0.0040933783,0.00014744054,0.00015856152,0.00076087104,0.00024135954,0.000052838845,0.0006857744,0.000022519367],"about_ca_topic_score_codex":0.0031103652,"about_ca_topic_score_gemma":0.0045700776,"teacher_disagreement_score":0.0031103652,"about_ca_system_score_codex":0.00060033955,"about_ca_system_score_gemma":0.0006082029,"threshold_uncertainty_score":0.011099458},"labels":[],"label_agreement":null},{"id":"W2015053071","doi":"10.1089/cap.2005.15.589","title":"Emerging Treatments for Child and Adolescent Social Phobia: AReview","year":2005,"lang":"en","type":"review","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Child and Adolescent Psychosocial and Emotional Development","field":"Psychology","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Psychology; Psychotherapist; Specific phobia; Child and adolescent psychiatry; Clinical psychology; Psychiatry; Anxiety; Anxiety disorder","score_opus":0.04229375385915948,"score_gpt":0.3887023513889224,"score_spread":0.34640859752976294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015053071","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023875933,0.99825543,0.00007472202,0.00024292895,0.000100105324,0.000008504378,0.0000095008445,0.000006684284,0.0010633965],"genre_scores_gemma":[0.0014262991,0.997285,0.00028070473,0.0002728731,0.00009740499,0.000017309547,0.000024072735,0.0000013573137,0.00059489696],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997553,0.000057856807,0.000036695867,0.000038437174,0.00008602841,0.000025605605],"domain_scores_gemma":[0.9997069,0.00014147973,0.000055874112,0.000008203573,0.00005850862,0.000029001929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065181963,0.0006998215,0.0013987954,0.0021769002,0.00031030888,0.000735192,0.0010052071,0.0014074256,0.0045875837],"category_scores_gemma":[0.00087476266,0.00024934614,0.0006400827,0.0013698818,0.00040815357,0.0008822978,0.0004972182,0.0019139632,0.0015101179],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006182457,0.00014831538,0.00032198118,0.013002468,0.00008850802,0.00031512236,0.00008388942,0.00010779949,0.0006742849,0.001275158,0.013297859,0.9706227],"study_design_scores_gemma":[0.00015493546,0.00027235283,0.0058628856,0.01852494,0.00034254164,0.006964613,0.00037407412,0.00014104263,0.00069809513,0.0021514792,0.96448654,0.000026611217],"about_ca_topic_score_codex":0.0015657239,"about_ca_topic_score_gemma":0.0035667229,"teacher_disagreement_score":0.0045875837,"about_ca_system_score_codex":0.0005823411,"about_ca_system_score_gemma":0.00073704956,"threshold_uncertainty_score":0.015347004},"labels":[],"label_agreement":null},{"id":"W2015430685","doi":"10.1089/cap.2011.0042","title":"The Effect of Methylphenidate on Prefrontal Cognitive Functioning, Inattention, and Hyperactivity in Velocardiofacial Syndrome","year":2011,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Congenital heart defects research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Methylphenidate; Attention deficit hyperactivity disorder; Placebo; Discontinuation; Psychology; Randomized controlled trial; Cognition; Rating scale; Adverse effect; Executive functions; Psychiatry; Pediatrics; Medicine; Clinical psychology; Internal medicine; Developmental psychology","score_opus":0.009370209047611827,"score_gpt":0.28915770557349263,"score_spread":0.2797874965258808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015430685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945287,0.0045995302,0.000063866704,0.00018472939,0.00003040833,0.000049953313,0.00010758741,0.0000075301223,0.00042777302],"genre_scores_gemma":[0.9961359,0.0030017162,0.0003631682,0.00009586597,0.000046733287,0.00004232289,0.00011405362,0.0000021702376,0.00019793563],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99965537,0.0001552904,0.00004301432,0.000030700812,0.000078083875,0.00003759064],"domain_scores_gemma":[0.99913824,0.0003972154,0.00025652733,0.000027309105,0.000051488933,0.00012919673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007507406,0.00051061844,0.0006156857,0.00019838611,0.00020316083,0.0001752225,0.00036553427,0.0005310119,0.0012228552],"category_scores_gemma":[0.0021664475,0.00015442313,0.0005300925,0.00012815242,0.0002602693,0.00020841876,0.00020876522,0.00068526535,0.000103698556],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28637534,0.012831339,0.20664537,0.0040957183,0.004253193,0.0017992592,0.00037723174,0.0013288598,0.051842853,0.00014909045,0.0014323833,0.42886943],"study_design_scores_gemma":[0.028450433,0.14480855,0.8012747,0.00038536757,0.0027148526,0.0032033073,0.00023616127,0.0014475085,0.0149776805,0.00009825916,0.0023732595,0.000030030209],"about_ca_topic_score_codex":0.002582002,"about_ca_topic_score_gemma":0.0062601,"teacher_disagreement_score":0.002582002,"about_ca_system_score_codex":0.00036366962,"about_ca_system_score_gemma":0.00043271872,"threshold_uncertainty_score":0.0051339865},"labels":[],"label_agreement":null},{"id":"W2020414031","doi":"10.1089/cap.2009.0035","title":"Aripiprazole in Children and Adolescents with Tourette's Disorder: An Open-Label Safety and Tolerability Study","year":2009,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Obsessive-Compulsive Spectrum Disorders","field":"Psychology","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Research Resources; York University; Bristol-Myers Squibb","keywords":"Aripiprazole; Tics; Tourette syndrome; Tolerability; Akathisia; Psychology; Tic disorder; Adverse effect; Somnolence; Psychiatry; Medicine; Internal medicine; Antipsychotic; Schizophrenia (object-oriented programming)","score_opus":0.008905372707232762,"score_gpt":0.320648764788987,"score_spread":0.3117433920817543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020414031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99819785,0.0010016698,0.00013776757,0.000042162883,0.000010328164,0.00016276404,0.00018053214,0.00001210644,0.00025473806],"genre_scores_gemma":[0.99715936,0.0011619679,0.0006717246,0.00011641528,0.00006174785,0.00018056908,0.00034248643,0.0000064253145,0.00029946875],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994462,0.00027601063,0.000067670546,0.000056334928,0.000118678545,0.00003515171],"domain_scores_gemma":[0.99856794,0.00049066596,0.00051197293,0.000081613034,0.00016320295,0.00018461829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010309627,0.000408076,0.0009328515,0.00016333321,0.00023048256,0.00030813707,0.00031787192,0.0004531164,0.0015005528],"category_scores_gemma":[0.001592537,0.00020201749,0.0005949266,0.000218564,0.00038230937,0.00036549036,0.00015523055,0.00090722076,0.00025031655],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28509086,0.042353928,0.24803923,0.0035751716,0.0040721637,0.0030942464,0.0021042149,0.002195647,0.12245206,0.0001588687,0.002430655,0.28443298],"study_design_scores_gemma":[0.052657627,0.47257623,0.4547786,0.00012513825,0.0012090919,0.0036932253,0.0005530096,0.0015747123,0.008857407,0.000046251378,0.0038793802,0.00004935553],"about_ca_topic_score_codex":0.0013983247,"about_ca_topic_score_gemma":0.0038766835,"teacher_disagreement_score":0.0015005528,"about_ca_system_score_codex":0.00036390286,"about_ca_system_score_gemma":0.0004933973,"threshold_uncertainty_score":0.005452335},"labels":[],"label_agreement":null},{"id":"W2020528188","doi":"10.1089/cap.2009.0092","title":"Time Course and Predictors of Health-Related Quality of Life Improvement and Medication Satisfaction in Children Diagnosed with Attention-Deficit/Hyperactivity Disorder Treated with the Methylphenidate Transdermal System","year":2010,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Methylphenidate; Attention deficit hyperactivity disorder; Medicine; Latent growth modeling; Quality of life (healthcare); Pediatrics; Psychiatry; Clinical psychology; Psychology; Developmental psychology","score_opus":0.00871593086235738,"score_gpt":0.29176994810680923,"score_spread":0.28305401724445184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020528188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994134,0.0001512306,0.00006236032,0.000051617386,0.0000020292125,0.00000432949,0.0001961131,0.0000026155012,0.00011622355],"genre_scores_gemma":[0.9993298,0.000086905355,0.000097204706,0.000009171741,0.0000028464149,0.000005826195,0.0003831505,0.0000013763563,0.000083708874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996222,0.000106719475,0.000035704405,0.00006211099,0.000099044875,0.00007415663],"domain_scores_gemma":[0.99823725,0.0004643387,0.0009076765,0.00005325901,0.00015039803,0.00018698585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060297735,0.00015827647,0.00024102426,0.00039127245,0.00021406486,0.00036721356,0.00022143518,0.00033764917,0.0011552194],"category_scores_gemma":[0.0032568118,0.00013382481,0.00065278134,0.00057119894,0.00018389325,0.00031070763,0.00035776632,0.00078261987,0.000108541324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000064853084,0.000033394714,0.9981772,0.00000373836,0.000020059608,0.000024334246,0.000043001124,0.00008382526,0.000057655736,0.0000053660565,0.00003018521,0.0014564863],"study_design_scores_gemma":[0.0000018628928,0.000049333743,0.99953604,0.0000021340416,0.000007126944,0.00004662605,0.000051964096,0.00024693916,0.000025644902,0.0000034870027,0.000027816022,0.0000010426985],"about_ca_topic_score_codex":0.012440194,"about_ca_topic_score_gemma":0.014411025,"teacher_disagreement_score":0.012440194,"about_ca_system_score_codex":0.000487115,"about_ca_system_score_gemma":0.0004399035,"threshold_uncertainty_score":0.02473557},"labels":[],"label_agreement":null},{"id":"W2023389491","doi":"10.1089/104454601750284036","title":"Sertraline Effects in Adolescent Major Depression and Dysthymia: A Six-Month Open Trial","year":2001,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Child and Adolescent Psychosocial and Emotional Development","field":"Psychology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Sertraline; Clinical Global Impression; Tolerability; Major depressive disorder; Depression (economics); Psychology; Antidepressant; Internal medicine; Adverse effect; Psychiatry; Anxiety; Hamilton Rating Scale for Depression; Medicine; Placebo; Mood","score_opus":0.01822957110168716,"score_gpt":0.33243128814341844,"score_spread":0.3142017170417313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023389491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940303,0.004278407,0.00017183393,0.00017606208,0.00008098806,0.00062310114,0.00023379199,0.000036300633,0.0003692106],"genre_scores_gemma":[0.99134845,0.00430992,0.0010693745,0.0004231461,0.0002857416,0.0013275793,0.00043673938,0.000008396258,0.00079068425],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996008,0.00023803505,0.000043548083,0.000039694758,0.00003616607,0.00004177619],"domain_scores_gemma":[0.99911183,0.00026262228,0.00018384993,0.00004975491,0.00005959548,0.00033228815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011012207,0.0006209009,0.0019562915,0.0002760555,0.00028754328,0.00038662582,0.00055984134,0.0011679155,0.0017449295],"category_scores_gemma":[0.0010745995,0.0002797225,0.0009517038,0.00024299943,0.00041619642,0.0004277601,0.00021222219,0.0015912637,0.00029054674],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8513115,0.031120567,0.0063691055,0.0026105873,0.0014244572,0.00035938137,0.00028612977,0.0007076004,0.010123833,0.00014361079,0.0010776819,0.09446555],"study_design_scores_gemma":[0.7248699,0.2552126,0.016707554,0.000092763104,0.00045940233,0.00025497074,0.000058630856,0.0007841464,0.000685897,0.000056464705,0.0008020081,0.000015632782],"about_ca_topic_score_codex":0.00046290242,"about_ca_topic_score_gemma":0.0016880311,"teacher_disagreement_score":0.0019562915,"about_ca_system_score_codex":0.00026419832,"about_ca_system_score_gemma":0.00046971493,"threshold_uncertainty_score":0.005837381},"labels":[],"label_agreement":null},{"id":"W2028405262","doi":"10.1089/cap.2009.0050","title":"A Naturalistic Study of Predictors and Risks of Atypical Antipsychotic Use in an Attention-Deficit/Hyperactivity Disorder Clinic","year":2009,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Child and Family Research Institute; Children's & Women's Health Centre of British Columbia; Queen's University; University of British Columbia","funders":"","keywords":"Risperidone; Attention deficit hyperactivity disorder; Medicine; Pediatrics; Psychiatry; Atypical antipsychotic; Impulsivity; Antipsychotic; Psychology; Global Assessment of Functioning; Schizophrenia (object-oriented programming)","score_opus":0.060597808155666566,"score_gpt":0.4072420352242173,"score_spread":0.34664422706855075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028405262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99968135,0.000017132354,0.000048565857,0.000027066231,0.0000021802853,0.000028764085,0.00006843543,0.000001705927,0.00012482402],"genre_scores_gemma":[0.9992499,0.000025073825,0.0002109404,0.00008461093,0.0000073481283,0.00006927887,0.00021932807,0.0000021687576,0.00013129278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872845,0.00071669155,0.000064853266,0.00019052366,0.00017296762,0.00012639517],"domain_scores_gemma":[0.99695206,0.00075525325,0.0011512255,0.0002321861,0.00028249325,0.00062675244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00102465,0.00030743045,0.00035140727,0.000742394,0.0014504119,0.0006826795,0.00050663424,0.0005448296,0.0013416129],"category_scores_gemma":[0.0046218163,0.00056201284,0.0003568327,0.0004915248,0.0009675246,0.00066774455,0.000804647,0.0008690022,0.00035897284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027174872,0.0006722659,0.99683565,0.0000074838417,0.000024087301,0.0002426781,0.0007440985,0.00003144397,0.00023801695,0.000032844506,0.00018887734,0.0007108679],"study_design_scores_gemma":[0.000111691705,0.0016217598,0.9942674,0.000009188118,0.000014024617,0.0011169879,0.0017826314,0.0005425748,0.00008004238,0.000067563466,0.00036964944,0.000016516906],"about_ca_topic_score_codex":0.008967935,"about_ca_topic_score_gemma":0.010709887,"teacher_disagreement_score":0.008967935,"about_ca_system_score_codex":0.0008450534,"about_ca_system_score_gemma":0.00085782504,"threshold_uncertainty_score":0.017831445},"labels":[],"label_agreement":null},{"id":"W2028842872","doi":"10.1089/cap.2012.0095","title":"The Bidirectional Relationship Between Body Mass Index and Treatment Outcome in Adolescents with Treatment-Resistant Depression","year":2013,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Center, University of Pittsburgh; H. Lundbeck A/S; National Institute of Mental Health; Valeant Pharmaceuticals International; Pfizer; University of Pittsburgh; Random House; GlaxoSmithKline; Eli Lilly and Company","keywords":"Venlafaxine; Citalopram; Body mass index; Fluoxetine; Overweight; Paroxetine; Depression (economics); Obesity; Moderation; Psychology; Internal medicine; Reuptake inhibitor; Medicine; Psychiatry; Antidepressant; Serotonin","score_opus":0.022159149410011198,"score_gpt":0.3178506902871567,"score_spread":0.2956915408771455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028842872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983701,0.0008237632,0.00008531428,0.00017211422,0.0000074982067,0.000011952804,0.00010351449,0.0000023118657,0.00042337851],"genre_scores_gemma":[0.9993303,0.0002693245,0.00013089464,0.00003589192,0.0000075046023,0.000013730421,0.0001156401,0.0000012542143,0.000095543895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99934536,0.00034051744,0.00005783126,0.00006683187,0.00013869282,0.00005082201],"domain_scores_gemma":[0.9976901,0.00077557843,0.0011044679,0.00007003683,0.00016989802,0.00018990369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001289577,0.00016545325,0.0002742972,0.0003064598,0.00020323544,0.00030731002,0.00016803076,0.0002495628,0.0013873734],"category_scores_gemma":[0.0049819243,0.00012252074,0.00027157113,0.000419325,0.0001421266,0.00021269661,0.00028875205,0.00069688016,0.00013996547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043601813,0.00015864635,0.99176073,0.000033902586,0.00012319011,0.000026388107,0.00009179732,0.0000469823,0.00023338123,0.000019304072,0.00007061271,0.006999128],"study_design_scores_gemma":[0.000018505954,0.00019697823,0.99937564,0.000013078359,0.000040336232,0.000055621334,0.00004841373,0.00012293101,0.00004793099,0.000020062233,0.000059373888,0.0000012262377],"about_ca_topic_score_codex":0.0011039564,"about_ca_topic_score_gemma":0.0020862808,"teacher_disagreement_score":0.0013873734,"about_ca_system_score_codex":0.00017465238,"about_ca_system_score_gemma":0.00017904076,"threshold_uncertainty_score":0.006820023},"labels":[],"label_agreement":null},{"id":"W2031279085","doi":"10.1089/cap.2007.0121","title":"Medication Effects on Symptoms of Attention-Deficit/Hyperactivity Disorder in Children with Fetal Alcohol Spectrum Disorder","year":2007,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Prenatal Substance Exposure Effects","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"South Health Campus; University of Toronto; University of Calgary","funders":"Canadian Institutes of Health Research; Health Research Board","keywords":"Impulsivity; Attention deficit hyperactivity disorder; Psychiatry; Population; Placebo; Psychology; Attention deficit; Clinical psychology; Medical record; Pediatrics; Medicine","score_opus":0.004201872689662348,"score_gpt":0.2738893730181872,"score_spread":0.2696875003285249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031279085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99801934,0.0013372764,0.000017009539,0.00007227376,0.0000060411894,0.0000109991015,0.00009769076,0.0000060323237,0.00043331043],"genre_scores_gemma":[0.9976941,0.0015169856,0.00029269344,0.000077443474,0.000013396655,0.000019676094,0.00020664222,0.00000268883,0.00017634923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992987,0.00031464046,0.00008481114,0.000050235714,0.00018981501,0.000061867046],"domain_scores_gemma":[0.99855584,0.00050624786,0.00062037545,0.000045681863,0.00011769452,0.00015411132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005250045,0.00021460907,0.0005806468,0.00040797837,0.00030781847,0.00022680039,0.00019810995,0.00027465206,0.0007706265],"category_scores_gemma":[0.0036089744,0.00013728366,0.00033600567,0.0003913189,0.00031602298,0.00020340834,0.00019178554,0.00042171116,0.00009258017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028539428,0.0011323275,0.89678353,0.00040107188,0.00042576212,0.0012020865,0.0007605481,0.0002107032,0.007850102,0.00004787234,0.00063953846,0.08769266],"study_design_scores_gemma":[0.000056454726,0.0019108327,0.99626535,0.000022920543,0.00007842949,0.0005867835,0.00014274637,0.000031357846,0.00059586775,0.000009778172,0.00029543907,0.0000039955253],"about_ca_topic_score_codex":0.0125508625,"about_ca_topic_score_gemma":0.038566113,"teacher_disagreement_score":0.0125508625,"about_ca_system_score_codex":0.00066699815,"about_ca_system_score_gemma":0.00057450053,"threshold_uncertainty_score":0.02495563},"labels":[],"label_agreement":null},{"id":"W2032713301","doi":"10.1089/cap.2007.0047","title":"Acute Dystonic Reaction in an Adolescent on Risperidone When a Concomitant Stimulant Medication is Discontinued","year":2007,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Risperidone; Stimulant; Concomitant; Dystonia; Regimen; Psychiatry; Medicine; Psychology; Anesthesia; Internal medicine; Schizophrenia (object-oriented programming)","score_opus":0.0187589057190461,"score_gpt":0.3587415697001004,"score_spread":0.3399826639810543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032713301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943704,0.0010342402,0.00045200973,0.00079964154,0.00007439807,0.000052452626,0.00004408142,0.000040467203,0.0031322956],"genre_scores_gemma":[0.99838305,0.00045979687,0.0002602666,0.00041685684,0.0000593406,0.000008928385,0.000022106207,0.0000051495244,0.0003844017],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998111,0.000042108364,0.000028610715,0.00003270801,0.00003673566,0.00004879851],"domain_scores_gemma":[0.9993648,0.00020944195,0.0001751387,0.000025282643,0.000032727537,0.00019266453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001693723,0.0004990097,0.00053420814,0.0005100629,0.00076898764,0.0003809838,0.00026311487,0.0017358599,0.00095113],"category_scores_gemma":[0.0015041985,0.00033359157,0.00048531473,0.00023663662,0.00054844207,0.0003955725,0.00034135947,0.0018819888,0.0002544117],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036519766,0.00019368662,0.049019508,0.00007503026,0.00003969716,0.9340394,0.0010116323,0.00014090812,0.009341871,0.00017795511,0.00042678547,0.005168292],"study_design_scores_gemma":[0.00010970753,0.0023036073,0.14940675,0.00004486525,0.00010227028,0.8410969,0.00067869184,0.0006579233,0.0039897547,0.000099945595,0.0014788148,0.000030754523],"about_ca_topic_score_codex":0.0030091829,"about_ca_topic_score_gemma":0.006845797,"teacher_disagreement_score":0.0030091829,"about_ca_system_score_codex":0.0007420675,"about_ca_system_score_gemma":0.0003005367,"threshold_uncertainty_score":0.005983293},"labels":[],"label_agreement":null},{"id":"W2035277845","doi":"10.1089/104454601317261546","title":"Diagnosis and Measurement of Adolescent Depression: A Review of Commonly Utilized Instruments","year":2001,"lang":"en","type":"review","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Child and Adolescent Psychosocial and Emotional Development","field":"Psychology","cited_by":167,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Strengths and weaknesses; Depression (economics); Clinical psychology; Reliability (semiconductor); Psychology; Depressive symptoms; Psychiatry; Medicine; Anxiety","score_opus":0.06319308395512349,"score_gpt":0.3714598139898184,"score_spread":0.30826673003469496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035277845","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045887817,0.99857616,0.00033093925,0.00025057315,0.000058412694,0.000031958127,0.000052684474,0.000007296355,0.00023313948],"genre_scores_gemma":[0.002713706,0.9954984,0.0014218924,0.00012598,0.000047809823,0.000065389555,0.00007119608,0.0000025697518,0.000053091262],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941948,0.0022268563,0.0016706934,0.0005154001,0.0012766302,0.000115561554],"domain_scores_gemma":[0.985405,0.010522965,0.0017506992,0.00023814129,0.001924686,0.000158502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009739456,0.0011696239,0.00351742,0.01040171,0.00043680528,0.0015124853,0.001912461,0.0009328302,0.001282791],"category_scores_gemma":[0.017595733,0.0006678623,0.0013020489,0.010646704,0.0009377912,0.002095922,0.00094311003,0.00118012,0.0005248617],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007744977,0.000046926725,0.003858315,0.043670006,0.00027167148,0.00012824815,0.00025630178,0.00012770637,0.00021007584,0.0005755738,0.0048462907,0.9459313],"study_design_scores_gemma":[0.00022732373,0.00078600936,0.101456776,0.3130013,0.004740656,0.007258435,0.0027866066,0.00084691937,0.0017551198,0.004423578,0.5625151,0.00020223972],"about_ca_topic_score_codex":0.004127095,"about_ca_topic_score_gemma":0.0064659338,"teacher_disagreement_score":0.01040171,"about_ca_system_score_codex":0.0014231734,"about_ca_system_score_gemma":0.0033310917,"threshold_uncertainty_score":0.05150777},"labels":[],"label_agreement":null},{"id":"W2036618705","doi":"10.1089/104454602760219153","title":"Screening for Adolescent Depression: Comparison of the Kutcher Adolescent Depression Scale with the Beck Depression Inventory","year":2002,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Child and Adolescent Psychosocial and Emotional Development","field":"Psychology","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint Mary's University; St. Mary's University; Dalhousie University","funders":"","keywords":"Beck Depression Inventory; Major depressive episode; Receiver operating characteristic; Depression (economics); Psychology; Mini-international neuropsychiatric interview; Psychometrics; Psychiatry; Clinical psychology; Medicine; Internal medicine; Anxiety","score_opus":0.032803107080846286,"score_gpt":0.317094860035461,"score_spread":0.28429175295461473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036618705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995552,0.0012866643,0.00093284843,0.00015479758,0.000050205213,0.00014195639,0.0003791523,0.000023087823,0.0014792237],"genre_scores_gemma":[0.99319893,0.0009445259,0.0044937064,0.00008271362,0.00004120341,0.000175963,0.0007613387,0.0000066639614,0.00029496287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99641114,0.002019126,0.00040487558,0.00020100815,0.0008413173,0.00012248305],"domain_scores_gemma":[0.99485993,0.002631271,0.0010901099,0.00020203005,0.0008597363,0.000356978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046440056,0.0003124463,0.00048300257,0.0016927641,0.0001414885,0.0003908363,0.00041266278,0.00036768892,0.0006997428],"category_scores_gemma":[0.011038353,0.0002462427,0.0004415386,0.00073779654,0.00017442339,0.0006033013,0.0005231899,0.0006067239,0.00016974157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007762021,0.00023257002,0.9564648,0.000067011344,0.00022447477,0.00004575803,0.00017542855,0.00014276679,0.00036003822,0.00006324354,0.00048315714,0.040964477],"study_design_scores_gemma":[0.0001139108,0.0011903541,0.9962767,0.000028807011,0.00008637181,0.00037659926,0.00014806386,0.0011384527,0.00015762114,0.000043122378,0.00043084132,0.000009048075],"about_ca_topic_score_codex":0.0021281485,"about_ca_topic_score_gemma":0.0052442267,"teacher_disagreement_score":0.0046440056,"about_ca_system_score_codex":0.00029529113,"about_ca_system_score_gemma":0.00035769233,"threshold_uncertainty_score":0.024560153},"labels":[],"label_agreement":null},{"id":"W2039102859","doi":"10.1089/cap.2007.0071","title":"Comorbidity Moderates Response to Methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)","year":2007,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institute of Mental Health","keywords":"Methylphenidate; Placebo; Moderation; Psychology; Attention deficit hyperactivity disorder; Comorbidity; Randomized controlled trial; Clinical psychology; Psychiatry; Medicine; Internal medicine","score_opus":0.02613862642283634,"score_gpt":0.35959585379474435,"score_spread":0.333457227371908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039102859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988663,0.0006478368,0.000026938833,0.000047223337,0.000009230299,0.000037766855,0.00019252546,0.000004788265,0.00016725482],"genre_scores_gemma":[0.99899703,0.00022679273,0.00018212537,0.000033138593,0.000017432762,0.00003414888,0.000355483,0.0000019152926,0.00015213559],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911314,0.00049738924,0.000075875025,0.000119837074,0.00012703755,0.000066709814],"domain_scores_gemma":[0.99871683,0.00034359036,0.00063100795,0.000067515866,0.00007979734,0.00016131718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014718908,0.00043565588,0.0007210369,0.00022318536,0.0003571075,0.00041825307,0.00027098405,0.00045515684,0.0017113156],"category_scores_gemma":[0.0029978456,0.00031722587,0.0007267718,0.00034943342,0.00021999827,0.00021803616,0.0003808077,0.00056636886,0.00009371408],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05673606,0.0013851122,0.91532314,0.000330615,0.0027140032,0.00014600423,0.00023496735,0.00020700785,0.0040231138,0.000059459613,0.00060960045,0.01823097],"study_design_scores_gemma":[0.0010315247,0.0029180995,0.9948861,0.000016045407,0.0005329757,0.00006357373,0.00004184687,0.00013683556,0.00020393613,0.000019353809,0.0001461523,0.0000035823286],"about_ca_topic_score_codex":0.0058767046,"about_ca_topic_score_gemma":0.01189642,"teacher_disagreement_score":0.0058767046,"about_ca_system_score_codex":0.00048257204,"about_ca_system_score_gemma":0.0006767417,"threshold_uncertainty_score":0.011684954},"labels":[],"label_agreement":null},{"id":"W2039303946","doi":"10.1089/104454602760386932","title":"A Retrospective Assessment of Citalopram in Children and Adolescents with Pervasive Developmental Disorders","year":2002,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Autism Spectrum Disorder Research","field":"Neuroscience","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Citalopram; Tics; Adverse effect; Anxiety; Psychology; Population; Psychiatry; Aggression; Pervasive developmental disorder; Pediatrics; Autism; Medicine; Clinical psychology; Internal medicine; Developmental disorder; Antidepressant","score_opus":0.010901145619563683,"score_gpt":0.29296089264242203,"score_spread":0.28205974702285835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039303946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99895006,0.00050100917,0.000053144977,0.000027536933,0.0000045329057,0.000013740624,0.000076079195,0.000004067039,0.00036986783],"genre_scores_gemma":[0.9990163,0.0004932758,0.00013163015,0.000060864662,0.000012126608,0.00001758404,0.00015688845,0.0000025399777,0.00010870745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999419,0.000084677,0.000096103075,0.000104670085,0.0002004745,0.000095087125],"domain_scores_gemma":[0.99850464,0.00029880053,0.00064226356,0.00007622789,0.00019501278,0.00028311755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030028264,0.0003439498,0.0004284512,0.0011352332,0.0005148474,0.00046268714,0.00026818327,0.00047024668,0.000606117],"category_scores_gemma":[0.0018453917,0.00034547923,0.00044624176,0.0007447522,0.00043066195,0.0003130238,0.0004411318,0.000768628,0.0001644308],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047785285,0.000047473277,0.99220157,0.000017802955,0.000016473854,0.0043826457,0.00026038912,0.00001764037,0.00037510053,0.000012402971,0.000064650645,0.0025559745],"study_design_scores_gemma":[0.000009194237,0.00043052825,0.96537334,0.000009657659,0.00004046333,0.03273267,0.00050887186,0.000056460176,0.00024242667,0.000011438606,0.0005780719,0.0000068332024],"about_ca_topic_score_codex":0.0045089857,"about_ca_topic_score_gemma":0.00574291,"teacher_disagreement_score":0.0045089857,"about_ca_system_score_codex":0.0005443741,"about_ca_system_score_gemma":0.0005866256,"threshold_uncertainty_score":0.008965433},"labels":[],"label_agreement":null},{"id":"W2039773663","doi":"10.1089/cap.2011.0009","title":"Preliminary Findings Regarding Proinflammatory Markers and Brain-Derived Neurotrophic Factor Among Adolescents with Bipolar Spectrum Disorders","year":2011,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Institute of Mental Health; U.S. Public Health Service","keywords":"Proinflammatory cytokine; Bipolar disorder; Brain-derived neurotrophic factor; Neurotrophic factors; Mood; Internal medicine; Interleukin 6; Psychology; Spectrum disorder; Mood disorders; Interleukin; Medicine; Clinical psychology; Oncology; Psychiatry; Endocrinology; Inflammation; Cytokine; Anxiety","score_opus":0.008886516125171719,"score_gpt":0.23787937918898686,"score_spread":0.22899286306381514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039773663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994462,0.0002550104,0.000024328403,0.000039562172,0.000003812148,0.0000039317333,0.000053346448,7.419464e-7,0.0001730368],"genre_scores_gemma":[0.9996338,0.00013591982,0.00005459194,0.000026312422,0.00000638942,0.0000051010124,0.000067789704,4.621423e-7,0.000069640875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981457,0.000054202475,0.000025284859,0.000025521695,0.00004961557,0.00003084467],"domain_scores_gemma":[0.9991743,0.00017741915,0.00034446447,0.000022189759,0.00011233952,0.00016925466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003420574,0.00020980586,0.0001803835,0.00040027534,0.00028899495,0.0003149492,0.00008440521,0.00024333633,0.0008986442],"category_scores_gemma":[0.0015393735,0.00014610018,0.00015278334,0.0002815913,0.00016373864,0.00015795624,0.0001373828,0.00040038102,0.00011906297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080618556,0.000038737653,0.997841,0.000008553233,0.000014413834,0.00006704062,0.0001075929,0.000009948339,0.00046917333,0.000005202066,0.000034116198,0.0013235749],"study_design_scores_gemma":[0.0000035140965,0.00010610981,0.9994578,0.0000044393632,0.000012522485,0.00015226498,0.00011457439,0.000022500528,0.000069328584,0.0000064954215,0.000049792703,7.1935034e-7],"about_ca_topic_score_codex":0.00296244,"about_ca_topic_score_gemma":0.0078082425,"teacher_disagreement_score":0.00296244,"about_ca_system_score_codex":0.00014449157,"about_ca_system_score_gemma":0.00016270413,"threshold_uncertainty_score":0.0058903694},"labels":[],"label_agreement":null},{"id":"W2042514742","doi":"10.1089/cap.2010.0131","title":"Olanzapine Use for the Adjunctive Treatment of Adolescents with Anorexia Nervosa","year":2011,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Eating Disorders and Behaviors","field":"Psychology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Carleton University; Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Olanzapine; Anorexia nervosa; Comorbidity; Medicine; Psychiatry; Retrospective cohort study; Propensity score matching; Adjunctive treatment; Pediatrics; Eating disorders; Psychology; Schizophrenia (object-oriented programming); Internal medicine","score_opus":0.04013208379144207,"score_gpt":0.3187582064809389,"score_spread":0.2786261226894968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042514742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999358,0.00037951916,0.00001609753,0.00002057981,0.0000028450327,0.000011555384,0.000058342466,0.0000012847239,0.00015178355],"genre_scores_gemma":[0.999342,0.00035055447,0.0000974056,0.000022291952,0.0000045807187,0.0000097453585,0.00010511496,6.089014e-7,0.000067626715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997998,0.000050845312,0.00003100317,0.00002452335,0.00006519696,0.000028716728],"domain_scores_gemma":[0.999356,0.00009256185,0.00042166517,0.00000966593,0.00004453045,0.000075680466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024197916,0.00013979794,0.00031807716,0.00030770936,0.0002791247,0.00028420615,0.00016602565,0.00018805689,0.0006279959],"category_scores_gemma":[0.0011034438,0.000090774694,0.00025219805,0.0003123474,0.000116271374,0.00015432452,0.00014306356,0.00027689507,0.00006931378],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004552877,0.00017778088,0.9888819,0.000056619167,0.000043985434,0.00067899766,0.00015545101,0.000028639504,0.0011915622,0.000013509908,0.0000927085,0.008223582],"study_design_scores_gemma":[0.000029168878,0.0008517135,0.99617684,0.000030673764,0.000048397545,0.0018323673,0.00034494203,0.00009561572,0.00025651642,0.0000072143253,0.00032402665,0.0000024603628],"about_ca_topic_score_codex":0.0035780866,"about_ca_topic_score_gemma":0.009569621,"teacher_disagreement_score":0.0035780866,"about_ca_system_score_codex":0.0003826943,"about_ca_system_score_gemma":0.00052400836,"threshold_uncertainty_score":0.0071145296},"labels":[],"label_agreement":null},{"id":"W2045245723","doi":"10.1089/cap.2006.16.621","title":"AProspective, Open-Label Trial of Galantamine in Autistic Disorder","year":2006,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Autism Spectrum Disorder Research","field":"Neuroscience","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Health Research Board","keywords":"Childhood Autism Rating Scale; Galantamine; Irritability; Autism; Psychology; Rating scale; Psychiatry; Clinical psychology; Autism spectrum disorder; Medicine; Internal medicine; Cognition; Developmental psychology","score_opus":0.025504095747442744,"score_gpt":0.3521093817053368,"score_spread":0.32660528595789406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045245723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958984,0.0013428987,0.00021879662,0.0001493376,0.000082417486,0.0011843638,0.00029168642,0.00006155554,0.00077044434],"genre_scores_gemma":[0.99258363,0.0010958283,0.0012729068,0.0005188182,0.00021352102,0.0022438485,0.0008453953,0.000018939701,0.0012070981],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992888,0.0003726436,0.000073766445,0.000092485214,0.00006912041,0.00010317973],"domain_scores_gemma":[0.999049,0.00030298147,0.00017227282,0.00009591426,0.00005760338,0.00032208505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012299881,0.0015024572,0.0021300297,0.0004663166,0.0005578854,0.00073349103,0.00118345,0.001800897,0.0030148863],"category_scores_gemma":[0.0013470722,0.00048096638,0.0008667005,0.0003548419,0.0015975822,0.0007371928,0.00047298113,0.0025720594,0.0006358069],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8698351,0.050552234,0.0034065354,0.0009292044,0.00071127294,0.00034718716,0.00030897142,0.00048738092,0.021565547,0.00010200171,0.0008703149,0.050884295],"study_design_scores_gemma":[0.62958807,0.35861042,0.0076407925,0.000039129933,0.00015112654,0.00027707656,0.00006865763,0.000392679,0.0021787006,0.00006884955,0.00096305273,0.00002140664],"about_ca_topic_score_codex":0.0010975144,"about_ca_topic_score_gemma":0.0025286025,"teacher_disagreement_score":0.0030148863,"about_ca_system_score_codex":0.0007685027,"about_ca_system_score_gemma":0.0010243171,"threshold_uncertainty_score":0.010085821},"labels":[],"label_agreement":null},{"id":"W2046461248","doi":"10.1089/cap.2009.0110","title":"Executive Function Deficits in Children with Attention-Deficit/Hyperactivity Disorder and Improvement with Lisdexamfetamine Dimesylate in an Open-Label Study","year":2010,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Cilag; Medical Research Council; H. Lundbeck A/S; Purdue Pharma; Supernus Pharmaceuticals; Neurocrine Biosciences; Jazz Pharmaceuticals; Purdue University; GlaxoSmithKline; Hospital for Sick Children; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb; University of Ottawa; Sanofi; UCB Pharma; Abbott Laboratories","keywords":"Irritability; Attention deficit hyperactivity disorder; Rating scale; Psychology; Psychiatry; Adverse effect; Akathisia; Stimulant; Medicine; Internal medicine; Anxiety; Schizophrenia (object-oriented programming); Antipsychotic; Developmental psychology","score_opus":0.016075222187868294,"score_gpt":0.3232579390044564,"score_spread":0.3071827168165881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046461248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971474,0.0015882482,0.00011844454,0.000045092977,0.000018007157,0.00040290022,0.00035934118,0.000017818016,0.00030290298],"genre_scores_gemma":[0.9955414,0.0014187347,0.00073028187,0.00017845402,0.00008596452,0.0006401249,0.000987922,0.0000061963024,0.00041099166],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99937195,0.00023455614,0.000088846304,0.00009737295,0.00014756282,0.000059666334],"domain_scores_gemma":[0.9985892,0.00030128073,0.00055931293,0.00009396795,0.00016384223,0.0002924338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014446052,0.000825912,0.0020278157,0.0003971807,0.00033491114,0.000328268,0.00044747812,0.0006509645,0.0012968453],"category_scores_gemma":[0.0013141412,0.00024512372,0.0010490337,0.00039498697,0.00041999668,0.00043353374,0.00022977755,0.001124375,0.00024848655],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44872242,0.08403687,0.24566968,0.0024921496,0.004773571,0.0010713835,0.0006987477,0.0008893234,0.030217426,0.0000840534,0.0016393807,0.17970507],"study_design_scores_gemma":[0.14565346,0.35478625,0.48830822,0.00012573057,0.001510833,0.0010580433,0.00013977093,0.0010071275,0.004602449,0.000050041886,0.0027114907,0.000046623223],"about_ca_topic_score_codex":0.0014577709,"about_ca_topic_score_gemma":0.0034004513,"teacher_disagreement_score":0.0020278157,"about_ca_system_score_codex":0.00065122725,"about_ca_system_score_gemma":0.0007196019,"threshold_uncertainty_score":0.007639885},"labels":[],"label_agreement":null},{"id":"W2046723760","doi":"10.1089/10445460152595540","title":"Methylphenidate Selectively Improves Story Retelling in Children with Attention Deficit Hyperactivity Disorder","year":2001,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Health Canada","keywords":"Methylphenidate; Psychology; Stimulant; Attention deficit hyperactivity disorder; Comprehension; Grammar; Narrative; Placebo; Clinical psychology; Developmental psychology; Psychiatry; Medicine; Linguistics","score_opus":0.013458064024164995,"score_gpt":0.3036448383958802,"score_spread":0.2901867743717152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046723760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99917656,0.00043613813,0.00005496584,0.00003740328,0.000005658889,0.000013115719,0.000047036705,0.000011687288,0.00021743082],"genre_scores_gemma":[0.99774915,0.0009858934,0.0006911953,0.000047189467,0.000009730623,0.000029335359,0.00018100045,0.0000054331445,0.00030107322],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9998079,0.000063170235,0.000024234003,0.000024164723,0.000054215816,0.000026387876],"domain_scores_gemma":[0.99952877,0.00017315062,0.00016663296,0.00002215825,0.0000355748,0.000073694144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022790418,0.00034068828,0.00043702667,0.00013362894,0.0001839071,0.00017353901,0.00023108964,0.00024424304,0.001259849],"category_scores_gemma":[0.0021326463,0.00014236587,0.00020037766,0.000101295744,0.00019411354,0.00019501608,0.00022996121,0.00037138685,0.00016700194],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03976198,0.0104624275,0.20676643,0.0023204952,0.0015013411,0.0039881025,0.0045772204,0.000985519,0.33979434,0.0001880546,0.0022448348,0.38740933],"study_design_scores_gemma":[0.0031646288,0.04335209,0.8759573,0.00016295076,0.0010521058,0.004826378,0.0014616218,0.0010971285,0.06348193,0.0002077429,0.0052048536,0.00003133567],"about_ca_topic_score_codex":0.0021943634,"about_ca_topic_score_gemma":0.005427785,"teacher_disagreement_score":0.0021943634,"about_ca_system_score_codex":0.00018193606,"about_ca_system_score_gemma":0.00026388714,"threshold_uncertainty_score":0.0043631196},"labels":[],"label_agreement":null},{"id":"W2050018284","doi":"10.1089/104454602760386897","title":"Treatment of Mood Lability and Explosive Rage with Minerals and Vitamins: Two Case Studies in Children","year":2002,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Obsessive-Compulsive Spectrum Disorders","field":"Psychology","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"Health Research Board","keywords":"Mood; Lability; Psychology; Rage (emotion); Micronutrient; CBCL; Lithium (medication); Psychiatry; Medicine; Chemistry","score_opus":0.022051338285512805,"score_gpt":0.3398213016256732,"score_spread":0.3177699633401604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050018284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878913,0.0033207098,0.0012549564,0.0010403735,0.00014258882,0.00030519397,0.00016814501,0.00004492759,0.0058317105],"genre_scores_gemma":[0.98948026,0.00414653,0.0026492844,0.0006233212,0.00016903995,0.00013156523,0.00011882483,0.000039252038,0.0026419838],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9988079,0.00022122396,0.00017444901,0.00017028152,0.00026040143,0.0003657789],"domain_scores_gemma":[0.9985629,0.00044300916,0.00039869855,0.00007837883,0.00010137191,0.0004157271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005464686,0.0020223756,0.0014351767,0.0014132182,0.00328623,0.001291655,0.0013421457,0.003749312,0.0013818567],"category_scores_gemma":[0.0037903232,0.0010608895,0.0017063202,0.0012408616,0.002173188,0.00085747486,0.001115238,0.0036567873,0.0004239585],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025929778,0.0011628708,0.0565371,0.0003742963,0.00011513468,0.9217587,0.006529291,0.0003375383,0.0015873677,0.0009854615,0.0008713965,0.009481661],"study_design_scores_gemma":[0.00009677706,0.00091931585,0.026726695,0.00008915776,0.00009703639,0.96538705,0.0019162124,0.00017999683,0.001621432,0.00014412384,0.0027904469,0.000031831314],"about_ca_topic_score_codex":0.013270142,"about_ca_topic_score_gemma":0.019093107,"teacher_disagreement_score":0.013270142,"about_ca_system_score_codex":0.0026319942,"about_ca_system_score_gemma":0.0014261153,"threshold_uncertainty_score":0.026385784},"labels":[],"label_agreement":null},{"id":"W2051678629","doi":"10.1089/cap.2009.0011","title":"Micronutrients Versus Standard Medication Management in Autism: A Naturalistic Case–Control Study","year":2010,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Autism Spectrum Disorder Research","field":"Neuroscience","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"South Health Campus; University of Manitoba; University of Saskatchewan; University of Calgary","funders":"Health Canada; Alberta Children's Hospital Foundation; Children's Hospital Foundation","keywords":"Micronutrient; Irritability; Childhood Autism Rating Scale; Autism; Pill; Autism spectrum disorder; Aggression; Mood; Rating scale; Psychology; Adverse effect; Medicine; Pervasive developmental disorder; Psychiatry; Pediatrics; Internal medicine; Developmental psychology; Cognition; Pharmacology","score_opus":0.015286338662763537,"score_gpt":0.34495218383213544,"score_spread":0.3296658451693719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051678629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993906,0.00023873922,0.00006160948,0.000015033742,0.0000054409934,0.000049121845,0.000025977786,0.0000027456947,0.00021079616],"genre_scores_gemma":[0.999172,0.0001771648,0.00023831557,0.000037560458,0.000022069833,0.0000935882,0.000087150554,0.000002110175,0.00017018657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983335,0.0006506754,0.00015467178,0.00044969856,0.00028134388,0.00013004079],"domain_scores_gemma":[0.9985833,0.0005699213,0.00035852936,0.00015745644,0.00013963378,0.00019108021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012630876,0.00061218604,0.0009701299,0.0012559263,0.0016391994,0.00073430134,0.0008193674,0.001150432,0.0018918782],"category_scores_gemma":[0.0031734973,0.00059126894,0.0007165929,0.00070772565,0.0010821074,0.00044574414,0.0007301039,0.00056517223,0.00024860314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010151732,0.010550284,0.94927937,0.00034484445,0.00077106693,0.009230009,0.002217805,0.00011390057,0.0056028417,0.0003614144,0.00048403195,0.010892823],"study_design_scores_gemma":[0.0016396648,0.017946715,0.96001357,0.000051074203,0.0003833456,0.015725393,0.0015205923,0.0010738882,0.00042383437,0.00017861738,0.0009892787,0.00005406295],"about_ca_topic_score_codex":0.005959673,"about_ca_topic_score_gemma":0.0058108843,"teacher_disagreement_score":0.005959673,"about_ca_system_score_codex":0.0008197918,"about_ca_system_score_gemma":0.00041487598,"threshold_uncertainty_score":0.01184994},"labels":[],"label_agreement":null},{"id":"W2051988290","doi":"10.1089/cap.2009.0107","title":"Childhood Stimulant Treatment and Teen Depression: Is There a Relationship?","year":2010,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"","keywords":"Stimulant; Depression (economics); Psychology; Psychiatry; Clinical psychology; Medicine","score_opus":0.02041025338208161,"score_gpt":0.33992206971771466,"score_spread":0.319511816335633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051988290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9712272,0.021342713,0.00012202835,0.004046015,0.000061262814,0.000016103479,0.00016524846,0.0000104513665,0.0030089435],"genre_scores_gemma":[0.9924905,0.006322972,0.00015099559,0.00037546566,0.00011202724,0.000010482141,0.00010155663,0.0000036809674,0.0004323523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995191,0.00019504454,0.000036501988,0.00007190914,0.0000972553,0.000080270715],"domain_scores_gemma":[0.9957724,0.0015760899,0.0017297426,0.00010284744,0.00018692466,0.00063186605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007674504,0.00017212555,0.00035043276,0.00065896334,0.00034426257,0.00095363765,0.00045554878,0.0013130821,0.0055842665],"category_scores_gemma":[0.004447991,0.00027982815,0.0003970791,0.00087799935,0.00048474624,0.0006782735,0.0003749743,0.0009360531,0.0002578933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011469387,0.000079779275,0.994175,0.00002856318,0.00008607542,0.0001611841,0.00010901353,0.000011099217,0.000080035024,0.000098736135,0.00011286015,0.0049429997],"study_design_scores_gemma":[0.000009696036,0.000119086035,0.99870324,0.000051442614,0.00005596668,0.0003712285,0.00025187925,0.000057719964,0.000022807959,0.000090513495,0.00026391307,0.0000023811199],"about_ca_topic_score_codex":0.0046631284,"about_ca_topic_score_gemma":0.0091118375,"teacher_disagreement_score":0.0055842665,"about_ca_system_score_codex":0.00036762372,"about_ca_system_score_gemma":0.00040518155,"threshold_uncertainty_score":0.018681228},"labels":[],"label_agreement":null},{"id":"W2056089333","doi":"10.1089/cap.2000.10.39","title":"Adverse Response to Methylphenidate in Combination with Valproic Acid","year":2000,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Hospital for Sick Children","keywords":"Methylphenidate; Valproic Acid; Adverse effect; Attention deficit hyperactivity disorder; Epilepsy; Medicine; Dyskinesia; Psychiatry; Pediatrics; Pharmacology; Anesthesia; Internal medicine","score_opus":0.010594268516763304,"score_gpt":0.31382838758048626,"score_spread":0.30323411906372294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056089333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897626,0.003101306,0.0012214431,0.00060332555,0.00012454827,0.00019699025,0.00019487171,0.00007522789,0.004719716],"genre_scores_gemma":[0.99702364,0.0009641321,0.00049481675,0.0005239866,0.000076793345,0.000031474327,0.00014182295,0.000017337241,0.00072607945],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9987161,0.00050424325,0.0001851309,0.00012822641,0.00037000363,0.000096331045],"domain_scores_gemma":[0.9974031,0.0010834117,0.0006693976,0.0001416352,0.0003779962,0.00032444808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068191125,0.0007032459,0.0009877519,0.0003639301,0.00078307936,0.00030512485,0.00034373358,0.0010450433,0.0008513327],"category_scores_gemma":[0.005682813,0.00024513892,0.0007544981,0.0003594103,0.00037056126,0.00027482124,0.00033252058,0.0012641196,0.00022361714],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011966121,0.0017010358,0.4415294,0.0011579961,0.0018082211,0.32021758,0.0013547445,0.0015042658,0.08065525,0.0003539412,0.0029844614,0.134767],"study_design_scores_gemma":[0.0007622836,0.026530309,0.46931577,0.00017708224,0.0012556886,0.4352376,0.00047998055,0.0021991194,0.050038215,0.00028075842,0.013634717,0.00008845373],"about_ca_topic_score_codex":0.0023263488,"about_ca_topic_score_gemma":0.0049529653,"teacher_disagreement_score":0.0023263488,"about_ca_system_score_codex":0.00066745246,"about_ca_system_score_gemma":0.0004228736,"threshold_uncertainty_score":0.004842758},"labels":[],"label_agreement":null},{"id":"W205612426","doi":"10.1089/cap.2014.0014","title":"Treatment Receipt and Outcomes from a Clinic Employing the Attention-Deficit/Hyperactivity Disorder Treatment Guideline of the Children's Medication Algorithm Project","year":2014,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Atomoxetine; Methylphenidate; Attention deficit hyperactivity disorder; Guideline; Medicine; Dosing; Psychiatry; Stimulant; Atomoxetine hydrochloride; Medical prescription; Pediatrics; Internal medicine","score_opus":0.025009224807571867,"score_gpt":0.3577263945893565,"score_spread":0.33271716978178467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W205612426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99260545,0.0003454727,0.000074014526,0.00050618063,0.000022201055,0.000080615624,0.004923444,0.000012104671,0.0014305038],"genre_scores_gemma":[0.9948743,0.00021662202,0.00018565205,0.00014086027,0.000023949773,0.00009844807,0.004033216,0.000010596658,0.0004162978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995552,0.0008809411,0.00055949535,0.000652977,0.0014933213,0.00086125336],"domain_scores_gemma":[0.9838886,0.0014184454,0.0104823215,0.00029705587,0.0020722186,0.0018413063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015310817,0.00023474405,0.00047207775,0.0013015418,0.0011891791,0.0012396825,0.0009951972,0.00056822266,0.0031711962],"category_scores_gemma":[0.013229705,0.00030225416,0.00083360955,0.0027706125,0.00037650848,0.00083801977,0.0014627491,0.0016091649,0.00023377065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011173166,0.00009836118,0.995479,0.000040867537,0.00007822863,0.000029746912,0.00017014523,0.00006338235,0.000028737317,0.000026415424,0.0009885787,0.0028848078],"study_design_scores_gemma":[0.000014787492,0.000061465245,0.9993375,0.000025266216,0.000023715322,0.000044876353,0.00021395554,0.00006986766,0.000019240102,0.000006472621,0.00017981896,0.000003042183],"about_ca_topic_score_codex":0.22084332,"about_ca_topic_score_gemma":0.28393906,"teacher_disagreement_score":0.22084332,"about_ca_system_score_codex":0.0043897326,"about_ca_system_score_gemma":0.004428538,"threshold_uncertainty_score":0.4391157},"labels":[],"label_agreement":null},{"id":"W2056943186","doi":"10.1089/104454603322572688","title":"Diagnosis and Measurement of Anxiety Disorder in Adolescents: A Review of Commonly Used Instruments","year":2003,"lang":"en","type":"review","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Child and Adolescent Psychosocial and Emotional Development","field":"Psychology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Anxiety; Concordance; Clinical psychology; Medical diagnosis; Psychology; Psychiatry; Specific phobia; Strengths and weaknesses; Self-report study; Anxiety disorder; Depression (economics); Validity; Psychometrics; Medicine","score_opus":0.039126340529006015,"score_gpt":0.3463450284235302,"score_spread":0.3072186878945242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056943186","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025008622,0.998825,0.0002889738,0.00018533306,0.000066435896,0.00003630817,0.000049335573,0.00000830716,0.00029023874],"genre_scores_gemma":[0.0014135654,0.9970606,0.0011932807,0.000102440776,0.000056802448,0.000059576443,0.000051992,0.000001984382,0.000059772843],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9963437,0.0011977879,0.0010325784,0.00036681138,0.000979591,0.000079410274],"domain_scores_gemma":[0.9931631,0.004804507,0.00084426533,0.000113254246,0.00097621494,0.00009871375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005282664,0.0011681458,0.0033574637,0.008632515,0.00038144898,0.001178571,0.0017767163,0.00096531207,0.0016346494],"category_scores_gemma":[0.0102627445,0.0004999728,0.001049436,0.007195603,0.00092571427,0.0016254917,0.0008331029,0.0011344666,0.00066598697],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058135418,0.00005174623,0.0015824661,0.045845244,0.00018150061,0.00012703091,0.00020310267,0.00012804005,0.00022932891,0.0006350649,0.007108457,0.9438499],"study_design_scores_gemma":[0.00022762241,0.0006414938,0.04871191,0.26507172,0.003336457,0.008350343,0.00198449,0.0006911134,0.0015020565,0.0056529306,0.6636471,0.00018288284],"about_ca_topic_score_codex":0.003786105,"about_ca_topic_score_gemma":0.004864404,"teacher_disagreement_score":0.008632515,"about_ca_system_score_codex":0.0009906008,"about_ca_system_score_gemma":0.0027724851,"threshold_uncertainty_score":0.02793777},"labels":[],"label_agreement":null},{"id":"W2057771075","doi":"10.1089/cap.2010.0104","title":"A Brief Motivational Intervention for Preventing Medication-Associated Weight Gain Among Youth with Bipolar Disorder: Treatment Development and Case Report","year":2011,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Institute of Mental Health; University of Pittsburgh","keywords":"Weight gain; Mood; Bipolar disorder; Psychiatry; Overweight; Intervention (counseling); Population; Obesity; Medicine; Psychology; Clinical psychology; Body weight; Internal medicine","score_opus":0.017960600671557834,"score_gpt":0.2821469754480726,"score_spread":0.26418637477651474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057771075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97094744,0.0017929418,0.0074266875,0.00583628,0.00026158933,0.004346424,0.00011210119,0.00021587555,0.0090606725],"genre_scores_gemma":[0.9410085,0.0048799557,0.04251391,0.002607251,0.00022787642,0.004348625,0.00017188306,0.00003644538,0.004205653],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99972576,0.000100717836,0.000020413383,0.00002597049,0.000044061253,0.00008305756],"domain_scores_gemma":[0.99982554,0.00005064588,0.000021625276,0.000006453606,0.000009935875,0.00008589632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040989928,0.00056697003,0.00034239725,0.00047449706,0.0015950478,0.0002496918,0.0006388507,0.0015506336,0.0013475188],"category_scores_gemma":[0.0012492418,0.00028360932,0.00047101584,0.00019370753,0.00047116316,0.00026497376,0.000844677,0.001344115,0.00021364419],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012433721,0.084550515,0.04474711,0.0014662679,0.00011282419,0.17244796,0.010655248,0.0019073414,0.017548738,0.0048231627,0.01740528,0.64309216],"study_design_scores_gemma":[0.008345348,0.12223109,0.27073675,0.0021570215,0.00071266654,0.41209632,0.016219677,0.028937964,0.029281827,0.0069874506,0.10186345,0.00043039687],"about_ca_topic_score_codex":0.0029404827,"about_ca_topic_score_gemma":0.0073343576,"teacher_disagreement_score":0.0029404827,"about_ca_system_score_codex":0.0006293881,"about_ca_system_score_gemma":0.0010790593,"threshold_uncertainty_score":0.005846739},"labels":[],"label_agreement":null},{"id":"W2058316338","doi":"10.1089/cap.2007.0039","title":"Cognitive and Behavioral Effects of Multilayer-Release Methylphenidate in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder","year":2007,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada); York University; University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Methylphenidate; Placebo; Attention deficit hyperactivity disorder; Crossover study; Psychology; Cognition; Adverse effect; Randomized controlled trial; Medicine; Pediatrics; Psychiatry; Internal medicine","score_opus":0.016887771446841462,"score_gpt":0.35169128466904515,"score_spread":0.3348035132222037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058316338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965773,0.0027452172,0.00009375029,0.00005648479,0.00002805763,0.000090561465,0.00007529765,0.000017616385,0.00031563963],"genre_scores_gemma":[0.9960383,0.0021446382,0.0010282062,0.00014352663,0.00006721463,0.00010807272,0.00015572242,0.000004233648,0.00030996758],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997795,0.00008237909,0.000030540963,0.0000306315,0.00005635124,0.000020558902],"domain_scores_gemma":[0.9996159,0.00011029286,0.00015371744,0.000014688698,0.000023729914,0.00008170531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044320492,0.0004354996,0.00084858434,0.00013635152,0.00014178874,0.00020168204,0.0003337608,0.0003527892,0.0010718349],"category_scores_gemma":[0.0008559802,0.00015775154,0.00032034103,0.0001239486,0.00022117901,0.00017893956,0.0001623217,0.00073817704,0.0001182065],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37089193,0.028983649,0.044472516,0.004687668,0.003147687,0.00074621406,0.00052745343,0.001298582,0.10337048,0.00011761268,0.0013290106,0.44042724],"study_design_scores_gemma":[0.12179961,0.47158352,0.3777277,0.0002905969,0.0021488213,0.0020322795,0.00027560076,0.0016070438,0.018358987,0.00007087392,0.0040559336,0.00004893969],"about_ca_topic_score_codex":0.0012094744,"about_ca_topic_score_gemma":0.0027829583,"teacher_disagreement_score":0.0012094744,"about_ca_system_score_codex":0.00020551734,"about_ca_system_score_gemma":0.00029830777,"threshold_uncertainty_score":0.0035856366},"labels":[],"label_agreement":null},{"id":"W2059029409","doi":"10.1089/cap.2014.0044","title":"Therapeutic Drug Levels of Second Generation Antipsychotics in Youth: A Systematic Review","year":2015,"lang":"en","type":"review","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Olanzapine; Quetiapine; Risperidone; Aripiprazole; Medicine; Clozapine; Antipsychotic; Psychiatry; Population; Atypical antipsychotic; Drug; Therapeutic drug monitoring; Schizophrenia (object-oriented programming); Pediatrics","score_opus":0.09869687209182448,"score_gpt":0.40886145746294744,"score_spread":0.31016458537112296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059029409","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00088345207,0.9985677,0.000036555575,0.00006415459,0.00003193011,0.00006512406,0.00021108004,0.0000030141878,0.00013698378],"genre_scores_gemma":[0.009896264,0.989361,0.00020347853,0.0001763205,0.00003723654,0.00013070127,0.00014706077,0.000001968549,0.000045896963],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99661154,0.0007787003,0.0014584732,0.00031264283,0.00072419987,0.00011444287],"domain_scores_gemma":[0.98536545,0.009863181,0.0032726163,0.00012816336,0.0012061147,0.00016453928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031245174,0.0010126097,0.0058116145,0.007688077,0.00036619557,0.0018040902,0.0012254448,0.0013079091,0.0032233638],"category_scores_gemma":[0.015249953,0.00068779907,0.0059022154,0.009034933,0.0005296564,0.0015891802,0.0009511567,0.0007467025,0.00022361413],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023354859,0.000015933974,0.0013344523,0.9501787,0.0058998545,0.00011332933,0.00014504239,0.00006878388,0.00012007326,0.00013404943,0.0012151686,0.040541112],"study_design_scores_gemma":[0.00026392858,0.00030836844,0.010508912,0.8941129,0.07033113,0.0009449618,0.00036788482,0.000100336714,0.00021366903,0.00021030084,0.022593105,0.00004451043],"about_ca_topic_score_codex":0.006118981,"about_ca_topic_score_gemma":0.015585082,"teacher_disagreement_score":0.007688077,"about_ca_system_score_codex":0.002162505,"about_ca_system_score_gemma":0.006278063,"threshold_uncertainty_score":0.016524255},"labels":[],"label_agreement":null},{"id":"W2060334009","doi":"10.1089/cap.2007.0068","title":"Methylphenidate Effects on Functional Outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)","year":2007,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institute of Mental Health","keywords":"Methylphenidate; Psychology; Attention deficit hyperactivity disorder; Placebo; Rating scale; Clinical psychology; Clinical Global Impression; Randomized controlled trial; Social skills; Psychiatry; Medicine; Developmental psychology; Internal medicine","score_opus":0.020024573996137524,"score_gpt":0.3375230742147151,"score_spread":0.3174985002185776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060334009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99721825,0.0016490191,0.000029273342,0.00006960124,0.000018465584,0.00014347318,0.00055679004,0.000010696756,0.000304411],"genre_scores_gemma":[0.9968099,0.0011613817,0.00030700825,0.00008411465,0.000031204272,0.00019405766,0.0008107097,0.000002528328,0.00059905055],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997662,0.00008296639,0.000030099543,0.00003595778,0.000050793005,0.000033984743],"domain_scores_gemma":[0.99972934,0.000040565923,0.00009968711,0.000017942079,0.000037688867,0.00007483406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054449396,0.00048054475,0.00094656285,0.00021605591,0.00036342375,0.0002306527,0.00030248938,0.00046291764,0.0018366938],"category_scores_gemma":[0.00063148834,0.00019091016,0.00044961023,0.0002446136,0.00020433519,0.00016262519,0.00023468002,0.00063923624,0.0001300431],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45708302,0.017332425,0.23115765,0.0023987857,0.0047728033,0.0007053235,0.0004018264,0.00066648953,0.04556027,0.0000812007,0.0039025953,0.23593757],"study_design_scores_gemma":[0.04153694,0.09281478,0.85876375,0.00010653843,0.0014347495,0.00046444338,0.0001108248,0.0002931035,0.0029031686,0.000042458156,0.0015128624,0.000016335502],"about_ca_topic_score_codex":0.005188418,"about_ca_topic_score_gemma":0.014186811,"teacher_disagreement_score":0.005188418,"about_ca_system_score_codex":0.000442048,"about_ca_system_score_gemma":0.0006082777,"threshold_uncertainty_score":0.0103164315},"labels":[],"label_agreement":null},{"id":"W2061413929","doi":"10.1089/cap.2006.0008","title":"Striatal Creatine and Glutamate/Glutamine in Attention-Deficit/Hyperactivity Disorder","year":2007,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Institute of Mental Health; Canadian Institutes of Health Research; National Institutes of Health; Research Nova Scotia","keywords":"Glutamine; Glutamate receptor; Attention deficit hyperactivity disorder; Creatine; Psychology; Attention deficit disorder; Neuroscience; Attention deficit; Psychiatry; Medicine; Internal medicine; Biochemistry; Chemistry; Amino acid","score_opus":0.013952708440076443,"score_gpt":0.32630905674065863,"score_spread":0.3123563483005822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061413929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993493,0.00043021722,0.000022814356,0.000021016247,0.000001209885,0.0000028222485,0.000026320868,0.0000022680886,0.00014417345],"genre_scores_gemma":[0.99949896,0.00018757928,0.00011051759,0.000014699927,0.0000017408523,0.0000027894323,0.00004111922,0.000001143816,0.000141285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99992156,0.000021617681,0.0000066547627,0.000015837886,0.000019711375,0.000014689533],"domain_scores_gemma":[0.9998067,0.000028129602,0.00010405726,0.000004145671,0.000023387922,0.000033689146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019527136,0.0002828176,0.00021732612,0.0005187431,0.00026710896,0.00026667054,0.00017577708,0.00034385239,0.0014982241],"category_scores_gemma":[0.0005400798,0.00018923558,0.00007457187,0.00024064542,0.00027437907,0.00012178552,0.00018518037,0.00021199328,0.00007947648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033144397,0.0004487134,0.91735965,0.00019902083,0.00018992927,0.0022398706,0.00044094818,0.0003236358,0.057028215,0.00008448403,0.00021846301,0.018152662],"study_design_scores_gemma":[0.000059306014,0.0004336323,0.9941281,0.000012187555,0.00005690158,0.002190465,0.00019172826,0.0002137185,0.002490623,0.000040908093,0.00017924533,0.0000031892894],"about_ca_topic_score_codex":0.007150039,"about_ca_topic_score_gemma":0.015405105,"teacher_disagreement_score":0.007150039,"about_ca_system_score_codex":0.00045487296,"about_ca_system_score_gemma":0.0002144573,"threshold_uncertainty_score":0.0142169},"labels":[],"label_agreement":null},{"id":"W2062940857","doi":"10.1089/cap.2010.0122","title":"Missed Diagnosis of Tardive Dystonia in an Adolescent Girl Treated with Risperidone","year":2011,"lang":"en","type":"letter","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Risperidone; Girl; Medicine; Pediatrics; Psychiatry; Dystonia; Child and adolescent psychiatry; Psychology; Schizophrenia (object-oriented programming); Developmental psychology","score_opus":0.022218968809667457,"score_gpt":0.28863706031654107,"score_spread":0.2664180915068736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062940857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88341403,0.004564183,0.0012740396,0.084658355,0.002567703,0.00016540174,0.0005503376,0.00019367729,0.0226123],"genre_scores_gemma":[0.98145723,0.0015405276,0.0012433525,0.010342203,0.0026663037,0.0000322632,0.00014306177,0.000051466057,0.002523687],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99924904,0.000096641445,0.00012974425,0.00018359204,0.00014528671,0.00019568784],"domain_scores_gemma":[0.9969709,0.0013809561,0.0005767138,0.00007706439,0.00026230904,0.00073194236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036223713,0.0011759553,0.0012893743,0.0014516127,0.0026569006,0.0010282936,0.0014564125,0.0080365855,0.0025948985],"category_scores_gemma":[0.006702774,0.0008965779,0.0012153161,0.00079533533,0.0012586657,0.001669208,0.00083757384,0.005800728,0.00057874003],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056934427,0.00003699364,0.012075235,0.0000250541,0.000008033035,0.98500997,0.00012102512,0.000083461906,0.00027508923,0.0001715412,0.0012720597,0.0008645564],"study_design_scores_gemma":[0.00004253269,0.00017155164,0.018174252,0.00008342051,0.000034530487,0.9783384,0.0003346346,0.0010099685,0.00029673567,0.00030362137,0.0011879511,0.000022366798],"about_ca_topic_score_codex":0.011654549,"about_ca_topic_score_gemma":0.017028699,"teacher_disagreement_score":0.011654549,"about_ca_system_score_codex":0.0027885162,"about_ca_system_score_gemma":0.001489538,"threshold_uncertainty_score":0.023173451},"labels":[],"label_agreement":null},{"id":"W2068167367","doi":"10.1089/104454604773840553","title":"Improved Mood and Behavior During Treatment with a Mineral-Vitamin Supplement: An Open-Label Case Series of Children","year":2004,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Lethbridge; University of Alberta; University of Calgary","funders":"","keywords":"CBCL; Young Mania Rating Scale; Mood; Irritability; Psychiatry; Randomized controlled trial; Mood swing; Child Behavior Checklist; Psychology; Mania; Clinical psychology; Medicine; Bipolar disorder; Anxiety; Internal medicine","score_opus":0.013061465976110704,"score_gpt":0.30685676785588584,"score_spread":0.29379530187977515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068167367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99640226,0.0010869707,0.0003668092,0.00038380848,0.000053738226,0.00020587437,0.00007050364,0.000013224343,0.0014168564],"genre_scores_gemma":[0.99627256,0.0013361241,0.0009065564,0.00037130548,0.000078058605,0.00020183975,0.00009632987,0.000011101419,0.0007261167],"study_design_codex":"case_report","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99910647,0.0002615596,0.00013993937,0.00014333446,0.00015574484,0.00019288422],"domain_scores_gemma":[0.99895215,0.0004436193,0.00025429972,0.000078163896,0.00007078235,0.00020105408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051046396,0.00076583505,0.0011880774,0.00055004144,0.0025868644,0.00087748875,0.0005763513,0.0023574177,0.0008758824],"category_scores_gemma":[0.003434887,0.0004371379,0.0010121602,0.0006499171,0.0016443375,0.0005291432,0.00056394265,0.0019877506,0.00027081126],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004534701,0.008312001,0.25596365,0.0007103101,0.0003255287,0.6676035,0.00820279,0.00043013928,0.0065597356,0.00079526607,0.0018393557,0.04472303],"study_design_scores_gemma":[0.0015953426,0.01848222,0.113277204,0.00016470937,0.00030828625,0.8509165,0.0027654192,0.000587521,0.0058996337,0.00023086647,0.0056938487,0.000078468474],"about_ca_topic_score_codex":0.0045594107,"about_ca_topic_score_gemma":0.00823132,"teacher_disagreement_score":0.0045594107,"about_ca_system_score_codex":0.0017893618,"about_ca_system_score_gemma":0.0010043872,"threshold_uncertainty_score":0.012982786},"labels":[],"label_agreement":null},{"id":"W2068295874","doi":"10.1089/cap.2010.0011","title":"Age-Dependent Metabolic Effects of Second-Generation Antipsychotics in Second-Generation Antipsychotic-Naïve French Canadian Patients","year":2010,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cégep de Lévis","funders":"Purdue Pharma; Eli Lilly and Company","keywords":"Body mass index; Medicine; Triglyceride; Weight gain; Internal medicine; Antipsychotic; Population; Endocrinology; High-density lipoprotein; Metabolic syndrome; Young adult; Cholesterol; Obesity; Body weight; Schizophrenia (object-oriented programming); Psychiatry","score_opus":0.010987297763370494,"score_gpt":0.2862765194932708,"score_spread":0.27528922172990034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068295874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99872464,0.00050704274,0.000020967147,0.000049064587,0.0000030762906,0.000008351497,0.00022479746,0.0000023968573,0.0004597303],"genre_scores_gemma":[0.99914825,0.00033989063,0.000072399474,0.000033290722,0.000004464537,0.000004815581,0.00029088807,9.140942e-7,0.00010517078],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997086,0.00002897063,0.000018493874,0.000049430946,0.00009601063,0.00009845914],"domain_scores_gemma":[0.9993375,0.000063550164,0.0002917712,0.000019504248,0.0001590248,0.00012863993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003843573,0.00032857206,0.00029120038,0.000737488,0.0011784357,0.00039743943,0.0003126173,0.00033728144,0.00090075907],"category_scores_gemma":[0.0011826971,0.0001539311,0.0003902657,0.0010900161,0.0003128794,0.00017029665,0.00022260156,0.00031827495,0.00008737176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021903423,0.00002598568,0.9944882,0.000017326976,0.00002703697,0.0003052603,0.00024961494,0.0000555809,0.0003253507,0.000026591284,0.0001780043,0.0040820166],"study_design_scores_gemma":[0.000006259248,0.00004837102,0.99900925,0.000008141564,0.000015545465,0.00040207175,0.0001757779,0.00006639303,0.00004078593,0.000008920628,0.00021353572,0.0000048428556],"about_ca_topic_score_codex":0.7101873,"about_ca_topic_score_gemma":0.8046099,"teacher_disagreement_score":0.7101873,"about_ca_system_score_codex":0.00561537,"about_ca_system_score_gemma":0.0034701135,"threshold_uncertainty_score":0.58303887},"labels":[],"label_agreement":null},{"id":"W2071693787","doi":"10.1089/cap.2006.0013","title":"Metyrosine in Psychosis Associated with 22q11.2 Deletion Syndrome: Case Report","year":2007,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Congenital heart defects research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Psychosis; Psychiatry; Antipsychotic; Schizophrenia (object-oriented programming); Mood; Abnormality; Psychology; Deletion syndrome; Medicine; Phenotype; Genetics","score_opus":0.009130736638870684,"score_gpt":0.31239053982384024,"score_spread":0.30325980318496953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071693787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98854315,0.0029591918,0.002061868,0.0012795393,0.00011576101,0.00011441366,0.00010799996,0.00009602573,0.0047221165],"genre_scores_gemma":[0.99709845,0.00079499616,0.0009928202,0.00022728926,0.00019103642,0.000014918701,0.000029544917,0.000010500562,0.0006405104],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995828,0.000046317367,0.000040462157,0.00010253189,0.00006816561,0.00015969673],"domain_scores_gemma":[0.9992285,0.00020475106,0.00022224626,0.000051791,0.000038881702,0.0002538609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023169105,0.0017670299,0.00072504196,0.0016200521,0.0025025203,0.0011582628,0.00078323204,0.0032059494,0.0018904634],"category_scores_gemma":[0.0014508484,0.0010495511,0.00080262107,0.0008818683,0.0014722393,0.0009730717,0.001603189,0.0017904728,0.00046219278],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019575224,0.000021187818,0.0038202943,0.000017879744,0.000005445676,0.9941245,0.00019246255,0.000042662577,0.0008299093,0.0000966287,0.00007480507,0.0007546353],"study_design_scores_gemma":[0.0000064487253,0.000031982334,0.0015361554,0.0000038937237,0.000008852026,0.997666,0.00006449288,0.00007917659,0.00034667054,0.000052985175,0.00019872484,0.0000046478112],"about_ca_topic_score_codex":0.003998335,"about_ca_topic_score_gemma":0.004667603,"teacher_disagreement_score":0.003998335,"about_ca_system_score_codex":0.00080991065,"about_ca_system_score_gemma":0.0007722743,"threshold_uncertainty_score":0.007950127},"labels":[],"label_agreement":null},{"id":"W2077942320","doi":"10.1089/cap.2005.15.655","title":"Child and Adolescent Suicides in Virginia: 1987 to 2003","year":2005,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Suicide and Self-Harm Studies","field":"Psychology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Office of the Chief Medical Examiner","funders":"","keywords":"Suicide prevention; Medical examiner; Poison control; Suicide methods; Psychiatry; Injury prevention; Medicine; Occupational safety and health; Human factors and ergonomics; Medical emergency; Suicide rates","score_opus":0.014507592779327318,"score_gpt":0.3227113757142974,"score_spread":0.3082037829349701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077942320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894883,0.001175272,0.00007358477,0.00024934963,0.000027632766,0.000037723796,0.0073137367,0.0000122056945,0.0016221848],"genre_scores_gemma":[0.98603904,0.0024303836,0.0002678512,0.00021087054,0.000035064306,0.0000645338,0.009862548,0.000007890511,0.001081866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999564,0.00007649142,0.00007779282,0.00005198513,0.00012099579,0.0001087628],"domain_scores_gemma":[0.99818796,0.00013156867,0.0009428223,0.00003907081,0.0005391301,0.00015939801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040627652,0.00014051817,0.00024588188,0.0019911977,0.00048941234,0.0007040553,0.0004547366,0.00033173308,0.0007527195],"category_scores_gemma":[0.0024152144,0.00019810637,0.00029017855,0.001766463,0.00014979069,0.0003570222,0.00053213217,0.00065221416,0.00021978274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027449534,0.000018877236,0.9941579,0.000028109487,0.00002576504,0.00013930189,0.00038803244,0.000024004827,0.000036730482,0.000024733614,0.0013937007,0.003735334],"study_design_scores_gemma":[0.0000020753114,0.000016601456,0.99734324,0.00003977794,0.000009465532,0.00028939915,0.00055466074,0.000031537184,0.000056109962,0.0000063523125,0.001649048,0.0000018345082],"about_ca_topic_score_codex":0.17051941,"about_ca_topic_score_gemma":0.35867473,"teacher_disagreement_score":0.17051941,"about_ca_system_score_codex":0.002175026,"about_ca_system_score_gemma":0.0016370937,"threshold_uncertainty_score":0.33905375},"labels":[],"label_agreement":null},{"id":"W2079668835","doi":"10.1089/cap.2010.0052","title":"Treatment of Catatonia with Electroconvulsive Therapy in Adolescents","year":2012,"lang":"en","type":"letter","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Electroconvulsive Therapy Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Children's & Women's Health Centre of British Columbia","funders":"","keywords":"Catatonia; Electroconvulsive therapy; Psychiatry; Lorazepam; Psychology; Child and adolescent psychiatry; Medicine; Schizophrenia (object-oriented programming)","score_opus":0.012640811450898475,"score_gpt":0.299959950575507,"score_spread":0.28731913912460855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079668835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65908945,0.07452778,0.00068537745,0.2128149,0.0062893983,0.00027881144,0.00026239073,0.00005122176,0.046000585],"genre_scores_gemma":[0.9006256,0.023930497,0.0007778113,0.064840056,0.0048486046,0.00015984876,0.000108202104,0.000011491923,0.0046977866],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9994679,0.00021131789,0.00009560317,0.000029779078,0.00012612305,0.00006930648],"domain_scores_gemma":[0.99819523,0.0010080441,0.00033354532,0.000030147781,0.00012304276,0.00031005454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054027315,0.00027777103,0.00072848453,0.00040230723,0.0007032704,0.00044139428,0.000466183,0.003998052,0.0011252268],"category_scores_gemma":[0.003890112,0.00016999734,0.00053783745,0.00037626395,0.00056174665,0.00048582358,0.00026739587,0.0021774843,0.0002229716],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021942535,0.0015506494,0.17545387,0.0024398933,0.00043814688,0.56379735,0.0014178505,0.0004000181,0.005206486,0.005534701,0.06349106,0.17807569],"study_design_scores_gemma":[0.0038572473,0.0043105767,0.26442358,0.0022868947,0.0005453405,0.60684276,0.001912557,0.0009413051,0.0024250292,0.0021625245,0.1102123,0.000079983234],"about_ca_topic_score_codex":0.0028790254,"about_ca_topic_score_gemma":0.011061176,"teacher_disagreement_score":0.003998052,"about_ca_system_score_codex":0.0011376537,"about_ca_system_score_gemma":0.0011929923,"threshold_uncertainty_score":0.008254349},"labels":[],"label_agreement":null},{"id":"W2081415145","doi":"10.1089/cap.2008.0133","title":"Dopamine Transporter Genotype and Stimulant Side Effect Factors in Youth Diagnosed with Attention-Deficit/Hyperactivity Disorder","year":2009,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Douglas Mental Health University Institute","funders":"National Institute of Mental Health; U.S. Public Health Service; Brain Research Foundation","keywords":"Stimulant; Methylphenidate; Placebo; Attention deficit hyperactivity disorder; Dopamine transporter; Psychology; Genotype; Psychiatry; Medicine; Internal medicine; Dopamine; Dopaminergic; Genetics","score_opus":0.012535714498940925,"score_gpt":0.29556086684966276,"score_spread":0.28302515235072184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081415145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999645,0.00014881288,0.0000111854315,0.000017829085,0.0000031271495,0.0000049071477,0.000080117155,0.0000017677445,0.00008733621],"genre_scores_gemma":[0.9994554,0.00012740823,0.000056511184,0.000021944126,0.000007171092,0.000008738374,0.00023290633,0.0000013268476,0.00008866191],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999561,0.00013444276,0.000047700683,0.00006245876,0.00012158768,0.00007282939],"domain_scores_gemma":[0.9986247,0.00028632703,0.00066498533,0.00004010734,0.000088162764,0.00029567644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058685266,0.0003552794,0.00052498525,0.0007260453,0.0004017768,0.0004936885,0.00027118667,0.00050275464,0.0011631288],"category_scores_gemma":[0.0021379346,0.00036479256,0.00037243578,0.0006823423,0.0002449791,0.00022842326,0.0002776789,0.0006588296,0.00016789733],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014188015,0.00006519635,0.9988213,0.0000048087236,0.000018302257,0.00010801634,0.000050234175,0.0000112581265,0.00015436737,0.0000033369179,0.000026568114,0.00059464027],"study_design_scores_gemma":[0.000007512009,0.00011653377,0.99947923,0.0000027297083,0.000012823441,0.00022237816,0.00006974355,0.00003735439,0.000023783918,0.0000038712483,0.00002308008,0.0000010468667],"about_ca_topic_score_codex":0.009129406,"about_ca_topic_score_gemma":0.015303422,"teacher_disagreement_score":0.009129406,"about_ca_system_score_codex":0.0004768821,"about_ca_system_score_gemma":0.0003652589,"threshold_uncertainty_score":0.018152535},"labels":[],"label_agreement":null},{"id":"W2084189391","doi":"10.1089/cap.2012.0086","title":"Attention-Deficit/Hyperactivity Disorder Drugs and Growth: An Italian Prospective Observational Study","year":2013,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Agenzia Italiana del Farmaco, Ministero della Salute; York University","keywords":"Observational study; Attention deficit hyperactivity disorder; Psychiatry; Medicine; Psychology; Internal medicine","score_opus":0.030813270365320635,"score_gpt":0.34300397873183136,"score_spread":0.31219070836651075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084189391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99811906,0.000659078,0.000053262454,0.00004023188,0.000005305351,0.00004576996,0.00055734854,0.000004358269,0.0005153977],"genre_scores_gemma":[0.99785113,0.0005604354,0.00022022768,0.00006952397,0.000025654097,0.000073751,0.0009778898,0.0000047610156,0.00021660897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931276,0.00028019733,0.000048303602,0.00013164898,0.00013150205,0.00009558141],"domain_scores_gemma":[0.9980757,0.00036243568,0.0009781892,0.00018501167,0.00012094199,0.00027778602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009895199,0.000584595,0.0006267557,0.0008583798,0.00048020587,0.00053238275,0.0004505352,0.0005767945,0.0013525293],"category_scores_gemma":[0.0018551544,0.00035047217,0.0006893103,0.0011166177,0.00045852637,0.00030933917,0.00043197192,0.0006512251,0.00033595026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005581325,0.00030845765,0.9972717,0.00004232135,0.00009786879,0.00013696891,0.00008943867,0.000035060777,0.00022262355,0.000012886558,0.00013184977,0.0010926209],"study_design_scores_gemma":[0.000063194246,0.00071542495,0.9986639,0.000008223315,0.00004837293,0.00020191038,0.000047567195,0.000060368675,0.000025607356,0.000004867699,0.00015737578,0.0000031843392],"about_ca_topic_score_codex":0.013185817,"about_ca_topic_score_gemma":0.011013332,"teacher_disagreement_score":0.013185817,"about_ca_system_score_codex":0.00070050114,"about_ca_system_score_gemma":0.0007092928,"threshold_uncertainty_score":0.026218176},"labels":[],"label_agreement":null},{"id":"W2085942575","doi":"10.1089/cap.2008.0166","title":"Atomoxetine and Neuropsychological Function in Children With Attention-Deficit/Hyperactivity Disorder: Results of a Pilot Study","year":2009,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Eli Lilly (Canada)","funders":"AstraZeneca","keywords":"Atomoxetine; Attention deficit hyperactivity disorder; Neuropsychology; Atomoxetine hydrochloride; Psychology; Psychiatry; Clinical psychology; Medicine; Cognition; Methylphenidate","score_opus":0.01838352182241931,"score_gpt":0.31678307522100335,"score_spread":0.29839955339858404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085942575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992887,0.00034116642,0.000034177196,0.000029572733,0.0000035010328,0.00003840718,0.000111074354,0.000006317281,0.00014710486],"genre_scores_gemma":[0.99858284,0.0003120257,0.0002874181,0.00008620158,0.000011442076,0.00009522728,0.00038952733,0.0000033918682,0.00023184772],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991936,0.00033389867,0.00007518523,0.000096260985,0.00018192109,0.00011919918],"domain_scores_gemma":[0.99774855,0.00067784474,0.0007072461,0.00014730921,0.00031965115,0.0003995091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014555986,0.00047638576,0.0008863494,0.00042741201,0.00060586206,0.00045540556,0.0003621648,0.0005691862,0.0005731357],"category_scores_gemma":[0.0027068972,0.00029286003,0.0007160491,0.00040817462,0.00040109426,0.00047747343,0.0003165075,0.0008954041,0.00019050702],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008326127,0.006567726,0.9582927,0.00009685756,0.00040327676,0.00089366146,0.0010621225,0.0001039582,0.0032229575,0.000018732571,0.0002690229,0.020742776],"study_design_scores_gemma":[0.00044626908,0.01837266,0.978893,0.000012763863,0.00018343881,0.0006133044,0.00028154347,0.00012910631,0.00060958415,0.000013853021,0.0004332425,0.000011214345],"about_ca_topic_score_codex":0.0074709607,"about_ca_topic_score_gemma":0.013119241,"teacher_disagreement_score":0.0074709607,"about_ca_system_score_codex":0.00058179494,"about_ca_system_score_gemma":0.0007535919,"threshold_uncertainty_score":0.014854968},"labels":[],"label_agreement":null},{"id":"W2087760961","doi":"10.1089/cap.2008.0001","title":"Maintenance Study for Adolescent Depression","year":2008,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Child and Adolescent Psychosocial and Emotional Development","field":"Psychology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Johnson and Johnson; Canadian Institutes of Health Research; Dalhousie University; H. Lundbeck A/S; Eli Lilly and Company","keywords":"Depression (economics); Psychology; Psychiatry; Psychotherapist; Medicine; Clinical psychology","score_opus":0.02469849991787601,"score_gpt":0.3216926244934904,"score_spread":0.29699412457561436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087760961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45182654,0.3302667,0.0069084074,0.013049617,0.0073114648,0.071551405,0.09160373,0.00050079473,0.026981207],"genre_scores_gemma":[0.6923772,0.10789996,0.029593065,0.010930217,0.0038263053,0.09511579,0.034425877,0.00016581724,0.02566577],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9979019,0.0011584692,0.00024888405,0.00027242626,0.00033652503,0.0000818071],"domain_scores_gemma":[0.99818486,0.0003860543,0.00072303537,0.00014663188,0.00030347184,0.00025602945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004128099,0.000880462,0.0023256792,0.0005947656,0.00039191078,0.00083688303,0.00065615517,0.0008814743,0.007680583],"category_scores_gemma":[0.0045528556,0.000504416,0.002455914,0.00077615096,0.00019866097,0.00057116756,0.00062277843,0.0022293886,0.0010428597],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.47214735,0.0046702567,0.06508126,0.03747666,0.048202764,0.00052203285,0.00054328196,0.00059612055,0.008330263,0.0043541463,0.046045583,0.3120303],"study_design_scores_gemma":[0.7010496,0.026224451,0.17323725,0.0040262262,0.026380645,0.00058184844,0.00013019991,0.00054159865,0.0010253555,0.0014219693,0.065317966,0.000062830404],"about_ca_topic_score_codex":0.0010083263,"about_ca_topic_score_gemma":0.0019681999,"teacher_disagreement_score":0.007680583,"about_ca_system_score_codex":0.00060576736,"about_ca_system_score_gemma":0.0010513068,"threshold_uncertainty_score":0.025694132},"labels":[],"label_agreement":null},{"id":"W2089312344","doi":"10.1089/cap.2006.16.416","title":"Methylphenidate Blood Levels and Therapeutic Response in Children with Attention-Deficit Hyperactivity Disorder I. Effects of Different Dosing Regimens","year":2006,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Methylphenidate; Dosing; Attention deficit hyperactivity disorder; Medicine; Psychiatry; Psychology; Pharmacology","score_opus":0.010558661771258082,"score_gpt":0.29393750653118245,"score_spread":0.28337884475992436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089312344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993463,0.0003383468,0.00005145454,0.000015816686,0.000006596061,0.000029111045,0.00004767447,0.000010723571,0.00015403531],"genre_scores_gemma":[0.99903095,0.00032017587,0.00025168812,0.000037108002,0.00001453324,0.000054811793,0.00013722913,0.0000044268536,0.00014909696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925524,0.00029487893,0.000053916046,0.000074860305,0.00022956064,0.00009145392],"domain_scores_gemma":[0.9984713,0.00050704926,0.00063022797,0.00006290304,0.00009002756,0.00023848756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006017218,0.00046349716,0.0006514489,0.00032980042,0.00018487127,0.000278263,0.00025945864,0.00049162016,0.00079801213],"category_scores_gemma":[0.003349478,0.00031371394,0.00028424084,0.00027441018,0.00041142057,0.0003373023,0.0001905428,0.0009752863,0.00016590206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1809782,0.020965286,0.47667405,0.0008285943,0.0013375594,0.0012031454,0.0016304114,0.0018853782,0.11040021,0.000114034716,0.0012643147,0.20271882],"study_design_scores_gemma":[0.003072019,0.1098007,0.86803716,0.000032674427,0.00032809773,0.0010490901,0.00028092178,0.0010142018,0.015402335,0.000043510743,0.00090702984,0.000032193788],"about_ca_topic_score_codex":0.0011917346,"about_ca_topic_score_gemma":0.0011398238,"teacher_disagreement_score":0.0011917346,"about_ca_system_score_codex":0.00049713603,"about_ca_system_score_gemma":0.00025574953,"threshold_uncertainty_score":0.003606975},"labels":[],"label_agreement":null},{"id":"W2095239922","doi":"10.1089/cap.2005.15.293","title":"Open-Label Pilot Study of St. John's Wort in Adolescent Depression","year":2005,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Natural Compound Pharmacology Studies","field":"Agricultural and Biological Sciences","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Royal Ottawa Mental Health Centre; Children's Hospital of Eastern Ontario","funders":"","keywords":"Depression (economics); Medicine; Major depressive disorder; Antidepressant; Clinical trial; Adverse effect; Rating scale; Open label; Psychiatry; Internal medicine; Psychology; Anxiety; Mood","score_opus":0.051877948315897204,"score_gpt":0.34405156564901734,"score_spread":0.29217361733312014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095239922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970355,0.00048608793,0.00037762706,0.00008581598,0.00005530207,0.0013905676,0.0001926245,0.00002329809,0.00035325342],"genre_scores_gemma":[0.9948907,0.00069913856,0.0014393013,0.00019887973,0.00015186929,0.0016655196,0.00031210214,0.0000067530973,0.0006356945],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99926656,0.000442877,0.000065176355,0.000069836715,0.00007841865,0.0000771546],"domain_scores_gemma":[0.9987031,0.00044332433,0.00025659346,0.000110452755,0.00011164396,0.00037481354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016019944,0.0007808715,0.0015126012,0.00031733568,0.00037098804,0.00043633624,0.0006009306,0.00079677545,0.0029936444],"category_scores_gemma":[0.0013940731,0.000442686,0.00065524277,0.0002672427,0.00093251735,0.0006901612,0.00030514027,0.0021329212,0.0005737219],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5330507,0.23316154,0.015701247,0.001861938,0.0009667532,0.00074980734,0.0010764606,0.0012388072,0.08798904,0.0002527098,0.0013153687,0.12263565],"study_design_scores_gemma":[0.08272619,0.9027078,0.011471404,0.000025807693,0.00009272451,0.0001367845,0.00007286684,0.0004547121,0.0017183542,0.000035372086,0.00054685137,0.0000111273075],"about_ca_topic_score_codex":0.00055514224,"about_ca_topic_score_gemma":0.00095590536,"teacher_disagreement_score":0.0029936444,"about_ca_system_score_codex":0.00024851333,"about_ca_system_score_gemma":0.0007811662,"threshold_uncertainty_score":0.010014713},"labels":[],"label_agreement":null},{"id":"W2096183542","doi":"10.1089/cap.2010.0006","title":"Anxiety As a Predictor of Treatment Outcome in Children and Adolescents with Depression","year":2010,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Child and Adolescent Psychosocial and Emotional Development","field":"Psychology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto","funders":"Canadian Institutes of Health Research; National Institutes of Health; National Institute of Mental Health; Ontario Ministry of Health and Long-Term Care; Eli Lilly and Company","keywords":"Fluoxetine; Depression (economics); Internal medicine; Anxiety; Confidence interval; Placebo; Odds ratio; Logistic regression; Psychology; Major depressive disorder; Randomized controlled trial; Psychiatry; Medicine; Mood","score_opus":0.008049061599799073,"score_gpt":0.29196037316344875,"score_spread":0.2839113115636497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096183542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972186,0.0022109428,0.000043718785,0.00014689102,0.000009473686,0.000009823288,0.00019300358,0.0000017689179,0.00016576024],"genre_scores_gemma":[0.9989692,0.00056191557,0.00010384087,0.000037606555,0.000020342859,0.000017800761,0.00024421734,9.708016e-7,0.00004405407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887556,0.0006682564,0.00009210956,0.000110594316,0.00015915014,0.00009421442],"domain_scores_gemma":[0.9938699,0.0027551588,0.0026149394,0.00009008782,0.00022545992,0.00044445656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013973096,0.00027529462,0.00050030317,0.0003835012,0.00021934458,0.00050001906,0.00026856913,0.00050888263,0.0014087833],"category_scores_gemma":[0.0071155475,0.00017457346,0.0006959265,0.0005991531,0.00031684776,0.0002609912,0.0002549578,0.00079745875,0.000104747945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027577396,0.000028441576,0.9978352,0.000023611568,0.000101276884,0.000039808234,0.000022478936,0.000023190569,0.000021755875,0.0000068324193,0.000058495345,0.0015631064],"study_design_scores_gemma":[0.000054288903,0.00023878463,0.9989574,0.00002980747,0.00014876641,0.00021828138,0.00006652409,0.00016672477,0.000027820684,0.000014917252,0.000074585194,0.000002020302],"about_ca_topic_score_codex":0.002536485,"about_ca_topic_score_gemma":0.0033229901,"teacher_disagreement_score":0.002536485,"about_ca_system_score_codex":0.0002884791,"about_ca_system_score_gemma":0.0004187029,"threshold_uncertainty_score":0.007389784},"labels":[],"label_agreement":null},{"id":"W2103785967","doi":"10.1089/104454602762599844","title":"Methylphenidate Improves Stroop Naming Speed, But Not Response Interference, in Children with Attention Deficit Hyperactivity Disorder","year":2002,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Stroop effect; Methylphenidate; Psychology; Audiology; Attention deficit hyperactivity disorder; Crossover study; Placebo; Psychiatry; Cognition; Medicine","score_opus":0.020390071618136073,"score_gpt":0.30705203724662694,"score_spread":0.2866619656284909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103785967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99814343,0.001254429,0.00006511788,0.000089446105,0.00002809612,0.000044719534,0.000078095414,0.000017072667,0.00027952643],"genre_scores_gemma":[0.9964766,0.0017667945,0.00082025584,0.00016325848,0.000047323258,0.00009018767,0.00019869131,0.000007793656,0.00042908607],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997178,0.00009877059,0.000039981474,0.000030946896,0.00007812629,0.00003439946],"domain_scores_gemma":[0.99937975,0.00020736062,0.00023565057,0.000027642309,0.000053568074,0.00009601283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045647603,0.000697206,0.00090029655,0.00019557937,0.00023999489,0.00021111402,0.00035440645,0.0004876507,0.0015638571],"category_scores_gemma":[0.0021776047,0.0002503108,0.00036109763,0.00016932032,0.000274512,0.0003555115,0.00021578415,0.0007651782,0.00018833108],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18866988,0.03584887,0.16444169,0.0048128753,0.003962263,0.0019866284,0.0016541223,0.0010909823,0.21343194,0.00013353469,0.002496438,0.38147074],"study_design_scores_gemma":[0.0317989,0.16715494,0.75648254,0.00019610566,0.002345273,0.002498251,0.0004906437,0.00096559734,0.03472105,0.00014228075,0.0031645263,0.00003990703],"about_ca_topic_score_codex":0.0023623786,"about_ca_topic_score_gemma":0.0059409873,"teacher_disagreement_score":0.0023623786,"about_ca_system_score_codex":0.00025200238,"about_ca_system_score_gemma":0.00046993617,"threshold_uncertainty_score":0.005231619},"labels":[],"label_agreement":null},{"id":"W2106153986","doi":"10.1089/cap.2010.0145","title":"The Pharmacoepidemiology of Antipsychotic Medications for Canadian Children and Adolescents: 2005–2009","year":2011,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Risperidone; Antipsychotic; Medicine; Pharmacoepidemiology; Psychiatry; Aripiprazole; Drug; Pediatrics; Schizophrenia (object-oriented programming); Pharmacology; Medical prescription","score_opus":0.02820130598582011,"score_gpt":0.3398022989798355,"score_spread":0.3116009929940154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106153986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67513096,0.028706862,0.0006761202,0.0050047548,0.00023187438,0.00027774947,0.26485267,0.00018784888,0.024931163],"genre_scores_gemma":[0.93333817,0.015103337,0.0021024663,0.0012850979,0.00010095573,0.00010485648,0.045135885,0.000044077085,0.0027852461],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979845,0.000057627843,0.00015977124,0.0002102851,0.0012477469,0.00034004042],"domain_scores_gemma":[0.99563724,0.00012524678,0.0010597955,0.000052911077,0.0026839154,0.00044090734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079809316,0.00048603042,0.00049666327,0.004294294,0.001585482,0.0010797884,0.0013290023,0.00043614185,0.00261672],"category_scores_gemma":[0.004173765,0.00036031532,0.0010325403,0.009415782,0.00046244796,0.00045097285,0.00057416275,0.00080518005,0.00027392738],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001287899,0.000034577428,0.9498313,0.0006692681,0.00030164045,0.00019047443,0.0005037974,0.0004916482,0.00020766846,0.00036683062,0.022967236,0.024306936],"study_design_scores_gemma":[0.000010568845,0.000015084808,0.98874146,0.00015067332,0.00007892132,0.00017730781,0.0002793892,0.0002785461,0.00011572318,0.000013875561,0.010121238,0.00001726878],"about_ca_topic_score_codex":0.99702376,"about_ca_topic_score_gemma":0.99770445,"teacher_disagreement_score":0.04760325,"about_ca_system_score_codex":0.04760325,"about_ca_system_score_gemma":0.054396596,"threshold_uncertainty_score":0.34538734},"labels":[],"label_agreement":null},{"id":"W2115189358","doi":"10.1089/104454603322163844","title":"Response to Methylphenidate in Children with Attention Deficit Hyperactivity Disorder and Manic Symptoms in the Multimodal Treatment Study of Children with Attention Deficit Hyperactivity Disorder Titration Trial","year":2003,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital","funders":"University of Pittsburgh; National Institute of Mental Health; U.S. Department of Education; U.S. Department of Energy","keywords":"Methylphenidate; CBCL; Attention deficit hyperactivity disorder; Mania; Psychology; Child Behavior Checklist; Stimulant; Psychiatry; Bipolar disorder; Clinical psychology; Pediatrics; Cognition; Medicine","score_opus":0.015072679861860361,"score_gpt":0.3166408828051757,"score_spread":0.3015682029433154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115189358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967874,0.0017004869,0.00007450782,0.000234691,0.00002569101,0.00030442755,0.00044140618,0.000012084192,0.00041931824],"genre_scores_gemma":[0.9964144,0.00081417506,0.0005785894,0.00022840886,0.000049324764,0.0007766127,0.000796887,0.000005502341,0.00033603012],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99828655,0.0011289187,0.00012153738,0.00012757066,0.0002301187,0.00010524706],"domain_scores_gemma":[0.99820364,0.00046768726,0.0007697043,0.000091328846,0.00008855762,0.0003791914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027364618,0.00046862056,0.001350495,0.00022780751,0.00031345114,0.00045047552,0.00040944252,0.000760912,0.0015147792],"category_scores_gemma":[0.004687812,0.00025403115,0.00077547116,0.0002727968,0.0002868902,0.00039205633,0.00043189534,0.00139902,0.00015522433],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5480747,0.0085759,0.33207268,0.00133802,0.0053726146,0.00048826233,0.0006462188,0.00079978694,0.007587089,0.00024737525,0.0035140242,0.091283314],"study_design_scores_gemma":[0.258539,0.105298415,0.62761074,0.00029243538,0.0017287404,0.0006315617,0.00014712992,0.0014306206,0.0016332053,0.0001763057,0.0024684372,0.00004346374],"about_ca_topic_score_codex":0.0015206966,"about_ca_topic_score_gemma":0.0028533672,"teacher_disagreement_score":0.0027364618,"about_ca_system_score_codex":0.0005035616,"about_ca_system_score_gemma":0.0008003779,"threshold_uncertainty_score":0.014472008},"labels":[],"label_agreement":null},{"id":"W2120154366","doi":"10.1089/cap.2015.0099","title":"Nonmedical Use of Attention-Deficit/Hyperactivity Disorder Medication Among Secondary School Students in The Netherlands","year":2015,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Attention deficit hyperactivity disorder; Medical prescription; Psychiatry; Medicine; Self-medication; Attention deficit; Population; Family medicine; Clinical psychology; Psychology; Environmental health","score_opus":0.029353784862937434,"score_gpt":0.3525795419529242,"score_spread":0.32322575708998674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120154366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99833506,0.00040487607,0.000020968366,0.000083802464,0.000008009305,0.000014234677,0.00039380704,0.0000011913152,0.0007380714],"genre_scores_gemma":[0.9989097,0.0003243623,0.000039514474,0.00005327827,0.000006069313,0.000014672191,0.00027692266,0.0000017915088,0.00037369566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991629,0.00019215554,0.00013023363,0.00015066634,0.00023954178,0.00012457237],"domain_scores_gemma":[0.9988023,0.00017319532,0.00053445174,0.000022055377,0.00017424849,0.00029370654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066368375,0.00014706573,0.00038762816,0.0010534027,0.0004615843,0.0011211673,0.00037134349,0.00036218463,0.002401217],"category_scores_gemma":[0.0015518381,0.00026547874,0.0003930173,0.0011764718,0.00022580245,0.00044311793,0.0005413866,0.0003614839,0.00033146216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019081112,0.000081836166,0.9965044,0.000033155487,0.000024119061,0.00011336792,0.0004632843,0.000010140621,0.00010266679,0.000019394945,0.00022935109,0.0023991934],"study_design_scores_gemma":[0.0000056267563,0.000043612166,0.9981184,0.000025675827,0.000011177769,0.00010645644,0.0011907959,0.000059366925,0.0000377285,0.000009022411,0.0003899115,0.0000023352404],"about_ca_topic_score_codex":0.08069735,"about_ca_topic_score_gemma":0.15968452,"teacher_disagreement_score":0.08069735,"about_ca_system_score_codex":0.0010584712,"about_ca_system_score_gemma":0.0012094601,"threshold_uncertainty_score":0.16045529},"labels":[],"label_agreement":null},{"id":"W2130573803","doi":"10.1089/cap.2007.0076","title":"Effects of Source of DNA on Genotyping Success Rates and Allele Percentages in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)","year":2007,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institute of Mental Health","keywords":"Genotyping; Buccal swab; Genotype; Single-nucleotide polymorphism; Genetics; Allele; Attention deficit hyperactivity disorder; Polymorphism (computer science); Biology; SNP; Medicine; Gene; Psychiatry","score_opus":0.012231510600694486,"score_gpt":0.3254006162511317,"score_spread":0.3131691056504372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130573803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988097,0.00019776504,0.00037652496,0.0000707657,0.000006612789,0.00003348932,0.00018600165,0.000012219424,0.00030696392],"genre_scores_gemma":[0.99895656,0.00004967218,0.0005028127,0.00003928704,0.000007736157,0.000040492647,0.00017739639,0.000009268378,0.0002167036],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9872628,0.00859415,0.0007253814,0.001523605,0.001625922,0.00026821534],"domain_scores_gemma":[0.9591876,0.029452998,0.0065062847,0.0025796886,0.0015604751,0.00071291055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011149243,0.0003541999,0.00045729787,0.0006926004,0.00041059894,0.00044076945,0.000452648,0.00075906527,0.0018625063],"category_scores_gemma":[0.041344427,0.00035939642,0.0004452263,0.0005076404,0.00044341452,0.00038788636,0.0005796321,0.00058325066,0.00021307459],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005810423,0.00016166206,0.9763777,0.000050162063,0.0005911407,0.00040557198,0.0005739729,0.00024626832,0.0026737796,0.000034626468,0.00025300973,0.012821684],"study_design_scores_gemma":[0.00020490176,0.0027668916,0.9919844,0.000029498524,0.00044672468,0.0010651555,0.0002466435,0.0011299618,0.0017494307,0.000055314584,0.0003068246,0.000014230775],"about_ca_topic_score_codex":0.0013631202,"about_ca_topic_score_gemma":0.0019022967,"teacher_disagreement_score":0.011149243,"about_ca_system_score_codex":0.00017032736,"about_ca_system_score_gemma":0.00019037248,"threshold_uncertainty_score":0.058963537},"labels":[],"label_agreement":null},{"id":"W2163986455","doi":"10.1089/cap.2007.0075","title":"Clinical Presentation of Attention-Deficit/Hyperactivity Disorder in Preschool Children: The Preschoolers with Attention-Deficit/Hyperactivity Treatment Study (PATS)","year":2007,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":197,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institute of Mental Health","keywords":"Attention deficit hyperactivity disorder; Attention deficit; Psychology; Presentation (obstetrics); Attention deficit disorder; Psychiatry; Clinical psychology; Medicine","score_opus":0.024132765651075774,"score_gpt":0.3697576964797646,"score_spread":0.34562493082868884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163986455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984219,0.0003253282,0.00003911964,0.00006385214,0.000005555837,0.00012039176,0.00050948944,0.0000063171374,0.0005080784],"genre_scores_gemma":[0.9979279,0.00032781536,0.00030976642,0.000056556808,0.000008505844,0.00014113303,0.00088826875,0.0000023533828,0.00033758103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958664,0.000092068825,0.00008985316,0.00006980614,0.00008134629,0.00008023834],"domain_scores_gemma":[0.99940014,0.00010001284,0.00025628522,0.000016414011,0.000089935915,0.00013723323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006566791,0.0003370998,0.00041457074,0.0011776648,0.00093907025,0.00044670948,0.00037674938,0.00047434258,0.001631962],"category_scores_gemma":[0.0013276417,0.0002483352,0.00026556582,0.0007561471,0.00038199683,0.0004254674,0.0006000392,0.00052654155,0.00020486464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011049987,0.00012310632,0.9930173,0.00006956669,0.000014804881,0.0013778561,0.00096690183,0.000020982123,0.0007219563,0.000018507742,0.00042622854,0.0031322346],"study_design_scores_gemma":[0.000009632411,0.00016812165,0.9971564,0.000019179755,0.000006634423,0.0014247339,0.0009892482,0.000012414478,0.00006857924,0.000008448477,0.00013396544,0.000002683931],"about_ca_topic_score_codex":0.025228836,"about_ca_topic_score_gemma":0.06552466,"teacher_disagreement_score":0.025228836,"about_ca_system_score_codex":0.0012600039,"about_ca_system_score_gemma":0.0014250462,"threshold_uncertainty_score":0.050163984},"labels":[],"label_agreement":null},{"id":"W2197678865","doi":"10.1089/cap.2015.0132","title":"A Randomized Controlled Trial of Individual Family Psychoeducational Psychotherapy and Omega-3 Fatty Acids in Youth with Subsyndromal Bipolar Disorder","year":2015,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"National Center for Research Resources; National Institute of Mental Health","keywords":"Young Mania Rating Scale; Placebo; Mania; Psychology; Bipolar disorder; Bipolar I disorder; Depression (economics); Randomized controlled trial; Psychiatry; Psychoeducation; Schedule for Affective Disorders and Schizophrenia; Rating scale; Internal medicine; Clinical psychology; Medicine; Mood; Psychological intervention; Anxiety","score_opus":0.01843037034761244,"score_gpt":0.30712865531802697,"score_spread":0.2886982849704145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2197678865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9730954,0.0055432133,0.0010007415,0.0008310804,0.0013460929,0.014684523,0.00086417823,0.0002287002,0.0024060314],"genre_scores_gemma":[0.9665377,0.0031490747,0.0034069868,0.0011832371,0.00072447397,0.021154603,0.0004923879,0.00002346295,0.0033279862],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998889,0.0006535052,0.00010395353,0.00017508771,0.000059052305,0.000119424745],"domain_scores_gemma":[0.99854773,0.0004822142,0.0003013915,0.000098526274,0.000083386425,0.0004866344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018952037,0.0013199421,0.003154801,0.0005524984,0.0007181988,0.00078418496,0.0011075663,0.0018059829,0.012493252],"category_scores_gemma":[0.0025933946,0.0007990291,0.0013417847,0.00045629352,0.001212541,0.00094842014,0.00060324033,0.0024580376,0.00095197995],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9860723,0.005379224,0.00014435583,0.00044786037,0.00035657609,0.000018959669,0.000028624449,0.00007934692,0.00050072675,0.000043254204,0.0001975296,0.00673128],"study_design_scores_gemma":[0.97026426,0.028926458,0.0003086379,0.00002418654,0.000113824826,0.0000080919635,0.000011972611,0.00009101011,0.00006499041,0.000034951394,0.0001481755,0.0000034180011],"about_ca_topic_score_codex":0.0013999536,"about_ca_topic_score_gemma":0.0029537978,"teacher_disagreement_score":0.012493252,"about_ca_system_score_codex":0.0006864445,"about_ca_system_score_gemma":0.0015174992,"threshold_uncertainty_score":0.04179412},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2218827953","doi":"10.1089/cap.2015.0081","title":"An Alternative Approach to Scoring the MTA-SNAP-IV to Guide Attention-Deficit/Hyperactivity Disorder Medication Treatment Titration towards Symptom Remission: A Preliminary Consideration","year":2015,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Attention deficit hyperactivity disorder; Rating scale; Psychiatry; Psychology; Specialty; Clinical psychology; Pediatrics; Medicine; Developmental psychology","score_opus":0.04591147216231839,"score_gpt":0.37436830875142013,"score_spread":0.32845683658910174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2218827953","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33408377,0.008519406,0.59596866,0.017996585,0.0023074958,0.008879342,0.0039691925,0.0015824913,0.0266929],"genre_scores_gemma":[0.26661682,0.0021629801,0.7222295,0.0011283425,0.0002539112,0.0036732631,0.0012659327,0.00018616019,0.0024830662],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9613105,0.02322489,0.0053860075,0.0019090655,0.0076692346,0.000500408],"domain_scores_gemma":[0.9576009,0.015308503,0.004885995,0.0017885279,0.01972046,0.0006956499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04533398,0.0015435867,0.00146661,0.004540022,0.0009810457,0.0027111808,0.0034964818,0.0010816194,0.0029623047],"category_scores_gemma":[0.08514541,0.00052922766,0.0012463281,0.003988721,0.0010104068,0.0021378421,0.002155018,0.00263369,0.0010751899],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009506907,0.0007756563,0.39583004,0.001172503,0.0005422545,0.00036836573,0.0038953808,0.0026956059,0.0048146285,0.0054149926,0.026092933,0.55744696],"study_design_scores_gemma":[0.0008977379,0.0060209516,0.7828755,0.0048454297,0.0007127308,0.0047999895,0.012047859,0.091933444,0.007875804,0.009138288,0.07815408,0.0006981406],"about_ca_topic_score_codex":0.014600288,"about_ca_topic_score_gemma":0.06155485,"teacher_disagreement_score":0.04533398,"about_ca_system_score_codex":0.0020946774,"about_ca_system_score_gemma":0.004038592,"threshold_uncertainty_score":0.23975188},"labels":[],"label_agreement":null},{"id":"W2244640235","doi":"10.1089/cap.2013.0078","title":"Lack of Detectable Serum Levels Following Topical Fluoxetine Administration in a Child","year":2014,"lang":"en","type":"letter","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Fluoxetine; Mental health; Administration (probate law); Psychiatry; Pharmacy; Child and adolescent psychiatry; Medicine; Food and drug administration; Library science; Family medicine; Pharmacology; Political science; Internal medicine","score_opus":0.0626762372078146,"score_gpt":0.396478539530618,"score_spread":0.3338023023228034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2244640235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8578943,0.0049254196,0.001306825,0.10398707,0.0024831768,0.0001428464,0.0005454878,0.00023656763,0.028478296],"genre_scores_gemma":[0.97750926,0.0019034971,0.0008073315,0.015068949,0.0010655186,0.000019845595,0.000100097066,0.000025732266,0.0034998618],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9993773,0.000105749314,0.0000986865,0.000108459426,0.00013289589,0.00017696239],"domain_scores_gemma":[0.9970554,0.0014129172,0.0006298225,0.00009495313,0.00028975573,0.0005171769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003280775,0.0006413962,0.00079358846,0.0009146912,0.0012420074,0.0009319133,0.0010246279,0.006382013,0.0020046209],"category_scores_gemma":[0.00562307,0.0004390016,0.0007577231,0.0006077706,0.0009960794,0.0007491665,0.00040320374,0.004970285,0.00051510485],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000137682,0.0000938343,0.024756297,0.000062620245,0.000015816262,0.96638507,0.00048078844,0.000048666992,0.0012733606,0.0003197788,0.0035704842,0.0028556518],"study_design_scores_gemma":[0.000035347995,0.00069045846,0.04860898,0.00011269506,0.000071062874,0.94081813,0.0014149147,0.0005440181,0.0018948434,0.00028572482,0.0054896744,0.000034167104],"about_ca_topic_score_codex":0.010645387,"about_ca_topic_score_gemma":0.014878269,"teacher_disagreement_score":0.010645387,"about_ca_system_score_codex":0.001978225,"about_ca_system_score_gemma":0.0012181869,"threshold_uncertainty_score":0.021166861},"labels":[],"label_agreement":null},{"id":"W2253622974","doi":"10.1089/cap.2015.0063","title":"Prevalence and Correlates of Disruptive Mood Dysregulation Disorder Among Adolescents with Bipolar Disorder","year":2016,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"","keywords":"Bipolar disorder; Schedule for Affective Disorders and Schizophrenia; Conduct disorder; Psychiatry; Psychology; Mood; Mood disorders; Global Assessment of Functioning; Logistic regression; Bipolar I disorder; Population; Family history; Attention deficit hyperactivity disorder; Clinical psychology; Bipolar II disorder; Medicine; Schizophrenia (object-oriented programming); Internal medicine; Mania; Anxiety","score_opus":0.00496479064452059,"score_gpt":0.25835840553367156,"score_spread":0.25339361488915096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2253622974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994235,0.00015864719,0.000021442713,0.00002648635,0.0000034969335,0.000004224008,0.0001348489,0.000001924538,0.00022539949],"genre_scores_gemma":[0.999648,0.000084108724,0.00003859613,0.000017303482,0.0000051214893,0.000006007475,0.00015924739,9.352497e-7,0.000040733303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968255,0.000074437026,0.00004706941,0.00006142159,0.00008079246,0.000053706633],"domain_scores_gemma":[0.9992594,0.000092831004,0.00040284763,0.000021716232,0.00009330202,0.00012994782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003450178,0.00020402,0.00026710107,0.00067427114,0.0003501923,0.00051165815,0.00021861466,0.0002619522,0.001208544],"category_scores_gemma":[0.0013171805,0.00019566088,0.00016949234,0.00046604616,0.00020945728,0.0002498902,0.00037054182,0.00041339235,0.00017656693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000127449475,0.000010195296,0.9992656,0.0000026622818,0.000006019127,0.000039257986,0.000037433594,0.0000049949313,0.00009157697,0.0000034220384,0.00003797112,0.00048810802],"study_design_scores_gemma":[0.0000015651937,0.000028073566,0.99944264,0.000003887919,0.0000046281534,0.00029213965,0.00014404865,0.000025951058,0.000015627676,0.0000038715316,0.000037056827,5.609444e-7],"about_ca_topic_score_codex":0.0038425857,"about_ca_topic_score_gemma":0.0066056834,"teacher_disagreement_score":0.0038425857,"about_ca_system_score_codex":0.00022450773,"about_ca_system_score_gemma":0.00017529321,"threshold_uncertainty_score":0.007640481},"labels":[],"label_agreement":null},{"id":"W2273023960","doi":"10.1089/104454601750143564","title":"Can Methylphenidate Facilitate Sleep in Children with Attention Deficit Hyperactivity Disorder?","year":2001,"lang":"en","type":"letter","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Provincial Laboratory of Public Health","funders":"","keywords":"Attention deficit hyperactivity disorder; Methylphenidate; Psychiatry; Psychology; Attention deficit disorder; Autism spectrum disorder; Attention deficit; Autism","score_opus":0.01897150106373894,"score_gpt":0.2976611196121669,"score_spread":0.27868961854842794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2273023960","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.054850217,0.018602604,0.00022251636,0.89635605,0.013679662,0.00005577741,0.00032462124,0.000075219876,0.015833288],"genre_scores_gemma":[0.3112796,0.03162962,0.0015341061,0.5906359,0.04715275,0.00021643823,0.00028403342,0.000039177008,0.017228378],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975854,0.00005162837,0.000054069336,0.000029703402,0.000052664775,0.000053387812],"domain_scores_gemma":[0.99886656,0.00055303995,0.00014560917,0.000025677144,0.00011923746,0.00028995145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038104755,0.00045875568,0.0010382913,0.0002690825,0.001124586,0.00056447106,0.0007760296,0.011519725,0.0031476247],"category_scores_gemma":[0.0053154817,0.00025966726,0.000980244,0.00026634173,0.0005012345,0.0009530177,0.00036332762,0.0071695503,0.00084229273],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029834816,0.0008010039,0.09849781,0.0014511544,0.0005449081,0.16969204,0.0008515314,0.00055192894,0.0031252506,0.0031969391,0.51147324,0.20683071],"study_design_scores_gemma":[0.0050354986,0.0038261863,0.25238913,0.0027755937,0.0015908431,0.23579668,0.0035706994,0.002999277,0.0032260015,0.009815635,0.4787238,0.00025073497],"about_ca_topic_score_codex":0.009467925,"about_ca_topic_score_gemma":0.0402715,"teacher_disagreement_score":0.011519725,"about_ca_system_score_codex":0.0015657352,"about_ca_system_score_gemma":0.0014367548,"threshold_uncertainty_score":0.01882565},"labels":[],"label_agreement":null},{"id":"W2279513096","doi":"10.1089/cap.2015.0154","title":"Controlled Study of Obesity Among Adolescents with Bipolar Disorder","year":2016,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Schedule for Affective Disorders and Schizophrenia; Bipolar disorder; Body mass index; Suicide attempt; Odds ratio; Psychology; Psychiatry; Impulsivity; Bipolar I disorder; Obesity; Bipolar II disorder; Medicine; Family history; Univariate analysis; Conduct disorder; Confidence interval; Logistic regression; Clinical psychology; Poison control; Mania; Internal medicine; Injury prevention; Mood; Multivariate analysis","score_opus":0.006510512757849892,"score_gpt":0.2697927338574691,"score_spread":0.2632822210996192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2279513096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965649,0.0009693531,0.000232927,0.00003732153,0.000047684458,0.00034824287,0.0009645335,0.0000067549654,0.0008282477],"genre_scores_gemma":[0.9978859,0.0002517264,0.0003537262,0.000091314134,0.000032545337,0.00031987662,0.00074829365,0.0000038054816,0.00031273914],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991855,0.00036430918,0.00009013088,0.00015496921,0.00013692612,0.000068115325],"domain_scores_gemma":[0.99877673,0.00020577226,0.0005163493,0.0001312832,0.00017765087,0.00019214467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001448456,0.00039629024,0.00047618512,0.000460445,0.0008504125,0.0005321098,0.0002812988,0.00037981808,0.0019270574],"category_scores_gemma":[0.0021762725,0.00034736734,0.00040422266,0.0006144201,0.00033846003,0.00027711107,0.00030724498,0.0005911903,0.0002298025],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032092277,0.00042265703,0.9929289,0.00007419853,0.0003220401,0.00012128894,0.00011077776,0.000014656863,0.00046328665,0.00004414456,0.00030950957,0.0019793608],"study_design_scores_gemma":[0.0005395572,0.0019475885,0.99611086,0.0000233767,0.00022252374,0.00023299256,0.00012510456,0.00005978918,0.00007730746,0.000019186651,0.0006373069,0.000004338862],"about_ca_topic_score_codex":0.004062107,"about_ca_topic_score_gemma":0.006613272,"teacher_disagreement_score":0.004062107,"about_ca_system_score_codex":0.00035060686,"about_ca_system_score_gemma":0.0004073366,"threshold_uncertainty_score":0.008076966},"labels":[],"label_agreement":null},{"id":"W2283766822","doi":"10.1089/cap.2015.0157","title":"Repetitive Transcranial Magnetic Stimulation/Behavioral Intervention Clinical Trial: Long-Term Follow-Up of Outcomes in Congenital Hemiparesis","year":2016,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Stroke Rehabilitation and Recovery","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institutes of Health; American Academy for Cerebral Palsy and Developmental Medicine; National Center for Advancing Translational Sciences; University of Minnesota","keywords":"Transcranial magnetic stimulation; Hemiparesis; Physical therapy; Constraint-induced movement therapy; Anxiety; Depression (economics); Mood; Stroke (engine); Medicine; Psychology; Physical medicine and rehabilitation; Psychiatry; Rehabilitation; Stimulation; Internal medicine","score_opus":0.034760269288776395,"score_gpt":0.3990234787464139,"score_spread":0.3642632094576375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2283766822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982128,0.0011357073,0.000051441388,0.000043843116,0.000018359755,0.00018628305,0.00011666438,0.0000048785846,0.0002300089],"genre_scores_gemma":[0.9979321,0.0005389385,0.00026370023,0.000086979424,0.00007519779,0.0004737239,0.00033864364,0.0000016445317,0.00028922912],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991462,0.00038914988,0.000116887226,0.00012463398,0.00012220247,0.00010094516],"domain_scores_gemma":[0.99876,0.00030397726,0.0004754898,0.000075363314,0.00013978867,0.00024540367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018238418,0.00037144634,0.0011131205,0.00032195853,0.0003479636,0.00036648175,0.00045499307,0.0007506906,0.0012144228],"category_scores_gemma":[0.0016939265,0.00012715842,0.0008205254,0.00029593904,0.0003502941,0.0003153344,0.00026915126,0.00067418633,0.00016070448],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6365465,0.032901805,0.1669581,0.0024798373,0.005385103,0.0006138253,0.00035555582,0.00083288987,0.009253118,0.00012347625,0.001006075,0.14354374],"study_design_scores_gemma":[0.14116232,0.44191223,0.40857533,0.00023955363,0.0020643126,0.0007019298,0.00016422755,0.0011958593,0.00295199,0.00007383301,0.0009232881,0.000035054407],"about_ca_topic_score_codex":0.0007371114,"about_ca_topic_score_gemma":0.0017987594,"teacher_disagreement_score":0.0018238418,"about_ca_system_score_codex":0.00044652284,"about_ca_system_score_gemma":0.0007619802,"threshold_uncertainty_score":0.009645522},"labels":[],"label_agreement":null},{"id":"W2316132077","doi":"10.1089/cap.2013.0148","title":"Reading Outcomes of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Dyslexia Following Atomoxetine Treatment","year":2014,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"Yale University","keywords":"Atomoxetine; Dyslexia; Attention deficit hyperactivity disorder; Reading (process); Psychology; Atomoxetine hydrochloride; Psychiatry; Clinical psychology; Developmental psychology; Methylphenidate","score_opus":0.009648039340761952,"score_gpt":0.3048429499375862,"score_spread":0.29519491059682423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316132077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99909997,0.00032198813,0.000010847033,0.00002978132,0.00000390558,0.000016996255,0.0001496406,0.0000027467188,0.0003641604],"genre_scores_gemma":[0.9992828,0.00019114003,0.00004076264,0.00003085968,0.000008081503,0.000016430846,0.00030678057,0.0000012260839,0.00012192384],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996774,0.00007395675,0.000047859576,0.00004556161,0.0001035149,0.00005155948],"domain_scores_gemma":[0.9981766,0.0003733902,0.0009882974,0.00003890008,0.00023475419,0.00018797877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004658117,0.00022520365,0.00070579996,0.0005012027,0.00028455377,0.00041420103,0.00023202752,0.00034026144,0.0011626635],"category_scores_gemma":[0.0025998126,0.00011294407,0.0005154973,0.00050443236,0.00025822816,0.00034626733,0.00027089156,0.000626415,0.00015700435],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015694083,0.00060032785,0.9792069,0.0001520892,0.00026094305,0.00043838046,0.0004046295,0.000099471516,0.0007622209,0.000011274766,0.00023215795,0.016262246],"study_design_scores_gemma":[0.000027826563,0.0006984511,0.9986369,0.00000853236,0.000061094535,0.00022537615,0.00011846218,0.00003103324,0.00011559712,0.0000044963667,0.000070476,0.00000180522],"about_ca_topic_score_codex":0.005320834,"about_ca_topic_score_gemma":0.009850651,"teacher_disagreement_score":0.005320834,"about_ca_system_score_codex":0.0004384813,"about_ca_system_score_gemma":0.0003310289,"threshold_uncertainty_score":0.010579765},"labels":[],"label_agreement":null},{"id":"W2338083693","doi":"10.1089/cap.2016.0004","title":"Higher Incidence of Psychiatrist-Diagnosed Depression in Taiwanese Female School-Age Children and Adolescents with Type 1 Diabetes: A Nationwide, Population-Based, Retrospective Cohort Study","year":2016,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Cohort; Depression (economics); Incidence (geometry); Retrospective cohort study; Cohort study; Population; Rate ratio; Type 2 diabetes; Pediatrics; Diabetes mellitus; Type 1 diabetes; Poisson regression; Internal medicine; Confidence interval; Endocrinology","score_opus":0.006808506327211217,"score_gpt":0.2963234798597707,"score_spread":0.2895149735325595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338083693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99952173,0.00012488897,0.000030107944,0.000015732354,0.0000029294338,0.0000064548576,0.000187692,0.0000014245027,0.00010902945],"genre_scores_gemma":[0.99948007,0.000120666795,0.00005336042,0.000018549945,0.000005520544,0.000009061677,0.0002600786,8.883464e-7,0.000051879735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999653,0.00006859024,0.0000411593,0.00011374531,0.000067465815,0.00005611829],"domain_scores_gemma":[0.9991602,0.00009396288,0.00045831144,0.00006428117,0.00010425679,0.00011902037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049781456,0.00022829414,0.00028102993,0.00086137245,0.000334831,0.00051089376,0.0002698558,0.00033551548,0.0008095777],"category_scores_gemma":[0.0011209324,0.00033560008,0.00047247036,0.00086561433,0.00016569764,0.00029291224,0.00024167755,0.0003745445,0.000107472995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016070373,0.000006852195,0.99963593,0.000002211115,0.000021269756,0.000055238623,0.000024618796,0.0000049373434,0.000045467525,0.0000021410394,0.000021526492,0.00016357159],"study_design_scores_gemma":[0.0000041890344,0.000027814078,0.9994367,0.0000033797699,0.000018860303,0.00028133555,0.000101638136,0.000054485063,0.000021788424,0.000002376564,0.000046155223,0.0000013647681],"about_ca_topic_score_codex":0.012340649,"about_ca_topic_score_gemma":0.014994966,"teacher_disagreement_score":0.012340649,"about_ca_system_score_codex":0.0003581453,"about_ca_system_score_gemma":0.00036174833,"threshold_uncertainty_score":0.024537623},"labels":[],"label_agreement":null},{"id":"W2345610434","doi":"10.1089/cap.2015.0097","title":"Clinical Characteristics and Predictors of Outcome of Schizophrenia-Spectrum Psychosis in Children and Adolescents: A Systematic Review","year":2016,"lang":"en","type":"review","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child, Adolescent and Family Mental Health","funders":"","keywords":"Schizophrenia spectrum; Psychosis; Schizophrenia (object-oriented programming); Psychiatry; Psychology; Clinical psychology; Outcome (game theory)","score_opus":0.02637354722033663,"score_gpt":0.3872159889877408,"score_spread":0.36084244176740415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345610434","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005370518,0.9934888,0.00005562219,0.000107537555,0.000037008715,0.00012375253,0.00067809114,0.000003825652,0.00013494266],"genre_scores_gemma":[0.052289076,0.9461201,0.0003955926,0.00021919291,0.000050973962,0.0003148708,0.00055089535,0.0000035203104,0.000055760473],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9965899,0.00078353466,0.0016949386,0.00038465823,0.00044280099,0.000104211176],"domain_scores_gemma":[0.9831172,0.010662021,0.004707215,0.00018306363,0.0011043972,0.00022614181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035659994,0.0009118654,0.0055738934,0.0067705433,0.00040319105,0.0015304806,0.0012554163,0.0011481429,0.0020209902],"category_scores_gemma":[0.021495989,0.0007839522,0.0055557364,0.009146624,0.00068125967,0.0014248597,0.00093311816,0.0006933421,0.00013463771],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032628735,0.000031939166,0.016727379,0.9250318,0.017800175,0.00021659349,0.00032439025,0.00011249096,0.00012923931,0.0001465612,0.0012976049,0.03785564],"study_design_scores_gemma":[0.00039018126,0.0003450201,0.0795524,0.7706576,0.13322246,0.001287144,0.0007213795,0.00014578222,0.0001962721,0.000216255,0.013192804,0.0000726346],"about_ca_topic_score_codex":0.009009834,"about_ca_topic_score_gemma":0.024187496,"teacher_disagreement_score":0.009009834,"about_ca_system_score_codex":0.0019397885,"about_ca_system_score_gemma":0.006887886,"threshold_uncertainty_score":0.018859029},"labels":[],"label_agreement":null},{"id":"W2398392343","doi":"10.1089/cap.2015.0041","title":"Sertraline Treatment of Nonresponders to Extended Cognitive-Behavior Therapy in Pediatric Obsessive-Compulsive Disorder","year":2015,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Obsessive-Compulsive Spectrum Disorders","field":"Psychology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child, Adolescent and Family Mental Health","funders":"","keywords":"Sertraline; Obsessive compulsive; Cognition; Psychology; Cognitive behavioral therapy; Psychotherapist; Psychiatry; Clinical psychology; Medicine; Anxiety; Antidepressant","score_opus":0.02810574679571366,"score_gpt":0.3602919559486943,"score_spread":0.33218620915298064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398392343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99938464,0.00044960293,0.000015935515,0.000023011611,0.0000025827771,0.000010904698,0.000015524945,0.0000023190446,0.00009548651],"genre_scores_gemma":[0.99916685,0.00043160355,0.00015881956,0.000043631044,0.000007966792,0.000021767382,0.000058482645,0.0000012252615,0.00010965664],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997906,0.0000921935,0.000027621832,0.000021268665,0.000045286863,0.00002299895],"domain_scores_gemma":[0.9995608,0.00012572008,0.00018342893,0.0000131101815,0.00004049755,0.00007648243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003807701,0.00014289042,0.00040194864,0.0001474572,0.00017326522,0.00013696593,0.00020741267,0.00024875227,0.0007622017],"category_scores_gemma":[0.0011803451,0.0000758591,0.00022258097,0.00011093187,0.00013250513,0.00011758358,0.00010778376,0.0002844157,0.00009198801],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012389613,0.0038995966,0.80048543,0.0011725714,0.00047153045,0.003958448,0.0016825128,0.0003453237,0.027844967,0.000059264592,0.0007675789,0.14692304],"study_design_scores_gemma":[0.0012926401,0.016586617,0.9730631,0.00007661529,0.0001935211,0.0045678993,0.0007645197,0.00033290905,0.001955602,0.000025171532,0.0011345515,0.0000067357596],"about_ca_topic_score_codex":0.0011609956,"about_ca_topic_score_gemma":0.0039938428,"teacher_disagreement_score":0.0011609956,"about_ca_system_score_codex":0.0001742309,"about_ca_system_score_gemma":0.00029157623,"threshold_uncertainty_score":0.0025497675},"labels":[],"label_agreement":null},{"id":"W2406398214","doi":"10.1089/cap.2016.0050","title":"Manic Reaction in a Child Induced by Guanfacine-Extended Release","year":2016,"lang":"en","type":"letter","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Mental Health & Substance Use Services; Children's & Women's Health Centre of British Columbia; Centre for Addiction and Mental Health","funders":"","keywords":"Guanfacine; Chemistry; Pharmacology; Medicine; Anesthesia; Clonidine","score_opus":0.014341753859253997,"score_gpt":0.31938376438085714,"score_spread":0.3050420105216031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406398214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85954505,0.013265575,0.0024517106,0.068973504,0.0054071024,0.0003604269,0.00048391335,0.00052091887,0.048991747],"genre_scores_gemma":[0.9760385,0.002587817,0.0008929633,0.0125929825,0.0037029672,0.00004174478,0.000098961194,0.000050999774,0.003993122],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9992741,0.00013793807,0.000108465494,0.00015127024,0.00010838123,0.00021976992],"domain_scores_gemma":[0.9971969,0.0010044769,0.0007329208,0.0001443336,0.00013121085,0.0007901934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045790765,0.0017032179,0.001382723,0.0010112884,0.0018377273,0.0010344101,0.0013318761,0.008221971,0.0030502295],"category_scores_gemma":[0.005263079,0.0008356972,0.0022425682,0.0007621933,0.0017388279,0.0015979322,0.0010381344,0.009270299,0.0008478942],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058758502,0.000021156106,0.0014925082,0.00001948306,0.000009402293,0.99703026,0.00006280063,0.000028023225,0.00022712922,0.00017201704,0.00046327838,0.0004152155],"study_design_scores_gemma":[0.00010534915,0.0003014807,0.009374712,0.000034925724,0.0000552888,0.98655695,0.00024355092,0.00038126015,0.00047907443,0.00025482159,0.0021914295,0.000021248066],"about_ca_topic_score_codex":0.0042574527,"about_ca_topic_score_gemma":0.0059592044,"teacher_disagreement_score":0.008221971,"about_ca_system_score_codex":0.0032997457,"about_ca_system_score_gemma":0.0013601423,"threshold_uncertainty_score":0.023941398},"labels":[],"label_agreement":null},{"id":"W2407099732","doi":"10.1089/cap.2014.0167","title":"Tics Moderate Sertraline, but Not Cognitive-Behavior Therapy Response in Pediatric Obsessive-Compulsive Disorder Patients Who Do Not Respond to Cognitive-Behavior Therapy","year":2015,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Obsessive-Compulsive Spectrum Disorders","field":"Psychology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child, Adolescent and Family Mental Health","funders":"Region Midtjylland; TrygFonden; Stiftelsen Clas Groschinskys Minnesfond; Norges Forskningsråd; Strategiske Forskningsråd","keywords":"Sertraline; Tics; Cognition; Obsessive compulsive; Cognitive behavioral therapy; Clinical psychology; Psychology; Tourette syndrome; Psychotherapist; Cognitive therapy; Behavioral therapy; Exposure and response prevention; Psychiatry; Medicine; Anxiety; Antidepressant","score_opus":0.028523200406718116,"score_gpt":0.3476943303334478,"score_spread":0.3191711299267297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407099732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996458,0.00012487601,0.000009635393,0.000016703381,0.0000016205947,0.000009268326,0.000024111847,0.0000011146482,0.00016682709],"genre_scores_gemma":[0.9997099,0.000066649794,0.000060722836,0.000025865651,0.000004601371,0.000009201614,0.0000707167,8.5412466e-7,0.000051402574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996257,0.00011362901,0.000049106136,0.000060206505,0.00009380149,0.00005752845],"domain_scores_gemma":[0.9987412,0.00028274395,0.00068741024,0.000025950088,0.00008373316,0.00017891564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004728551,0.00021055536,0.00048495864,0.00033337442,0.00028135726,0.00039890743,0.00019560364,0.00032887666,0.0012902232],"category_scores_gemma":[0.0022669176,0.00016326096,0.00030205163,0.0003558794,0.0002844157,0.00023434708,0.0001753681,0.00036394555,0.0001105652],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007442716,0.0003609786,0.99144906,0.000044591885,0.00009148535,0.00034889416,0.00014776236,0.000040253846,0.0013519815,0.00001821526,0.000097164775,0.005305346],"study_design_scores_gemma":[0.000059547117,0.000453716,0.99851626,0.000007671291,0.000034237422,0.0005910094,0.00012142967,0.00007916416,0.00007082383,0.000007886654,0.00005673768,0.0000014569656],"about_ca_topic_score_codex":0.0038890953,"about_ca_topic_score_gemma":0.0077472003,"teacher_disagreement_score":0.0038890953,"about_ca_system_score_codex":0.00046960797,"about_ca_system_score_gemma":0.0005626174,"threshold_uncertainty_score":0.007732868},"labels":[],"label_agreement":null},{"id":"W2412217894","doi":"10.1089/cap.2016.29107.mmr","title":"Review of <i>Clinical Handbook of Psychotropic Drugs for Children and Adolescents,</i> 3rd Ed., edited by Dean Elbe, Kalyna Z. Bezchlibnyk-Butler, Adil S. Virani, and Ric M. Procyshyn","year":2016,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Fredericton; University of New Brunswick","funders":"","keywords":"Psychiatry; Child and adolescent psychiatry; Psychotropic drug; Psychology; Library science; Medicine; Drug; Computer science","score_opus":0.018724829531366664,"score_gpt":0.37795759381986865,"score_spread":0.359232764288502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412217894","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005625759,0.9945397,0.00015703196,0.0015689328,0.0018899178,0.000011203955,0.00008868144,0.000019398287,0.0016689006],"genre_scores_gemma":[0.0004867244,0.9920873,0.00048469668,0.0013621147,0.0022748462,0.000021526137,0.00015699978,0.000009331904,0.0031164712],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992385,0.00014574065,0.0001743931,0.00007756588,0.0003244935,0.000039397113],"domain_scores_gemma":[0.9982613,0.0006462341,0.00032086665,0.000045488647,0.00059436867,0.00013175538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011084323,0.0011337154,0.0016193743,0.004710994,0.00037290956,0.0015408987,0.0013349736,0.0011135134,0.014625275],"category_scores_gemma":[0.0029700128,0.0005574636,0.0008519722,0.0045018746,0.00054431806,0.0018989489,0.0007842313,0.0019837627,0.008826263],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057370635,0.00005283184,0.0002288243,0.011775609,0.00006303042,0.00014395808,0.00008898738,0.00011338464,0.00047545644,0.0013474112,0.48654625,0.49910694],"study_design_scores_gemma":[0.000012587689,0.000044172848,0.0011301995,0.0049172137,0.00004150415,0.0010785906,0.000046462897,0.000036624522,0.000110673405,0.00055229524,0.99201536,0.000014343574],"about_ca_topic_score_codex":0.00505905,"about_ca_topic_score_gemma":0.01201953,"teacher_disagreement_score":0.014625275,"about_ca_system_score_codex":0.0011004406,"about_ca_system_score_gemma":0.0037817154,"threshold_uncertainty_score":0.048926413},"labels":[],"label_agreement":null},{"id":"W2479169962","doi":"10.1089/cap.2016.0032","title":"Drug-Induced Akathisia in Children and Adolescents","year":2016,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child, Adolescent and Family Mental Health","funders":"","keywords":"Akathisia; Psychiatry; Child and adolescent psychiatry; Psychology; Library science; Medicine; Schizophrenia (object-oriented programming)","score_opus":0.006943248656059148,"score_gpt":0.28086474303110787,"score_spread":0.2739214943750487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2479169962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918989,0.0029401362,0.000049519433,0.00014690914,0.00001958204,0.000038055954,0.00013822991,0.000008213657,0.004760396],"genre_scores_gemma":[0.9973308,0.0019831941,0.00005963255,0.000055682813,0.000012576415,0.000008253346,0.00009572465,0.0000025298157,0.00045154727],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996592,0.0000933033,0.00005052641,0.000027052163,0.000088773064,0.00008115443],"domain_scores_gemma":[0.9990879,0.00021262851,0.00038847828,0.000025925005,0.00010757438,0.00017741905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003326988,0.000195513,0.00026806875,0.0008650112,0.0004831041,0.0005488777,0.00015452523,0.00035626537,0.002533888],"category_scores_gemma":[0.0022521836,0.0001681088,0.00036651775,0.000553397,0.00025805167,0.0003492426,0.0002960714,0.0006828571,0.0002538844],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021082653,0.00026136465,0.9788632,0.0001480841,0.000051875388,0.006087032,0.0004944141,0.000030266354,0.00082135014,0.000116033516,0.00049700803,0.012418628],"study_design_scores_gemma":[0.000014164333,0.00019349984,0.9850544,0.000052085987,0.000033282646,0.0129881175,0.00074632006,0.000040670315,0.0001699092,0.00002694576,0.000676756,0.000003861707],"about_ca_topic_score_codex":0.0074189776,"about_ca_topic_score_gemma":0.010257123,"teacher_disagreement_score":0.0074189776,"about_ca_system_score_codex":0.00065960427,"about_ca_system_score_gemma":0.0005879287,"threshold_uncertainty_score":0.014751613},"labels":[],"label_agreement":null},{"id":"W2491792734","doi":"10.1089/cap.2015.0189","title":"Effect of Atomoxetine Treatment on Reading and Phonological Skills in Children with Dyslexia or Attention-Deficit/Hyperactivity Disorder and Comorbid Dyslexia in a Randomized, Placebo-Controlled Trial","year":2016,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"National Institute of Child Health and Human Development; National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; U.S. Department of Health and Human Services; Shionogi; Maternal and Child Health Bureau; Otsuka America; Sunovion; U.S. National Library of Medicine; Institute of Education Sciences; Otsuka America Pharmaceutical; GlaxoSmithKline; National Institute of Mental Health; Pfizer; Supernus Pharmaceuticals; National Institute on Deafness and Other Communication Disorders; Shire; Eli Lilly and Company; U.S. Department of Education","keywords":"Dyslexia; Atomoxetine; Psychology; Attention deficit hyperactivity disorder; Placebo; Randomized controlled trial; Audiology; Psychiatry; Reading (process); Clinical psychology; Medicine; Methylphenidate; Internal medicine","score_opus":0.009153470811597718,"score_gpt":0.31774652821794,"score_spread":0.3085930574063423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2491792734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98268867,0.010559226,0.0003086673,0.0006447099,0.0005586024,0.002371439,0.00085457816,0.00015050848,0.001863639],"genre_scores_gemma":[0.98708713,0.0064857067,0.0011336715,0.0008004167,0.00030375927,0.0020622278,0.0006747162,0.000011956328,0.001440537],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99970454,0.00013692855,0.000039847568,0.000047999514,0.000029514082,0.000041195508],"domain_scores_gemma":[0.9995976,0.00016466169,0.00009510158,0.00001978249,0.00003601527,0.0000869177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005497524,0.00075444375,0.0024383443,0.0003223824,0.0003631619,0.00047441226,0.00067822955,0.0013620594,0.0037010482],"category_scores_gemma":[0.0010986793,0.00040870885,0.00089767337,0.00028791744,0.00046605724,0.00043703205,0.00017342207,0.0013067115,0.00040729193],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9264675,0.0070416713,0.0016325632,0.0038805834,0.0022606207,0.00019248691,0.00008298719,0.000235922,0.005477293,0.00014358439,0.0015879732,0.05099681],"study_design_scores_gemma":[0.93679935,0.054152373,0.006192901,0.00012730448,0.00090200064,0.000079510726,0.000047934343,0.00038466643,0.00050069304,0.0000558218,0.0007412851,0.000016221291],"about_ca_topic_score_codex":0.002274482,"about_ca_topic_score_gemma":0.007835193,"teacher_disagreement_score":0.0037010482,"about_ca_system_score_codex":0.0005653802,"about_ca_system_score_gemma":0.0006787527,"threshold_uncertainty_score":0.012381256},"labels":[],"label_agreement":null},{"id":"W2513178742","doi":"10.1089/cap.2015.0127","title":"Effectiveness of Antidepressant Medications for Symptoms of Irritability and Disruptive Behaviors in Children and Adolescents","year":2016,"lang":"en","type":"review","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Irritability; Aggression; Antidepressant; Psychiatry; Clinical psychology; Psychology; Depression (economics); Randomized controlled trial; Medicine; Autism; Anxiety; Internal medicine","score_opus":0.010430348861814107,"score_gpt":0.3570204986058003,"score_spread":0.3465901497439862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2513178742","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034584522,0.9631839,0.00007414781,0.00039045545,0.00009898483,0.00009490471,0.0005255786,0.000005760547,0.001041722],"genre_scores_gemma":[0.46786964,0.5291713,0.0009804543,0.0006883646,0.0001955876,0.00021415793,0.0006838201,0.0000056370523,0.00019108177],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99644756,0.0012284872,0.0013304984,0.0002681944,0.00063956843,0.00008572302],"domain_scores_gemma":[0.9897037,0.00555377,0.0038777532,0.00010142719,0.0006344298,0.00012904104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003348631,0.00038380918,0.001962767,0.0016504383,0.00016850198,0.00079962244,0.00053609366,0.00063283794,0.0009850966],"category_scores_gemma":[0.014452036,0.00030197794,0.0030723917,0.0016272623,0.00026556736,0.0004580456,0.00031611396,0.00069826096,0.000065090084],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006988748,0.0004188061,0.113126144,0.3733261,0.0785489,0.0007129155,0.0006349097,0.00077656755,0.001935971,0.0006287138,0.004273534,0.4186287],"study_design_scores_gemma":[0.0074719037,0.0066060834,0.54929376,0.22741285,0.17954521,0.0037486413,0.0011211442,0.00059381506,0.0024135467,0.0007526077,0.020938497,0.000101900376],"about_ca_topic_score_codex":0.0045305537,"about_ca_topic_score_gemma":0.011693787,"teacher_disagreement_score":0.0045305537,"about_ca_system_score_codex":0.0010747316,"about_ca_system_score_gemma":0.0012554438,"threshold_uncertainty_score":0.017709494},"labels":[],"label_agreement":null},{"id":"W2523785210","doi":"10.1089/cap.2016.0010","title":"A 52-Week Study of Olanzapine with a Randomized Behavioral Weight Counseling Intervention in Adolescents with Schizophrenia or Bipolar I Disorder","year":2016,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical; Eli Lilly (Canada)","funders":"Eli Lilly Canada; National Institute of Mental Health; Eli Lilly and Company","keywords":"Young Mania Rating Scale; Olanzapine; Tolerability; Bipolar disorder; Psychology; Mania; Brief Psychiatric Rating Scale; Bipolar I disorder; Body mass index; Mood stabilizer; Psychiatry; Mood; Medicine; Schizophrenia (object-oriented programming); Internal medicine; Adverse effect; Psychosis","score_opus":0.014243122831940434,"score_gpt":0.31961966945192855,"score_spread":0.3053765466199881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523785210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962625,0.00031520845,0.00029295322,0.000099889374,0.00008332979,0.0022861264,0.0002116815,0.000048262733,0.00040002493],"genre_scores_gemma":[0.9893686,0.00068965286,0.0020840892,0.00037355788,0.00014521251,0.0052051595,0.0004894318,0.000016337948,0.001628066],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99914944,0.00040114738,0.00007456155,0.00014560902,0.00009036379,0.00013886373],"domain_scores_gemma":[0.9990429,0.00015289705,0.00017426406,0.000086843545,0.000068354624,0.00047472995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014318867,0.0012850637,0.0020174982,0.0005407283,0.00047915353,0.00063911075,0.00084646646,0.0011625367,0.004937376],"category_scores_gemma":[0.0013573879,0.000884477,0.0014742202,0.00032596372,0.00086703995,0.0006929523,0.0005840428,0.0023119892,0.000645119],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85298306,0.104697675,0.0020739152,0.00034091898,0.0006974041,0.000071363655,0.00013708061,0.00048806405,0.0066204276,0.000057285186,0.00038701462,0.03144578],"study_design_scores_gemma":[0.6355136,0.35534117,0.0075539807,0.000018731607,0.00019445099,0.000028266923,0.000040180686,0.00045441126,0.00054960547,0.000035454595,0.00025477502,0.000015304411],"about_ca_topic_score_codex":0.002436187,"about_ca_topic_score_gemma":0.005705085,"teacher_disagreement_score":0.004937376,"about_ca_system_score_codex":0.000866942,"about_ca_system_score_gemma":0.001386155,"threshold_uncertainty_score":0.016517162},"labels":[],"label_agreement":null},{"id":"W2539104529","doi":"10.1089/cap.2016.0083","title":"Effect of Aptensio XR (Methylphenidate HCl Extended-Release) Capsules on Sleep in Children with Attention-Deficit/Hyperactivity Disorder","year":2016,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource; BC Children's Hospital; University of British Columbia","funders":"","keywords":"Bedtime; Placebo; Crossover study; Attention deficit hyperactivity disorder; Methylphenidate; Medicine; Psychology; Analysis of variance; Sleep onset; Internal medicine; Psychiatry; Insomnia","score_opus":0.007249732288307408,"score_gpt":0.29756726287712676,"score_spread":0.2903175305888194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2539104529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987602,0.0008041826,0.00004339361,0.000041176856,0.00001504271,0.000068813395,0.000116200106,0.00001108668,0.00013996972],"genre_scores_gemma":[0.9973437,0.0011910888,0.00054885866,0.00007607583,0.000033282326,0.00013168376,0.0002788798,0.000006014894,0.0003904389],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9995572,0.00023774651,0.00004021146,0.000059655886,0.000062339495,0.000042901454],"domain_scores_gemma":[0.99896514,0.0003667276,0.00031495385,0.000060171424,0.000051336265,0.00024164523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007373288,0.00079429656,0.0010813175,0.00019406728,0.00016835214,0.00028189106,0.0004405292,0.00045396853,0.0010991335],"category_scores_gemma":[0.0017589879,0.00030732495,0.0006048374,0.0001659989,0.00037895457,0.00032864284,0.00026284833,0.0008746981,0.00019457607],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7275996,0.029154565,0.028930442,0.0014499639,0.0018215817,0.00047847416,0.00063994905,0.0012199346,0.055634882,0.00007954195,0.0009479478,0.15204309],"study_design_scores_gemma":[0.11708655,0.6425431,0.22449622,0.000098719676,0.0008731415,0.0005211524,0.0002201693,0.00093193556,0.011684895,0.000047045054,0.0014546748,0.000042363754],"about_ca_topic_score_codex":0.0018376476,"about_ca_topic_score_gemma":0.0062993057,"teacher_disagreement_score":0.0018376476,"about_ca_system_score_codex":0.00034004563,"about_ca_system_score_gemma":0.0006508515,"threshold_uncertainty_score":0.0038993955},"labels":[],"label_agreement":null},{"id":"W2563824411","doi":"10.1089/cap.2016.0157","title":"Caregiver Treatment Preferences for Children with a New Versus Existing Attention-Deficit/Hyperactivity Disorder Diagnosis","year":2016,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institute of Mental Health","keywords":"Attention deficit hyperactivity disorder; Specialty; Psychiatry; Mental health; Medical prescription; Medicine; Stimulant; Psychology; Clinical psychology; Family medicine","score_opus":0.04564796787453266,"score_gpt":0.34961150078616726,"score_spread":0.3039635329116346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563824411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986298,0.00015666705,0.00012989578,0.00014466359,0.000006586148,0.00001088834,0.00008803467,0.0000014376742,0.00083203183],"genre_scores_gemma":[0.999126,0.00014099409,0.0003928428,0.000055113174,0.0000040225927,0.00001786966,0.000106763284,0.0000012503325,0.00015513047],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988519,0.00056151906,0.00011601621,0.00008683795,0.0002581341,0.00012557546],"domain_scores_gemma":[0.9966832,0.001410091,0.0011810291,0.000108216984,0.00030390258,0.00031360632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023321817,0.00017335494,0.0002340684,0.00028602744,0.00050523714,0.0007389491,0.00019124139,0.00022161113,0.0026758525],"category_scores_gemma":[0.0097503485,0.00009944759,0.00045306305,0.00030355802,0.00026232185,0.00042218983,0.0005427892,0.000429338,0.00013085798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006988155,0.00021095148,0.9530954,0.00015232828,0.00015356533,0.00029850553,0.0068192836,0.00037910495,0.0007513842,0.0002517562,0.0012125587,0.03597649],"study_design_scores_gemma":[0.000077424906,0.000601988,0.9634345,0.00020160727,0.00012511348,0.0010802447,0.029054506,0.001216135,0.00069250143,0.00046711008,0.0030188288,0.000030033449],"about_ca_topic_score_codex":0.005398939,"about_ca_topic_score_gemma":0.015589289,"teacher_disagreement_score":0.005398939,"about_ca_system_score_codex":0.0007470869,"about_ca_system_score_gemma":0.00062525435,"threshold_uncertainty_score":0.01233387},"labels":[],"label_agreement":null},{"id":"W2565399809","doi":"10.1089/cap.2016.0115","title":"Atomoxetine-Related Change in Sluggish Cognitive Tempo Is Partially Independent of Change in Attention-Deficit/Hyperactivity Disorder Inattentive Symptoms","year":2016,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"","keywords":"Atomoxetine; Attention deficit hyperactivity disorder; Dyslexia; Psychology; Placebo; Post-hoc analysis; Cognition; Neuropsychology; Audiology; Clinical psychology; Psychiatry; Medicine; Methylphenidate; Internal medicine; Reading (process)","score_opus":0.03183455766005385,"score_gpt":0.3453696900664906,"score_spread":0.31353513240643677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565399809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99853647,0.00038823494,0.0001505018,0.00003842599,0.00001045441,0.00012681056,0.00019167461,0.000020406293,0.0005369916],"genre_scores_gemma":[0.99878925,0.00019327403,0.00035157407,0.00003841871,0.000012960709,0.00007311716,0.00022894691,0.0000052199916,0.0003072124],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99950147,0.00015950034,0.00005306585,0.00006539604,0.00016642261,0.000054198885],"domain_scores_gemma":[0.9981628,0.0005870039,0.0008446059,0.00010261556,0.00014887138,0.0001541844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007333506,0.0002562406,0.0006498605,0.00017280258,0.00011559504,0.00022497361,0.00019873164,0.00024206039,0.001692185],"category_scores_gemma":[0.002444527,0.00015789011,0.00046318158,0.00017297552,0.00021749672,0.00019963621,0.00017549875,0.00055000687,0.00010044813],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27598205,0.009403934,0.26111516,0.00214342,0.00451519,0.00049330306,0.0004567597,0.0020093021,0.18371174,0.00017079458,0.001322422,0.258676],"study_design_scores_gemma":[0.003359253,0.03561048,0.9493494,0.00002414022,0.00048051315,0.00014542804,0.00004180506,0.00065744604,0.009786893,0.000028699498,0.0005052446,0.000010792859],"about_ca_topic_score_codex":0.0017229927,"about_ca_topic_score_gemma":0.004190388,"teacher_disagreement_score":0.0017229927,"about_ca_system_score_codex":0.000348626,"about_ca_system_score_gemma":0.00046162787,"threshold_uncertainty_score":0.0056608915},"labels":[],"label_agreement":null},{"id":"W2582874622","doi":"10.1089/cap.2016.0031","title":"Prevalence of Acute-Onset Subtypes in Pediatric Obsessive-Compulsive Disorder","year":2017,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Obsessive-Compulsive Spectrum Disorders","field":"Psychology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Obsessive compulsive; Psychiatry; Psychology; Medicine; Clinical psychology","score_opus":0.009274149741160769,"score_gpt":0.3181558542137159,"score_spread":0.30888170447255514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582874622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99930954,0.00021613322,0.000047869806,0.000028625533,0.0000020429113,0.000008938613,0.00015226999,0.0000038610283,0.00023076723],"genre_scores_gemma":[0.9993338,0.00020070821,0.00010200899,0.000012696404,0.000005521747,0.000009768988,0.00029617298,0.0000022980428,0.00003709639],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992225,0.00011922036,0.00010770467,0.00015537585,0.00025338965,0.00014184121],"domain_scores_gemma":[0.997315,0.00032841237,0.0016179798,0.00008003079,0.00029733032,0.0003612436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048700895,0.00020672048,0.0002837835,0.0011756165,0.00034008178,0.0005438985,0.0005189431,0.0003922775,0.0017395539],"category_scores_gemma":[0.0032791782,0.00027709495,0.00024695983,0.00092195126,0.00041283964,0.0004690628,0.0007367518,0.00050910894,0.00018233235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001657909,0.0000076966435,0.9986313,0.0000070000724,0.000006378941,0.00008685943,0.000083068044,0.000008025079,0.00009065781,0.000009420391,0.000051439256,0.0010015611],"study_design_scores_gemma":[0.0000024185513,0.000033591758,0.99818856,0.000010055486,0.0000070333367,0.0012705545,0.0003188788,0.00004655702,0.000038100407,0.000011381945,0.000071261624,0.0000015185713],"about_ca_topic_score_codex":0.0069034686,"about_ca_topic_score_gemma":0.007794869,"teacher_disagreement_score":0.0069034686,"about_ca_system_score_codex":0.00043615722,"about_ca_system_score_gemma":0.00046446777,"threshold_uncertainty_score":0.013726592},"labels":[],"label_agreement":null},{"id":"W2593623042","doi":"10.1089/cap.2016.0108","title":"An Evaluation Approach for the Performance of Dosing Regimens in Attention-Deficit/Hyperactivity Disorder Treatment","year":2017,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical; Children's Hospital of Eastern Ontario; University of Ottawa; Université de Montréal","funders":"Natural Sciences and Engineering Research Council of Canada; National Natural Science Foundation of China","keywords":"Methylphenidate; Dosing; Attention deficit hyperactivity disorder; Stimulant; Medicine; Regimen; Psychiatry; Psychology; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.044647789722515076,"score_gpt":0.38374996653004567,"score_spread":0.3391021768075306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593623042","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033072755,0.00026019054,0.96161884,0.00028110886,0.000038726463,0.00023827043,0.00015699663,0.00063574023,0.0036973958],"genre_scores_gemma":[0.45265225,0.00021325707,0.5439438,0.00014728909,0.000041353913,0.0006648801,0.00033669316,0.00013774716,0.0018627994],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9982718,0.00083345064,0.00011187812,0.000280799,0.00038545148,0.00011656672],"domain_scores_gemma":[0.99719536,0.0018530474,0.0002803451,0.000102364575,0.0004887124,0.000080236074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002660976,0.0012990686,0.0010031258,0.0014416277,0.00044502836,0.0012962334,0.0012243399,0.0011348412,0.0039005135],"category_scores_gemma":[0.008036589,0.0004452836,0.00082512345,0.0006470433,0.0005368185,0.0009993564,0.0011243653,0.000782045,0.0003375241],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019011856,0.00024061603,0.0040829103,0.00020880638,0.00011489012,0.00013928086,0.00017632074,0.8623704,0.0028872055,0.00819798,0.0014962306,0.119895324],"study_design_scores_gemma":[0.000011841766,0.00004645365,0.0002829033,0.000013861019,0.000016181082,0.00001262567,0.000021744872,0.9969406,0.0004924299,0.00175607,0.00040044807,0.000004951357],"about_ca_topic_score_codex":0.0057653175,"about_ca_topic_score_gemma":0.0041385307,"teacher_disagreement_score":0.0057653175,"about_ca_system_score_codex":0.0013702165,"about_ca_system_score_gemma":0.0020886818,"threshold_uncertainty_score":0.014072776},"labels":[],"label_agreement":null},{"id":"W2605673357","doi":"10.1089/cap.2016.0164","title":"Early Morning Functional Impairments in Stimulant-Treated Children with Attention-Deficit/Hyperactivity Disorder Versus Controls: Impact on the Family","year":2017,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; SickKids Foundation","funders":"","keywords":"Spouse; Attention deficit hyperactivity disorder; Morning; Stimulant; Psychology; Psychiatry; Clinical psychology; Medicine","score_opus":0.026479977533178444,"score_gpt":0.33567632521525537,"score_spread":0.30919634768207693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605673357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99967396,0.00011977223,0.000005226783,0.000012900389,0.0000017205127,0.0000018780385,0.00005009409,7.490674e-7,0.00013383543],"genre_scores_gemma":[0.9997571,0.00007106952,0.00001932055,0.000007773231,0.0000019937452,0.0000032724572,0.00008653586,6.038066e-7,0.000052325224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995414,0.00014592307,0.000045678353,0.00008569471,0.00008450689,0.00009692182],"domain_scores_gemma":[0.9985066,0.00024968863,0.00080094027,0.000030090421,0.000078326586,0.0003342672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004856692,0.00031059302,0.00030689954,0.0007190021,0.00040860422,0.0005562079,0.00024566278,0.00029768332,0.0013017711],"category_scores_gemma":[0.0024793218,0.00014942548,0.00035649553,0.0004484432,0.00039222103,0.00039118913,0.0005561509,0.0004094552,0.00009817932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018483066,0.00010536206,0.9966543,0.00001893843,0.000037668524,0.00015842338,0.0005156554,0.000027452275,0.00019439186,0.000008690563,0.00006714397,0.0020271635],"study_design_scores_gemma":[0.00000344612,0.00008837388,0.99917334,0.000004125968,0.00000963421,0.00015488415,0.00048088364,0.000020310723,0.00003261624,0.000003071348,0.00002791111,0.0000014556236],"about_ca_topic_score_codex":0.013581276,"about_ca_topic_score_gemma":0.025012592,"teacher_disagreement_score":0.013581276,"about_ca_system_score_codex":0.00058462203,"about_ca_system_score_gemma":0.00027788655,"threshold_uncertainty_score":0.02700442},"labels":[],"label_agreement":null},{"id":"W2606803751","doi":"10.1089/cap.2016.0146","title":"Repetitive Transcranial Magnetic Stimulation for the Treatment of Executive Function Deficits in Autism Spectrum Disorder: Clinical Trial Approach","year":2017,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Transcranial Magnetic Stimulation Studies","field":"Neuroscience","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Centre for Addiction and Mental Health; Hospital for Sick Children; University of Toronto","funders":"National Institute of Mental Health","keywords":"Transcranial magnetic stimulation; Autism spectrum disorder; Psychology; Dorsolateral prefrontal cortex; Neuropsychology; Autism; Physical medicine and rehabilitation; Randomized controlled trial; Executive functions; Neuroscience; Executive dysfunction; Brain stimulation; Clinical trial; Prefrontal cortex; Psychiatry; Audiology; Medicine; Cognition; Stimulation; Internal medicine","score_opus":0.059196052382328425,"score_gpt":0.3675577164541346,"score_spread":0.30836166407180615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606803751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7648983,0.034869723,0.0056636673,0.00695608,0.003152098,0.16387664,0.0062041185,0.0005381571,0.0138411755],"genre_scores_gemma":[0.7371872,0.015998343,0.009898748,0.005719272,0.0019943241,0.21452413,0.0026728457,0.000060224804,0.011944862],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983347,0.0010262644,0.00015508007,0.00019307408,0.00012106212,0.00016988462],"domain_scores_gemma":[0.99858606,0.00043315906,0.0003479595,0.00009891182,0.00018882396,0.00034509235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044350387,0.0017925543,0.0024281647,0.00056373957,0.0005480523,0.0014098455,0.0010318323,0.002884335,0.0115357265],"category_scores_gemma":[0.0038572375,0.00044331417,0.0018807736,0.00061230303,0.0008010249,0.0012497362,0.000538857,0.0027853476,0.0016012898],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.921637,0.014047194,0.00082000304,0.004720018,0.0018769483,0.00016490859,0.00012288486,0.0004668615,0.0041117347,0.00072975084,0.003114658,0.04818813],"study_design_scores_gemma":[0.929632,0.06555578,0.00074733613,0.00020396749,0.00044541442,0.00004498983,0.000025930121,0.00027398026,0.00031423016,0.00031123342,0.0024321978,0.000012919903],"about_ca_topic_score_codex":0.00060542737,"about_ca_topic_score_gemma":0.0019513525,"teacher_disagreement_score":0.0115357265,"about_ca_system_score_codex":0.0009826365,"about_ca_system_score_gemma":0.0023071582,"threshold_uncertainty_score":0.03859085},"labels":[],"label_agreement":null},{"id":"W2726321932","doi":"10.1089/cap.2016.0026","title":"Randomized, Double-Blind, Placebo-Controlled Trial Demonstrates the Efficacy and Safety of Oral Aripiprazole for the Treatment of Tourette's Disorder in Children and Adolescents","year":2017,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Obsessive-Compulsive Spectrum Disorders","field":"Psychology","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Otsuka Pharmaceutical","keywords":"Aripiprazole; Placebo; Tourette syndrome; Randomized controlled trial; Medicine; Clinical endpoint; Population; Tics; Randomization; Adverse effect; Internal medicine; Placebo-controlled study; Psychology; Psychiatry; Pediatrics; Double blind; Schizophrenia (object-oriented programming)","score_opus":0.015098741694445054,"score_gpt":0.336352780779681,"score_spread":0.321254039085236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2726321932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96706253,0.011058043,0.0012123092,0.001842464,0.0015200648,0.00927169,0.0028364349,0.0002587006,0.0049377293],"genre_scores_gemma":[0.97938997,0.0045458456,0.0030282699,0.0014074774,0.00070551777,0.007342024,0.0011267151,0.00003282723,0.0024213246],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99893504,0.00060692587,0.00011590521,0.00015647615,0.0000946247,0.00009095544],"domain_scores_gemma":[0.99822944,0.000635951,0.0005184247,0.000111532485,0.00014067665,0.00036400833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002694478,0.00092866266,0.0025782418,0.00029506485,0.00051848975,0.0008576465,0.0007027799,0.0018954733,0.009933871],"category_scores_gemma":[0.0036328388,0.0004495412,0.0013061173,0.00035609727,0.00092333107,0.000912849,0.00023301497,0.0024855824,0.0008704225],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9710476,0.005321322,0.0005085925,0.0013504899,0.0012059908,0.00003295257,0.000048833193,0.00013441461,0.002150874,0.00009590683,0.00127481,0.01682829],"study_design_scores_gemma":[0.9782704,0.019507792,0.0012064747,0.00004243902,0.00025397082,0.000017236858,0.000008524983,0.00013229104,0.00017928619,0.00003703069,0.0003391214,0.0000054618663],"about_ca_topic_score_codex":0.0009730602,"about_ca_topic_score_gemma":0.0028110219,"teacher_disagreement_score":0.009933871,"about_ca_system_score_codex":0.00055822503,"about_ca_system_score_gemma":0.0012161069,"threshold_uncertainty_score":0.033232093},"labels":[],"label_agreement":null},{"id":"W2766321264","doi":"10.1089/cap.2017.0036","title":"Movement Disorders in Children and Adolescents Receiving Antipsychotic Pharmacotherapy: A Population-Based Study","year":2017,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Manitoba Health; University of Manitoba","funders":"Johns Hopkins University","keywords":"Pharmacotherapy; Antipsychotic; Psychiatry; Movement disorders; Medicine; Population; Psychology; Clinical psychology; Pediatrics; Schizophrenia (object-oriented programming); Internal medicine; Environmental health","score_opus":0.010967943981367186,"score_gpt":0.33830409833191155,"score_spread":0.32733615435054436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766321264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991003,0.00013025975,0.000032980995,0.000026805204,0.000002550637,0.000017670432,0.00048719472,0.0000019626814,0.00020029557],"genre_scores_gemma":[0.9987155,0.00027104045,0.00011005289,0.000037289097,0.000007732439,0.000021680002,0.00069180044,0.000001870312,0.00014296825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996088,0.000045223864,0.000027851627,0.000075572374,0.00014126644,0.00010134753],"domain_scores_gemma":[0.9992137,0.00005744653,0.000335431,0.000034137298,0.00017773741,0.0001815876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037621896,0.000329228,0.00042099378,0.0011983543,0.00076782494,0.0008054061,0.0005458603,0.00041749066,0.00080206565],"category_scores_gemma":[0.0010372754,0.0003940041,0.0004644565,0.0018492304,0.00036258367,0.00039080647,0.0003774164,0.00062447804,0.00019302039],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009938583,0.0000147113215,0.99956423,0.0000026968596,0.000012931046,0.000048309354,0.00007575358,0.000006958992,0.000040231007,0.0000030078356,0.000030770174,0.00019039745],"study_design_scores_gemma":[0.0000036909673,0.00003226479,0.9993562,0.0000053546055,0.000010904149,0.00016315773,0.000284353,0.000033834564,0.000012453666,0.0000024886863,0.00009389925,0.0000014391851],"about_ca_topic_score_codex":0.3251373,"about_ca_topic_score_gemma":0.34390295,"teacher_disagreement_score":0.3251373,"about_ca_system_score_codex":0.0016456149,"about_ca_system_score_gemma":0.0019962795,"threshold_uncertainty_score":0.64648956},"labels":[],"label_agreement":null},{"id":"W2795652405","doi":"10.1089/cap.2017.0072","title":"Effects of Metformin on Spatial and Verbal Memory in Children with ASD and Overweight Associated with Atypical Antipsychotic Use","year":2018,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Holland Bloorview Kids Rehabilitation Hospital","funders":"","keywords":"Overweight; Atypical antipsychotic; Metformin; Antipsychotic; Psychology; Verbal memory; Clinical psychology; Medicine; Psychiatry; Schizophrenia (object-oriented programming); Obesity; Internal medicine; Cognition; Diabetes mellitus; Endocrinology","score_opus":0.003876757975892806,"score_gpt":0.23470639048287917,"score_spread":0.23082963250698635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795652405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990645,0.0006937801,0.000012026165,0.000042120482,0.000004927937,0.000008471451,0.000028096794,0.0000017504283,0.00014433402],"genre_scores_gemma":[0.9989411,0.00064550346,0.0001536887,0.00005696165,0.000008299043,0.000022346341,0.00006048047,9.151554e-7,0.000110791494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997433,0.000107511674,0.000036625817,0.000024416322,0.00004450813,0.00004368487],"domain_scores_gemma":[0.9992318,0.00028195686,0.00030005877,0.00002750842,0.000047724327,0.00011089594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068714644,0.0002692457,0.0004134227,0.0002427093,0.0002156963,0.00022756241,0.00017552117,0.0002959577,0.00079624564],"category_scores_gemma":[0.0018130015,0.00011579605,0.000540156,0.00019839217,0.00025586123,0.00023896535,0.000256798,0.0005246356,0.00005514483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13109219,0.0096451575,0.6370029,0.0009755413,0.0014349078,0.0013251755,0.0008086369,0.00057298166,0.015997427,0.00014828764,0.0008507958,0.200146],"study_design_scores_gemma":[0.003516067,0.05809643,0.9301755,0.00013346592,0.0007124352,0.0009083857,0.00064364605,0.00041639764,0.0044039665,0.00008753159,0.0008905025,0.000015656193],"about_ca_topic_score_codex":0.0018964814,"about_ca_topic_score_gemma":0.005144785,"teacher_disagreement_score":0.0018964814,"about_ca_system_score_codex":0.00038119595,"about_ca_system_score_gemma":0.0003770611,"threshold_uncertainty_score":0.0037709475},"labels":[],"label_agreement":null},{"id":"W2800909021","doi":"10.1089/cap.2017.0164","title":"L-Tryptophan As Treatment for Pediatric Non-Rapid Eye Movement Parasomnia","year":2018,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Sleep and Wakefulness Research","field":"Neuroscience","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Centre of Excellence for Child and Youth Mental Health","funders":"","keywords":"Parasomnia; Polysomnography; Medicine; Psychosocial; Pediatrics; Psychiatry; Psychology; Electroencephalography","score_opus":0.02934978133277189,"score_gpt":0.36530700314375103,"score_spread":0.33595722181097915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800909021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8488185,0.14517649,0.0005901752,0.0011086679,0.00019478625,0.00011719781,0.00029867794,0.00008646935,0.003609171],"genre_scores_gemma":[0.96359897,0.033673164,0.0013728231,0.00027381114,0.00013443855,0.000094842624,0.00027561758,0.000008738332,0.00056769926],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998599,0.000054404474,0.00002049126,0.000013922001,0.000030103141,0.000021066448],"domain_scores_gemma":[0.9996846,0.000093258976,0.00014284955,0.0000066680236,0.000024859632,0.000047771093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014151615,0.00015273833,0.00028751587,0.00024405774,0.00019743788,0.00015505051,0.00024475265,0.00029524832,0.0009644924],"category_scores_gemma":[0.000620098,0.000050697963,0.00027542113,0.00030048855,0.0001430828,0.00009670169,0.00012815438,0.000356613,0.00016714708],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042272825,0.0020510126,0.39119497,0.004344448,0.00059071474,0.012548304,0.00048320534,0.0005926157,0.011517368,0.00030037,0.007829816,0.56431997],"study_design_scores_gemma":[0.0018576072,0.01655587,0.88417745,0.0018708761,0.00078128115,0.04200538,0.00088917935,0.0007970203,0.008305772,0.00016987207,0.042562105,0.000027582835],"about_ca_topic_score_codex":0.0012748361,"about_ca_topic_score_gemma":0.0029125314,"teacher_disagreement_score":0.0012748361,"about_ca_system_score_codex":0.0002444574,"about_ca_system_score_gemma":0.00042287455,"threshold_uncertainty_score":0.0032265782},"labels":[],"label_agreement":null},{"id":"W2898240698","doi":"10.1089/cap.2017.0137","title":"Cortical Volume and Thickness Across Bipolar Disorder Subtypes in Adolescents: A Preliminary Study","year":2018,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Bipolar disorder; Volume (thermodynamics); Psychology; Brain size; Medicine; Psychiatry; Clinical psychology; Lithium (medication); Magnetic resonance imaging; Physics; Radiology","score_opus":0.00986270381566609,"score_gpt":0.31972585735092734,"score_spread":0.3098631535352613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898240698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99931145,0.00014653818,0.0000968477,0.0000072332723,0.0000015650002,0.000012221074,0.00015118692,0.0000027298386,0.000270306],"genre_scores_gemma":[0.999153,0.0001036182,0.00030291596,0.000009188537,0.000004348387,0.000015968053,0.00024155126,0.0000035701412,0.0001657732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99988794,0.000020887192,0.000011194084,0.00003208727,0.000032011714,0.00001575564],"domain_scores_gemma":[0.9996797,0.000055147553,0.00011499362,0.000031304615,0.00006699253,0.0000519044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037623526,0.00025151655,0.00017267394,0.000668717,0.00026028493,0.00033124263,0.00017252039,0.00020040746,0.0014850702],"category_scores_gemma":[0.0008449926,0.00020536453,0.0001963273,0.00034863333,0.00022938878,0.00022501608,0.00024469616,0.0002088817,0.00022300836],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074628013,0.00009835283,0.97813123,0.000047966172,0.000080506994,0.000390689,0.0010686957,0.00010084818,0.008006405,0.000060995488,0.00020119867,0.011066799],"study_design_scores_gemma":[0.000013224416,0.00013113479,0.99861574,0.000005780064,0.000019275187,0.00044498572,0.00019244375,0.000059020338,0.00030177846,0.0000202736,0.00019503299,0.0000012474435],"about_ca_topic_score_codex":0.0026908964,"about_ca_topic_score_gemma":0.00568893,"teacher_disagreement_score":0.0026908964,"about_ca_system_score_codex":0.0001551931,"about_ca_system_score_gemma":0.00014374139,"threshold_uncertainty_score":0.0053504705},"labels":[],"label_agreement":null},{"id":"W2911380759","doi":"10.1089/cap.2018.0115","title":"Atypical Antipsychotics for Irritability in Pediatric Autism: A Systematic Review and Network Meta-Analysis","year":2019,"lang":"en","type":"review","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Autism Spectrum Disorder Research","field":"Neuroscience","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster Children's Hospital; Thompson Rivers University; McMaster University; University of Toronto","funders":"","keywords":"Aripiprazole; Irritability; Risperidone; Autism; Meta-analysis; Psychiatry; Randomized controlled trial; Quetiapine; Medicine; Atypical antipsychotic; Placebo; Psychology; Adverse effect; Antipsychotic; Pediatrics; Internal medicine; Schizophrenia (object-oriented programming); Anxiety","score_opus":0.11741493158957868,"score_gpt":0.42067807092536336,"score_spread":0.3032631393357847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911380759","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0057316795,0.991437,0.0007891141,0.00025093582,0.00014737621,0.00061439973,0.00067393464,0.00003743601,0.00031815813],"genre_scores_gemma":[0.22093931,0.7684034,0.004431544,0.0010246144,0.00027357857,0.0032836588,0.001192105,0.000043069696,0.00040870561],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9893694,0.0052519008,0.0028407362,0.001055313,0.0011649822,0.0003175773],"domain_scores_gemma":[0.98287576,0.012016425,0.002902154,0.00049655355,0.0014735635,0.00023547442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0156561,0.0029258386,0.016271476,0.0075442595,0.0006842121,0.0027645694,0.0024655869,0.001910126,0.0038933353],"category_scores_gemma":[0.03362367,0.0014041668,0.03876216,0.0072642663,0.0006765656,0.0020596422,0.0019066209,0.0018849229,0.00027599023],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001428698,0.00003224002,0.002907019,0.3158183,0.6699888,0.00009050105,0.00007039605,0.0004811247,0.00014204465,0.00010937187,0.00048197244,0.008449496],"study_design_scores_gemma":[0.0006329707,0.00014412455,0.0026027123,0.022171706,0.97293186,0.00006756213,0.000033787972,0.00021516006,0.00006862345,0.00016115958,0.00095099764,0.000019315417],"about_ca_topic_score_codex":0.008985607,"about_ca_topic_score_gemma":0.021402774,"teacher_disagreement_score":0.016271476,"about_ca_system_score_codex":0.0034036394,"about_ca_system_score_gemma":0.0042519877,"threshold_uncertainty_score":0.08279836},"labels":[],"label_agreement":null},{"id":"W2914065250","doi":"10.1089/cap.2018.0093","title":"A Quantitative Comparison Approach for Methylphenidate Drug Regimens in Attention-Deficit/Hyperactivity Disorder Treatment","year":2019,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa; Université de Montréal","funders":"","keywords":"Methylphenidate; Attention deficit hyperactivity disorder; Drug; Attention deficit disorder; Attention deficit; Psychology; Psychiatry; Clinical psychology; Medicine","score_opus":0.03283924524721002,"score_gpt":0.37175492547990147,"score_spread":0.3389156802326915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914065250","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025536079,0.0004780801,0.9710844,0.00021336315,0.000046417277,0.00031930543,0.00016288056,0.00040866746,0.0017508337],"genre_scores_gemma":[0.45352438,0.00020645939,0.54403454,0.0001441345,0.00007852212,0.0007108683,0.00042982216,0.00010661861,0.00076473877],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9877517,0.007045714,0.0007006829,0.0012813315,0.003030847,0.00018961998],"domain_scores_gemma":[0.9819785,0.01344696,0.0016647358,0.00082732236,0.0018077889,0.0002748026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013950155,0.0010278333,0.0010206554,0.0040716976,0.0004828214,0.0015748385,0.001611586,0.00092434115,0.002663968],"category_scores_gemma":[0.03871952,0.00033845246,0.0012613347,0.0018470173,0.0010700317,0.002015869,0.0014395418,0.0011068628,0.0002602212],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073754863,0.0005389769,0.019716268,0.0006873725,0.0006073277,0.00019100848,0.0005282274,0.32002705,0.008938435,0.050748125,0.0024481444,0.59483147],"study_design_scores_gemma":[0.000035024197,0.0006621593,0.004772271,0.000058119167,0.0000832229,0.000098509976,0.0000942761,0.9717865,0.0026961288,0.017436575,0.0022430154,0.000034229834],"about_ca_topic_score_codex":0.0017744739,"about_ca_topic_score_gemma":0.0014696607,"teacher_disagreement_score":0.013950155,"about_ca_system_score_codex":0.001894594,"about_ca_system_score_gemma":0.0018791471,"threshold_uncertainty_score":0.073776364},"labels":[],"label_agreement":null},{"id":"W2916037909","doi":"10.1089/cap.2018.0167","title":"Adherence to Antipsychotic Adverse Effect Monitoring Among a Referred Sample of Children with Intellectual Disabilities","year":2019,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Down syndrome and intellectual disability research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Calgary; University of Toronto","funders":"","keywords":"Medicine; Adverse effect; Antipsychotic; Risperidone; Cohort; Pediatrics; Population; Psychiatry; Schizophrenia (object-oriented programming); Internal medicine; Environmental health","score_opus":0.02254896682571524,"score_gpt":0.33782976954144456,"score_spread":0.31528080271572934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916037909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999363,0.000076263015,0.000016426946,0.00003069865,0.0000019168058,0.000016724203,0.00025134737,0.000002006337,0.00024161079],"genre_scores_gemma":[0.99933356,0.00012423273,0.00006766395,0.00003271272,0.000005790146,0.000023445777,0.0003538423,0.0000016743202,0.000057058853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834037,0.00028079684,0.00026495405,0.00025345778,0.0006049921,0.00025554388],"domain_scores_gemma":[0.9939865,0.0006967435,0.0040022917,0.00021158821,0.00074711925,0.00035576674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000954022,0.00024139152,0.00038297405,0.001582168,0.00081218977,0.0008416737,0.0006496509,0.0003987466,0.0009107453],"category_scores_gemma":[0.007202457,0.0002919434,0.00045768294,0.0017637677,0.0004696612,0.00046747105,0.0007502275,0.0007721018,0.00014316659],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013650266,0.00001868197,0.9988851,0.0000062889712,0.000008138813,0.000088286986,0.00025591018,0.000007402323,0.00005761371,0.0000033873243,0.000045513516,0.00061001506],"study_design_scores_gemma":[0.0000017713062,0.00003154169,0.9990814,0.000006897388,0.000004687753,0.0002807208,0.00048092837,0.000028983948,0.000029613388,0.0000018591919,0.00005010566,0.0000015043421],"about_ca_topic_score_codex":0.062143818,"about_ca_topic_score_gemma":0.060512893,"teacher_disagreement_score":0.062143818,"about_ca_system_score_codex":0.0015680469,"about_ca_system_score_gemma":0.0011769683,"threshold_uncertainty_score":0.12356418},"labels":[],"label_agreement":null},{"id":"W2926443144","doi":"10.1089/cap.2019.0015","title":"Inflammatory Cytokines in Children and Adolescents with Depressive Disorders: A Systematic Review and Meta-Analysis","year":2019,"lang":"en","type":"review","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Meta-analysis; Depression (economics); Clinical psychology; Medicine; Major depressive disorder; Web of science; Cytokine; Systematic review; Psychology; Psychiatry; MEDLINE; Internal medicine; Cognition; Biology","score_opus":0.02638652138945288,"score_gpt":0.321279638830874,"score_spread":0.29489311744142116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2926443144","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017514721,0.9972596,0.00023317787,0.0000997973,0.0000716281,0.00020898061,0.0002416015,0.000011598386,0.00012209255],"genre_scores_gemma":[0.054581705,0.94198984,0.0015007292,0.00039536928,0.00013746737,0.00081769825,0.00040596447,0.000011179796,0.00016007684],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99374986,0.0028100107,0.0018334558,0.0006451629,0.00072204665,0.00023946317],"domain_scores_gemma":[0.9888508,0.008214815,0.001634385,0.00029964652,0.00085946225,0.00014086995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010225618,0.00270432,0.016577872,0.006162169,0.00063680025,0.0028602565,0.0019077084,0.0019015308,0.0033242109],"category_scores_gemma":[0.02550008,0.0013782812,0.025743062,0.0063980683,0.00057363004,0.0014066161,0.0014137554,0.0014054085,0.00025145276],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010720389,0.000024758661,0.0029451873,0.67364025,0.30188817,0.00012493247,0.00009402218,0.0004090698,0.00020387325,0.00014469633,0.00078393146,0.018669149],"study_design_scores_gemma":[0.0004642591,0.0002186608,0.003869016,0.07009084,0.92171353,0.00015569295,0.00006324569,0.00015946022,0.00014444343,0.0001955192,0.0029020223,0.000023194609],"about_ca_topic_score_codex":0.005874518,"about_ca_topic_score_gemma":0.014747066,"teacher_disagreement_score":0.016577872,"about_ca_system_score_codex":0.0025121444,"about_ca_system_score_gemma":0.004054309,"threshold_uncertainty_score":0.054078937},"labels":[],"label_agreement":null},{"id":"W2949223627","doi":"10.1089/cap.2018.0140","title":"Immune-Related Comorbidities in Childhood-Onset Obsessive Compulsive Disorder: Lifetime Prevalence in the Obsessive Compulsive Disorder Collaborative Genetics Association Study","year":2019,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Obsessive-Compulsive Spectrum Disorders","field":"Psychology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"Canadian Institutes of Health Research; National Institute of Mental Health; BC Children's Hospital","keywords":"Obsessive compulsive; Psychiatry; Association (psychology); Comorbidity; Tic disorder; Psychology; Clinical psychology; Medicine; Psychotherapist; Tourette syndrome","score_opus":0.005034641726742389,"score_gpt":0.28643100434680424,"score_spread":0.28139636262006185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949223627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987614,0.0004568789,0.000054761116,0.0000707828,0.000007115202,0.0000051585357,0.00046842836,0.0000032171083,0.00017228385],"genre_scores_gemma":[0.9991522,0.0001822348,0.00009118472,0.000021783551,0.000013214193,0.0000073376627,0.00044936166,0.0000024152616,0.000080326696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885166,0.00028026415,0.00012767757,0.00035955565,0.00024066088,0.00014018654],"domain_scores_gemma":[0.9970222,0.0003206099,0.0016408566,0.00016378307,0.00027117174,0.00058120716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008832096,0.0004793244,0.00049064873,0.0012735297,0.0007081652,0.00087187486,0.0005909503,0.0007993547,0.0013432943],"category_scores_gemma":[0.00286833,0.00039585753,0.00054045185,0.0017428369,0.00038346465,0.00043103634,0.0007599377,0.00079708576,0.00012802552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025710207,0.0000106635325,0.9993938,0.0000037247348,0.000056762474,0.00011082437,0.000036487563,0.000011263279,0.000102995116,0.000006652849,0.000045490167,0.00019558334],"study_design_scores_gemma":[0.000005806507,0.000018638146,0.999257,0.0000057223215,0.000028357103,0.00047972673,0.00007553576,0.0000526089,0.000018849232,0.0000064213905,0.00004921886,0.0000020690256],"about_ca_topic_score_codex":0.020742755,"about_ca_topic_score_gemma":0.024632739,"teacher_disagreement_score":0.020742755,"about_ca_system_score_codex":0.0005037496,"about_ca_system_score_gemma":0.0004816114,"threshold_uncertainty_score":0.04124403},"labels":[],"label_agreement":null},{"id":"W2950364284","doi":"10.1089/cap.2018.0171","title":"Pharmacogenetics of Metformin for Medication-Induced Weight Gain in Autism Spectrum Disorder","year":2019,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Holland Bloorview Kids Rehabilitation Hospital; University of Toronto","funders":"Sanofi; Autism Speaks; U.S. Department of Health and Human Services; Health Resources and Services Administration; U.S. Department of Defense","keywords":"Metformin; Autism spectrum disorder; Medicine; Diabetes mellitus; Pharmacogenetics; Internal medicine; Placebo; Weight gain; Type 2 diabetes; Single-nucleotide polymorphism; Population; Endocrinology; Autism; Oncology; Genotype; Pharmacology; Psychiatry; Biology; Body weight; Gene; Genetics","score_opus":0.01000379071437605,"score_gpt":0.2989694973753706,"score_spread":0.2889657066609945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950364284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971023,0.0011814012,0.0006979071,0.00021665027,0.00001902618,0.00002525198,0.00022636734,0.00001607016,0.0005150176],"genre_scores_gemma":[0.99853325,0.00023350751,0.00090872875,0.00006027271,0.000009341698,0.000015709453,0.000108727036,0.000005328067,0.00012514142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992663,0.00031041124,0.00007127288,0.00014383532,0.00016568076,0.000042523156],"domain_scores_gemma":[0.9988938,0.00041085802,0.00053501374,0.000048776335,0.0000535645,0.00005802462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009431972,0.00029909832,0.0003356215,0.00046170445,0.00023046188,0.00038590556,0.00023635475,0.00034503045,0.0012561758],"category_scores_gemma":[0.0024045077,0.00011706281,0.00058179436,0.0003391168,0.00018083729,0.0001597289,0.00027892942,0.00041174365,0.000085918844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016892655,0.0001845465,0.9687394,0.000067419474,0.00079704664,0.00041627837,0.00007824273,0.00044591143,0.008340998,0.00018261578,0.00026185933,0.018796325],"study_design_scores_gemma":[0.00006315595,0.000351598,0.995083,0.000027873939,0.00023355529,0.00063403655,0.000040286428,0.0016956383,0.0013313578,0.00015702937,0.0003744512,0.000007957053],"about_ca_topic_score_codex":0.0020084355,"about_ca_topic_score_gemma":0.0039882944,"teacher_disagreement_score":0.0020084355,"about_ca_system_score_codex":0.0004814815,"about_ca_system_score_gemma":0.0002653254,"threshold_uncertainty_score":0.0049881935},"labels":[],"label_agreement":null},{"id":"W2965202281","doi":"10.1089/cap.2019.0018","title":"The Pharmacoepidemiology of Psychotropic Medication Use in Canadian Children from 2012 to 2016","year":2019,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medical prescription; Aripiprazole; Antipsychotic; Guanfacine; Pharmacoepidemiology; Psychiatry; Medicine; Methylphenidate; Attention deficit hyperactivity disorder; Adverse effect; Pharmacology; Schizophrenia (object-oriented programming); Internal medicine","score_opus":0.018016409777176185,"score_gpt":0.3372949577962465,"score_spread":0.31927854801907035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965202281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90278393,0.010003981,0.0002536698,0.0023254962,0.00009165685,0.00012569534,0.07352987,0.000059371218,0.010826325],"genre_scores_gemma":[0.98084015,0.004756159,0.00046819862,0.00035513678,0.00003404826,0.00003932479,0.012074148,0.00001159383,0.0014212511],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865437,0.000041365103,0.000086960245,0.00013840909,0.0007608501,0.0003181359],"domain_scores_gemma":[0.997735,0.00006914654,0.0005442231,0.000030496882,0.0012856594,0.0003353907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058053643,0.00041326255,0.0003805326,0.0025383884,0.0013665778,0.0010464161,0.0009439277,0.00040176473,0.0021040505],"category_scores_gemma":[0.002759363,0.00028190287,0.00097595516,0.0060184565,0.00040979887,0.00037147716,0.0005400036,0.0007501417,0.00022398114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059529026,0.00001896215,0.9868016,0.00017670008,0.00009735475,0.00010824403,0.0004354489,0.00016223124,0.000109778994,0.00009989897,0.0034989803,0.008431235],"study_design_scores_gemma":[0.0000040832447,0.000009864444,0.99671376,0.00005772674,0.000030876035,0.00008732069,0.00036157112,0.00013368993,0.000056468823,0.00000653426,0.0025298581,0.0000083196255],"about_ca_topic_score_codex":0.99615943,"about_ca_topic_score_gemma":0.99691904,"teacher_disagreement_score":0.03696236,"about_ca_system_score_codex":0.03696236,"about_ca_system_score_gemma":0.03916573,"threshold_uncertainty_score":0.26818192},"labels":[],"label_agreement":null},{"id":"W2969521336","doi":"10.1089/cap.2019.0097","title":"Treatment Patterns, Health Care Resource Utilization, and Health Care Cost Associated with Atypical Antipsychotics or Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in Quebec, Canada","year":2019,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Centre of Excellence for Child and Youth Mental Health; Queen's University; Takeda (Canada); University of Calgary; Université de Montréal","funders":"","keywords":"Discontinuation; Medicine; Medical prescription; Attention deficit hyperactivity disorder; Stimulant; Guanfacine; Psychiatry; Pediatrics; Health care; Methylphenidate; Pharmacology; Internal medicine","score_opus":0.014600609542112376,"score_gpt":0.3183630322699372,"score_spread":0.3037624227278248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969521336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98658353,0.0018179838,0.00006559338,0.0007338097,0.000016917287,0.00005706237,0.009055807,0.000012959213,0.0016564191],"genre_scores_gemma":[0.9955636,0.0007218729,0.00016184636,0.00020540295,0.000010775274,0.000028970282,0.0028803297,0.000004358535,0.00042285808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879813,0.00010481597,0.000116388845,0.00016285696,0.00043063817,0.00038709468],"domain_scores_gemma":[0.9971529,0.00017577987,0.0011210247,0.000048697275,0.0008697035,0.0006318086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005342219,0.00031852082,0.00043762717,0.0011894794,0.0014415674,0.0010138337,0.0013403333,0.00056330394,0.0018687067],"category_scores_gemma":[0.00226226,0.0003046159,0.00087954046,0.0038014469,0.000553684,0.00040464656,0.00058039726,0.0008883448,0.00014310259],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004674897,0.000031467054,0.9962269,0.000027306842,0.000070715374,0.00006236725,0.000119042525,0.00015356416,0.000046196707,0.000031461175,0.0010761727,0.002108115],"study_design_scores_gemma":[0.000009859129,0.000017771159,0.9988213,0.00003642054,0.000023523771,0.000050338964,0.00036034593,0.0003084412,0.000021968239,0.000006373119,0.00033785688,0.000005814601],"about_ca_topic_score_codex":0.9920838,"about_ca_topic_score_gemma":0.99555176,"teacher_disagreement_score":0.037636016,"about_ca_system_score_codex":0.037636016,"about_ca_system_score_gemma":0.021073654,"threshold_uncertainty_score":0.27306968},"labels":[],"label_agreement":null},{"id":"W2982790897","doi":"10.1089/cap.2019.0102","title":"Natural Health Product–Drug Interaction Causality Assessment in Pediatric Adverse Event Reports Associated with Attention-Deficit/Hyperactivity Disorder Medication","year":2019,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; University of Alberta; Children's Hospital of Eastern Ontario; University of Ottawa","funders":"University of Ottawa","keywords":"Attention deficit hyperactivity disorder; Causality (physics); Adverse effect; Adverse drug event; Psychiatry; Medicine; Adverse Event Reporting System; Drug; Extended release; Pharmacovigilance; Psychology; Natural product; Clinical psychology; Pharmacology","score_opus":0.011854496796618756,"score_gpt":0.36018349659029664,"score_spread":0.3483289997936779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982790897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67463875,0.19033495,0.029534638,0.0032933115,0.00051850505,0.0151014365,0.07344677,0.00033331072,0.012798272],"genre_scores_gemma":[0.8888335,0.029627759,0.04540096,0.0012430333,0.0004589383,0.0062270947,0.02748587,0.000043784825,0.0006790454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9293213,0.021969818,0.03208201,0.003968128,0.012096677,0.0005620332],"domain_scores_gemma":[0.6790008,0.16819534,0.12557973,0.0087902695,0.017511975,0.0009218706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04354064,0.00057079125,0.0014810968,0.012636628,0.00063301774,0.0014357994,0.0012243727,0.0008597353,0.0021046284],"category_scores_gemma":[0.115436606,0.00036401718,0.0033548814,0.01017872,0.0008958589,0.001437565,0.0019621078,0.0009418058,0.00024288894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085469696,0.00012991553,0.897309,0.023775326,0.0023943381,0.0013382396,0.0009918943,0.00072343095,0.00043434926,0.00077989395,0.0025678556,0.06870099],"study_design_scores_gemma":[0.00026969815,0.0009368815,0.9366535,0.010376844,0.0048031732,0.0055159773,0.0011141623,0.0022662333,0.0022406022,0.0020502442,0.033669762,0.00010298265],"about_ca_topic_score_codex":0.004166798,"about_ca_topic_score_gemma":0.006001297,"teacher_disagreement_score":0.04354064,"about_ca_system_score_codex":0.0013105676,"about_ca_system_score_gemma":0.004238016,"threshold_uncertainty_score":0.2302677},"labels":[],"label_agreement":null},{"id":"W2997245035","doi":"10.1089/cap.2019.0121","title":"Antidepressant Prescriptions, Including Tricyclics, Continue to Increase in Canadian Children","year":2020,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Child and Adolescent Psychosocial and Emotional Development","field":"Psychology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"University of Calgary","keywords":"Antidepressant; Medical prescription; Psychiatry; Medicine; Serotonin Uptake Inhibitors; Psychology; Pharmacology; Internal medicine; Anxiety; Serotonin; Fluoxetine","score_opus":0.02180506892868303,"score_gpt":0.30681911109319937,"score_spread":0.2850140421645163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997245035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69587284,0.045795668,0.0012628471,0.025668154,0.00048098122,0.00025728808,0.18260214,0.000252387,0.047807768],"genre_scores_gemma":[0.94161403,0.027757253,0.0023498225,0.0034926308,0.00013755597,0.00009723724,0.021203408,0.000045314144,0.0033027683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974619,0.00010886528,0.00014891673,0.00026885275,0.0014826624,0.00052882044],"domain_scores_gemma":[0.99293387,0.00026929335,0.0018267522,0.00012055932,0.004213164,0.0006363936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011624481,0.00043965428,0.0005598545,0.0026067856,0.0027624709,0.0019026751,0.0014792046,0.00060447486,0.005010755],"category_scores_gemma":[0.007848953,0.0003541864,0.0010275249,0.009023149,0.0007210239,0.0008994126,0.0009374731,0.0011379193,0.00040308153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010800596,0.000027140331,0.9098737,0.0010490027,0.00030905916,0.0002613075,0.0016958949,0.00030816442,0.00021127067,0.0014130125,0.036127623,0.048615817],"study_design_scores_gemma":[0.00001802735,0.00001980597,0.96930707,0.0006882381,0.00019368794,0.00025034478,0.0018708047,0.00031028382,0.00017149706,0.00010823469,0.027024968,0.000037246216],"about_ca_topic_score_codex":0.99746466,"about_ca_topic_score_gemma":0.99851805,"teacher_disagreement_score":0.045240093,"about_ca_system_score_codex":0.045240093,"about_ca_system_score_gemma":0.07098178,"threshold_uncertainty_score":0.32824135},"labels":[],"label_agreement":null},{"id":"W3007789977","doi":"10.1089/cap.2019.0031","title":"Similarities and Differences Across Bipolar Disorder Subtypes Among Adolescents","year":2020,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Bipolar disorder; Schedule for Affective Disorders and Schizophrenia; Anxiety; Psychiatry; Not Otherwise Specified; Psychology; Psychosocial; Suicidal ideation; Bipolar I disorder; Clinical psychology; Depression (economics); Family history; Schizophrenia (object-oriented programming); Medicine; Mania; Internal medicine; Mood; Poison control; Injury prevention","score_opus":0.013480856191546372,"score_gpt":0.2891503039091608,"score_spread":0.2756694477176144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007789977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994773,0.00014449791,0.000023386061,0.000016886068,0.0000026914765,0.00000564187,0.00006638305,9.0499026e-7,0.00026235607],"genre_scores_gemma":[0.99952483,0.00013467221,0.000045036984,0.000014778364,0.0000048946686,0.000006712843,0.00019770987,0.0000012096913,0.00007023767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998204,0.000032641066,0.000024028981,0.000043432592,0.000044111508,0.00003538751],"domain_scores_gemma":[0.99966514,0.00005377417,0.0001563613,0.000013197534,0.000041120173,0.00007047326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028096832,0.00013100881,0.00021940084,0.0007219807,0.00031392518,0.00043617887,0.00015229681,0.00023203105,0.001327191],"category_scores_gemma":[0.0011236373,0.00015413157,0.00019563794,0.0004279883,0.00018734994,0.00025622986,0.00023867775,0.00022930196,0.00014188165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005930803,0.000016549131,0.9965264,0.000009725096,0.000018976423,0.00007865464,0.00033440033,0.000014127495,0.0003411184,0.000031175554,0.00006930062,0.0025003508],"study_design_scores_gemma":[0.0000029320747,0.000026920361,0.99908996,0.000007244923,0.000005037265,0.00023697704,0.00048341881,0.000027506823,0.000019442914,0.00002626655,0.0000737735,5.957837e-7],"about_ca_topic_score_codex":0.0026309306,"about_ca_topic_score_gemma":0.006239091,"teacher_disagreement_score":0.0026309306,"about_ca_system_score_codex":0.0002012738,"about_ca_system_score_gemma":0.00016488534,"threshold_uncertainty_score":0.0052312613},"labels":[],"label_agreement":null},{"id":"W3008537081","doi":"10.1089/cap.2019.0179","title":"Development of a Composite Primary Outcome Score for Children with Attention-Deficit/Hyperactivity Disorder and Emotional Dysregulation","year":2020,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Lethbridge","funders":"National Center for Complementary and Integrative Health; National Center for Research Resources; National Center for Advancing Translational Sciences; National Institute of Mental Health","keywords":"Attention deficit hyperactivity disorder; Emotional dysregulation; Psychology; Clinical psychology; Attention deficit; Psychiatry","score_opus":0.028490232157642358,"score_gpt":0.31602221417499515,"score_spread":0.2875319820173528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008537081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9432635,0.0006201356,0.023863329,0.0005992759,0.00035419344,0.007323594,0.014438853,0.00035336753,0.009183808],"genre_scores_gemma":[0.91930526,0.00041817728,0.048412707,0.00019858808,0.00011630131,0.018248007,0.0118536465,0.00011288241,0.00133446],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.991979,0.0029408731,0.0012401764,0.000793762,0.0027039913,0.00034231474],"domain_scores_gemma":[0.97908974,0.0056646825,0.006110017,0.0011212922,0.006764934,0.0012493479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012360471,0.0009819556,0.001800968,0.003060271,0.0008030698,0.0011214756,0.0010333675,0.00054410566,0.00285595],"category_scores_gemma":[0.021447502,0.00033176475,0.0028247274,0.0018913966,0.00061251054,0.001071297,0.002125577,0.0018786401,0.00050604786],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002277901,0.0010531426,0.90875715,0.0008393306,0.0008131139,0.00009306856,0.000499248,0.0017636339,0.0017581576,0.00061220734,0.0034462211,0.07808691],"study_design_scores_gemma":[0.000245609,0.0024553512,0.9901552,0.00011977164,0.0002893948,0.0001175365,0.00029581832,0.0020237032,0.0017449611,0.00036638376,0.0021529053,0.000033363616],"about_ca_topic_score_codex":0.0023258806,"about_ca_topic_score_gemma":0.005395752,"teacher_disagreement_score":0.012360471,"about_ca_system_score_codex":0.0014498457,"about_ca_system_score_gemma":0.0033085067,"threshold_uncertainty_score":0.06536919},"labels":[],"label_agreement":null},{"id":"W3041514749","doi":"10.1089/cap.2020.0004","title":"Effects of Extended-Release Methylphenidate Treatment on Cognitive Task Performance in Children with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder","year":2020,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Methylphenidate; Impulsivity; Autism spectrum disorder; Attention deficit hyperactivity disorder; Dosing; Placebo; Autism Diagnostic Observation Schedule; Cognition; Psychology; Autism; Crossover study; Clinical psychology; Psychiatry; Pediatrics; Audiology; Medicine; Internal medicine","score_opus":0.008835958135404902,"score_gpt":0.2846932669110254,"score_spread":0.27585730877562054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041514749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99920624,0.00053022814,0.00002312645,0.000024119936,0.00000895887,0.000019959893,0.000042944426,0.000006373739,0.00013804568],"genre_scores_gemma":[0.99867755,0.0005952276,0.00034603325,0.000041093615,0.000014095116,0.00004153993,0.000118440905,0.0000026942823,0.0001634288],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996282,0.00014967845,0.000039618917,0.00004822314,0.00009703216,0.000037314203],"domain_scores_gemma":[0.99901235,0.00036100412,0.0003284346,0.000033869823,0.000057739755,0.00020650482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046567203,0.0006236617,0.00069932145,0.00018020626,0.00015432497,0.00018817959,0.00036565415,0.00042020174,0.0006894295],"category_scores_gemma":[0.0022772148,0.00021959191,0.00024336902,0.00012046146,0.00031899734,0.00021451026,0.00020764736,0.0005677514,0.000094064235],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28496325,0.04454214,0.23719455,0.0031343745,0.0038016513,0.001663399,0.0016622469,0.0026931856,0.13463803,0.000082950406,0.0015120468,0.2841122],"study_design_scores_gemma":[0.011180627,0.13513482,0.83952016,0.00009867061,0.0006539457,0.00088240125,0.0002942085,0.0007851765,0.010264759,0.000036164925,0.0011190205,0.00002999579],"about_ca_topic_score_codex":0.0022392364,"about_ca_topic_score_gemma":0.004823247,"teacher_disagreement_score":0.0022392364,"about_ca_system_score_codex":0.00026284409,"about_ca_system_score_gemma":0.0003500037,"threshold_uncertainty_score":0.0044524074},"labels":[],"label_agreement":null},{"id":"W3092567841","doi":"10.1089/cap.2019.0171","title":"Management of Acute Agitation and Aggression in Children and Adolescents with Pro Re Nata Oral Immediate Release Antipsychotics in the Pediatric Emergency Department","year":2020,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Healthcare Decision-Making and Restraints","field":"Psychology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surrey Memorial Hospital; Children's & Women's Health Centre of British Columbia","funders":"","keywords":"Quetiapine; Haloperidol; Medicine; Chlorpromazine; Antipsychotic; Emergency department; Risperidone; Population; Anesthesia; Adverse effect; Pro re nata; Pediatrics; Psychiatry; Internal medicine; Schizophrenia (object-oriented programming); Chemotherapy","score_opus":0.018146821605227674,"score_gpt":0.3502600853018701,"score_spread":0.3321132636966424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092567841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972632,0.0017490246,0.00016791886,0.000096763186,0.000010752982,0.000036207726,0.00014143826,0.000006283984,0.0005284595],"genre_scores_gemma":[0.9969573,0.0019871427,0.00055161497,0.0000814765,0.000032457086,0.00003604041,0.00025703735,0.0000026933171,0.00009422693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962175,0.00006184103,0.00008466599,0.00004099771,0.000119239,0.00007146364],"domain_scores_gemma":[0.9985978,0.00021226614,0.0009225478,0.000023643475,0.00008954504,0.00015419365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030928932,0.00019299921,0.0003672554,0.00059155864,0.00037766635,0.00034549818,0.00025443378,0.0002388371,0.000602508],"category_scores_gemma":[0.0017505601,0.00015646977,0.00030383078,0.00065236556,0.00030802487,0.0002895976,0.00027414033,0.0005073016,0.00010370953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017215742,0.00007851422,0.9784953,0.00012926907,0.000032264605,0.010038958,0.00020539155,0.00008073651,0.0006655842,0.000028719924,0.000342533,0.00973043],"study_design_scores_gemma":[0.00004153056,0.00074564863,0.92487603,0.00014272775,0.0000692743,0.07018893,0.0012739233,0.000313786,0.00093372277,0.000045096433,0.0013602426,0.000009167455],"about_ca_topic_score_codex":0.0015356153,"about_ca_topic_score_gemma":0.0045577637,"teacher_disagreement_score":0.0015356153,"about_ca_system_score_codex":0.0005395887,"about_ca_system_score_gemma":0.00092304475,"threshold_uncertainty_score":0.003915012},"labels":[],"label_agreement":null},{"id":"W3092752335","doi":"10.1089/cap.2020.0093","title":"<i>CYP2D6</i> and Antipsychotic Treatment Outcomes in Children and Youth: A Systematic Review","year":2020,"lang":"en","type":"review","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Alberta Children's Hospital; Centre for Addiction and Mental Health; Women and Children’s Health Research Institute; University of Alberta; University of Calgary","funders":"","keywords":"Risperidone; CYP2D6; Antipsychotic; Medicine; Adverse effect; Psychiatry; Atypical antipsychotic; Meta-analysis; Pharmacogenetics; Psychology; Systematic review; Schizophrenia (object-oriented programming); Clinical psychology; MEDLINE; Pharmacology; Internal medicine; Genotype; Biology; Genetics","score_opus":0.05049906127649482,"score_gpt":0.40822420831748857,"score_spread":0.35772514704099373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092752335","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013680476,0.99699354,0.00012882025,0.00027675118,0.0000921299,0.00027080264,0.00063560053,0.000009606842,0.00022473375],"genre_scores_gemma":[0.027739612,0.96859837,0.00088900904,0.0010272877,0.00018223084,0.00084533775,0.0005593435,0.000008623764,0.00015021813],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99302775,0.002127656,0.0026832323,0.0005805283,0.0012984709,0.0002822701],"domain_scores_gemma":[0.971738,0.01862326,0.007085763,0.00039499204,0.0019096077,0.00024838012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007757089,0.0014303058,0.008597484,0.009011649,0.00053462276,0.002677049,0.0016487812,0.0020882424,0.0040974515],"category_scores_gemma":[0.035711303,0.0009959314,0.009814533,0.009916145,0.00074788113,0.0016594945,0.0013888426,0.0010835144,0.00026300302],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021267365,0.000011771333,0.0022040482,0.957059,0.019372385,0.00009989063,0.00009681021,0.00007805553,0.00014175958,0.00014350611,0.001470721,0.019109353],"study_design_scores_gemma":[0.00034896177,0.0002227732,0.010710877,0.79770976,0.17473076,0.00056542695,0.00018443624,0.000120361794,0.00019073456,0.0002942963,0.014885203,0.000036427125],"about_ca_topic_score_codex":0.009435773,"about_ca_topic_score_gemma":0.024542337,"teacher_disagreement_score":0.009435773,"about_ca_system_score_codex":0.0036881352,"about_ca_system_score_gemma":0.011430833,"threshold_uncertainty_score":0.04102385},"labels":[],"label_agreement":null},{"id":"W3093308502","doi":"10.1089/cap.2020.0096","title":"Impact of Antipsychotic Guidelines on Laboratory Monitoring in Children with Neurodevelopmental Disorders","year":2020,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Holland Bloorview Kids Rehabilitation Hospital; University of Toronto","funders":"","keywords":"Medicine; Guideline; Pediatrics; Antipsychotic; Retrospective cohort study; Therapeutic drug monitoring; Emergency medicine; Psychiatry; Schizophrenia (object-oriented programming); Internal medicine; Drug","score_opus":0.036843823516516286,"score_gpt":0.38967505624729637,"score_spread":0.3528312327307801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093308502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772893,0.008538021,0.00026453676,0.005139805,0.00019938084,0.00011187399,0.00261652,0.000052685205,0.005787787],"genre_scores_gemma":[0.9954342,0.002111187,0.00075961463,0.0005158229,0.00006819311,0.000048849517,0.00089479215,0.000009805037,0.00015742912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.984666,0.003971961,0.0025412138,0.00082867447,0.007113708,0.00087846164],"domain_scores_gemma":[0.8876133,0.030209804,0.056930896,0.0019939144,0.019687692,0.0035645033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00840226,0.000156706,0.00024480958,0.0013517849,0.0006038961,0.0010464829,0.000761979,0.000474235,0.00086343096],"category_scores_gemma":[0.07014282,0.00022115688,0.00040939866,0.0025343203,0.00044090292,0.0007030851,0.0008102009,0.0009041254,0.0000718206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013442921,0.000039262522,0.97836566,0.00013611243,0.000034899334,0.00017572998,0.00052498723,0.00017118527,0.00012222862,0.00008321592,0.001639867,0.018572494],"study_design_scores_gemma":[0.0000054918787,0.000055177836,0.9975727,0.0001728713,0.000016700358,0.00018307632,0.00052330585,0.00010208748,0.00012534493,0.000009739049,0.0012277066,0.0000057861266],"about_ca_topic_score_codex":0.17241734,"about_ca_topic_score_gemma":0.22373034,"teacher_disagreement_score":0.17241734,"about_ca_system_score_codex":0.005406028,"about_ca_system_score_gemma":0.01128818,"threshold_uncertainty_score":0.3428275},"labels":[],"label_agreement":null},{"id":"W3094378719","doi":"10.1089/cap.2020.0109","title":"Efficacy and Safety of Multilayer, Extended-Release Methylphenidate (PRC-063) in Children 6–12 Years of Age with Attention-Deficit/Hyperactivity Disorder: A Laboratory Classroom Study","year":2020,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"Placebo; Methylphenidate; Attention deficit hyperactivity disorder; Randomized controlled trial; Adverse effect; Confidence interval; Medicine; Rating scale; Psychology; Pediatrics; Anesthesia; Internal medicine; Psychiatry; Developmental psychology","score_opus":0.013319638023734025,"score_gpt":0.30602913961207234,"score_spread":0.2927095015883383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094378719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989434,0.00042731257,0.00010450121,0.000033306824,0.0000131767665,0.00020945727,0.00010275253,0.00002197105,0.00014417976],"genre_scores_gemma":[0.99671125,0.0008573614,0.0011301871,0.0001310207,0.00005379284,0.00033194153,0.00040244526,0.000010251535,0.00037171468],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99922967,0.00033258164,0.00006960162,0.00012782044,0.000171355,0.00006899711],"domain_scores_gemma":[0.99878544,0.00024738966,0.00037415908,0.00009561792,0.000138588,0.00035893518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013679966,0.00089321285,0.0018607493,0.00029355864,0.00040144217,0.00037568563,0.00097392965,0.00086561305,0.0018465697],"category_scores_gemma":[0.0012752053,0.00043168254,0.00076257216,0.0002048379,0.0006715197,0.0005219727,0.0003316651,0.0014806702,0.0004466039],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5572268,0.16516502,0.027441846,0.0017560624,0.0013438298,0.0005809426,0.0006285298,0.0009058632,0.1312937,0.0000655962,0.0009757274,0.11261609],"study_design_scores_gemma":[0.11158086,0.8056858,0.06666983,0.00005563609,0.00056642643,0.00054102653,0.00014327084,0.00070428266,0.012929996,0.000023998924,0.0010624777,0.00003638082],"about_ca_topic_score_codex":0.0013155607,"about_ca_topic_score_gemma":0.0024301927,"teacher_disagreement_score":0.0018607493,"about_ca_system_score_codex":0.00046544307,"about_ca_system_score_gemma":0.0009849938,"threshold_uncertainty_score":0.007234752},"labels":[],"label_agreement":null},{"id":"W3125127148","doi":"10.1089/cap.2020.0115","title":"Interventions to Improve Metabolic Risk Screening Among Children and Adolescents on Antipsychotic Medication: A Systematic Review","year":2021,"lang":"en","type":"review","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McGill University; St Mary's Hospital Centre; University of Toronto; North York General Hospital; Centre for Addiction and Mental Health","funders":"","keywords":"Psychological intervention; Medicine; Antipsychotic; Guideline; Confounding; Psychiatry; Intensive care medicine; Schizophrenia (object-oriented programming); Internal medicine","score_opus":0.026725570282334677,"score_gpt":0.3900439137712135,"score_spread":0.3633183434888788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125127148","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021870853,0.9958055,0.00017111977,0.0002629173,0.00012191288,0.0007785363,0.00030836093,0.000017839235,0.0003467984],"genre_scores_gemma":[0.02274075,0.9739906,0.0013697237,0.00047332348,0.00007668451,0.0010407651,0.0001949647,0.000006704235,0.00010646986],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9944877,0.0021388778,0.0017898683,0.000349999,0.0010495146,0.00018405497],"domain_scores_gemma":[0.98061085,0.014158004,0.0032167123,0.00021327028,0.0015121073,0.0002891701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070857657,0.0013970993,0.007491432,0.00646704,0.00062522956,0.0021875708,0.0017327707,0.0018599329,0.004058807],"category_scores_gemma":[0.035350207,0.0010072821,0.0072740326,0.006164383,0.00061308726,0.0017385472,0.001159608,0.0015110889,0.00024798315],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028887086,0.00004402883,0.0006604511,0.9394647,0.0078874305,0.00006258816,0.00021032442,0.0000985485,0.000090993606,0.00011988497,0.0010165708,0.050055653],"study_design_scores_gemma":[0.0008567122,0.00033400868,0.004001999,0.91655356,0.06667262,0.00017070383,0.0002703987,0.00011991275,0.00021028992,0.00018052042,0.010598282,0.000031135038],"about_ca_topic_score_codex":0.010478496,"about_ca_topic_score_gemma":0.029672042,"teacher_disagreement_score":0.010478496,"about_ca_system_score_codex":0.003986848,"about_ca_system_score_gemma":0.012503692,"threshold_uncertainty_score":0.03747356},"labels":[],"label_agreement":null},{"id":"W3132661997","doi":"10.1089/cap.2020.0154","title":"An International Comparison of the Information in the Regulatory-Approved Drug Labeling and Prescribing Guidelines for Pediatric Depression","year":2021,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute for Health and Care Research","keywords":"Medicine; Escitalopram; Drug; Fluoxetine; Depression (economics); Drug labeling; Off-label use; Psychiatry; Psychotropic drug; Pharmacology; Antidepressant; Internal medicine","score_opus":0.06038093288972982,"score_gpt":0.4257784441872033,"score_spread":0.36539751129747344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132661997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91953987,0.02790462,0.0025650335,0.0020953668,0.00037216168,0.0005291679,0.020130454,0.000050526643,0.026812851],"genre_scores_gemma":[0.981712,0.0059976936,0.0030133876,0.0005447506,0.00007508563,0.0002166207,0.007898815,0.00003547098,0.0005062695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97240055,0.011095094,0.008296471,0.0022895061,0.005149409,0.0007690267],"domain_scores_gemma":[0.84945315,0.07630759,0.043533728,0.004578192,0.024670376,0.0014569695],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.022574015,0.00023250919,0.0004695329,0.009336314,0.00027999413,0.0016538681,0.0006303681,0.0006398881,0.0025210236],"category_scores_gemma":[0.07727142,0.00023672078,0.0008218967,0.011844283,0.0007146383,0.0015700946,0.0013950306,0.00060856645,0.00036365076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019533408,0.00018827895,0.83627456,0.00598478,0.0012708575,0.00030760549,0.009100114,0.00045695953,0.0013562874,0.002341624,0.005809248,0.13495627],"study_design_scores_gemma":[0.000053886706,0.00028001913,0.9723681,0.0024117057,0.00046591298,0.0004204463,0.003807118,0.00028757358,0.0008576699,0.00013194585,0.018878702,0.000036968497],"about_ca_topic_score_codex":0.005477947,"about_ca_topic_score_gemma":0.0059286156,"teacher_disagreement_score":0.977426,"about_ca_system_score_codex":0.0016029548,"about_ca_system_score_gemma":0.0022640345,"threshold_uncertainty_score":0.11938429},"labels":[],"label_agreement":null},{"id":"W3148859331","doi":"10.1089/cap.2020.0159","title":"Effect of Delayed-Release and Extended-Release Methylphenidate on Caregiver Strain and Validation of Psychometric Properties of the Caregiver Strain Questionnaire: Results from a Phase 3 Trial in Children with Attention-Deficit/Hyperactivity Disorder","year":2021,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"","keywords":"Methylphenidate; Placebo; Cronbach's alpha; Clinical Global Impression; Intraclass correlation; Attention deficit hyperactivity disorder; Psychology; Clinical psychology; Randomized controlled trial; Construct validity; Convergent validity; Impulsivity; Psychiatry; Medicine; Psychometrics; Internal medicine; Internal consistency","score_opus":0.014325087195026133,"score_gpt":0.3097999356968446,"score_spread":0.2954748485018185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3148859331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99674076,0.0014097475,0.00016336219,0.00009066446,0.000045385677,0.0008354303,0.00040274303,0.000025527204,0.00028647916],"genre_scores_gemma":[0.99594814,0.0009843204,0.00091868354,0.00014675454,0.000050528677,0.0012165369,0.00043792673,0.000010435698,0.000286727],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990337,0.0005196193,0.00010139765,0.00012612334,0.00012743977,0.00009177803],"domain_scores_gemma":[0.99796814,0.0005835252,0.00061272853,0.00019933308,0.00022665509,0.0004096994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032089024,0.0011517562,0.0019989556,0.00020985649,0.0003575544,0.0005343454,0.0008401041,0.00073942705,0.0017365399],"category_scores_gemma":[0.002979735,0.0003704609,0.0014472522,0.00025286883,0.00051277404,0.00062638964,0.00037181782,0.0020226191,0.00025714393],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8547745,0.028021567,0.010288122,0.001664206,0.0028828299,0.00009446954,0.00046564775,0.0007139615,0.009013621,0.000053162184,0.0007228902,0.09130506],"study_design_scores_gemma":[0.6374567,0.28698575,0.07065786,0.0001084346,0.0011308718,0.0001222036,0.00013651348,0.00088242884,0.0018770156,0.00007617121,0.000526704,0.00003929369],"about_ca_topic_score_codex":0.0020213125,"about_ca_topic_score_gemma":0.0052421526,"teacher_disagreement_score":0.0032089024,"about_ca_system_score_codex":0.00064850954,"about_ca_system_score_gemma":0.0010372956,"threshold_uncertainty_score":0.016970515},"labels":[],"label_agreement":null},{"id":"W3153200750","doi":"10.1089/cap.2020.0146","title":"Differential Treatment Effects of Methylphenidate and Atomoxetine on Executive Functions in Children with Attention-Deficit/Hyperactivity Disorder","year":2021,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Atomoxetine; Methylphenidate; Attention deficit hyperactivity disorder; Executive functions; Psychology; Neuropsychology; Cognitive flexibility; Atomoxetine hydrochloride; Working memory; Randomized controlled trial; Medicine; Psychiatry; Audiology; Clinical psychology; Cognition; Internal medicine","score_opus":0.009261973765927004,"score_gpt":0.29584878607841997,"score_spread":0.28658681231249294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153200750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99802774,0.0013686571,0.000031684795,0.000068434645,0.000025866419,0.000098500226,0.00008436371,0.0000047355784,0.00029002616],"genre_scores_gemma":[0.9976447,0.0012124404,0.00042379898,0.000108598586,0.000048195663,0.00016109437,0.00017481593,0.000002607006,0.00022385585],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99932134,0.00030271627,0.00008566628,0.00007015402,0.00014724342,0.00007294427],"domain_scores_gemma":[0.9991021,0.00041325815,0.00023089389,0.000034260647,0.000060881157,0.00015855928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008478182,0.0003707079,0.0012410649,0.00020720513,0.00017198955,0.0002847068,0.00035651596,0.00055540923,0.0013298044],"category_scores_gemma":[0.0020938923,0.00020054913,0.000693854,0.00018639861,0.00030428878,0.00030651444,0.00021613523,0.0008536648,0.00011571945],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6098587,0.028470188,0.09959445,0.002149184,0.00480267,0.00032366387,0.00047829084,0.0009779453,0.021900285,0.00014452866,0.00078952545,0.23051056],"study_design_scores_gemma":[0.16629048,0.29827732,0.5216164,0.00021553527,0.00269512,0.00038331564,0.0003230881,0.0011395739,0.0074201454,0.00010030321,0.001499215,0.00003953489],"about_ca_topic_score_codex":0.0022911178,"about_ca_topic_score_gemma":0.0069554513,"teacher_disagreement_score":0.0022911178,"about_ca_system_score_codex":0.00058416557,"about_ca_system_score_gemma":0.0006951089,"threshold_uncertainty_score":0.0045556426},"labels":[],"label_agreement":null},{"id":"W3161573753","doi":"10.1089/cap.2020.0110","title":"Psychotropic Polypharmacy Among Children and Youth with Autism: A Systematic Review","year":2021,"lang":"en","type":"review","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Autism Spectrum Disorder Research","field":"Neuroscience","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary; University of Guelph","funders":"","keywords":"Polypharmacy; Autism; Psychiatry; Medicine; Aggression; Population; Psychology; Adverse effect; Clinical psychology; Environmental health; Intensive care medicine; Pharmacology","score_opus":0.02796741716675911,"score_gpt":0.3504485209267252,"score_spread":0.3224811037599661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161573753","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006880262,0.9987627,0.00004021347,0.00009596152,0.000037323483,0.0000692177,0.00015476234,0.0000041782564,0.00014763075],"genre_scores_gemma":[0.006007921,0.9934635,0.00016741072,0.000120902,0.000022896314,0.0000785366,0.000086742686,0.0000012430661,0.00005092939],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9981913,0.0004107598,0.00071389874,0.00017508143,0.00042241067,0.00008656867],"domain_scores_gemma":[0.9926872,0.0050100097,0.0014876629,0.00007149498,0.00062105217,0.00012261275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022727954,0.0009880578,0.0041693216,0.0068718535,0.00045199023,0.0014716295,0.001023943,0.0011056077,0.0029022468],"category_scores_gemma":[0.0120799225,0.00063408917,0.004674356,0.0065029324,0.00043371337,0.0012226944,0.0010386296,0.00072612695,0.00017886877],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014496833,0.000014805662,0.0012244285,0.9221167,0.005543112,0.00015431004,0.00013264896,0.0000888272,0.00015073616,0.00015428546,0.0018625382,0.06841258],"study_design_scores_gemma":[0.00018889456,0.00019928157,0.009324725,0.89245707,0.06732269,0.0011137709,0.0003120886,0.00010613349,0.0002077444,0.00028439713,0.028445952,0.00003727534],"about_ca_topic_score_codex":0.0100202095,"about_ca_topic_score_gemma":0.029715879,"teacher_disagreement_score":0.0100202095,"about_ca_system_score_codex":0.0021453234,"about_ca_system_score_gemma":0.0072351713,"threshold_uncertainty_score":0.019923747},"labels":[],"label_agreement":null},{"id":"W3199123346","doi":"10.1089/cap.2021.0020","title":"Home-Based Telemental Health: A Proposed Privacy and Safety Protocol and Tool","year":2021,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Telemedicine and Telehealth Implementation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"","keywords":"Checklist; Protocol (science); Patient safety; Workflow; Nursing; Medicine; Telemedicine; Health care; Mental health; Operationalization; Medical emergency; Psychology; Computer science; Psychiatry; Database","score_opus":0.018988775357511534,"score_gpt":0.3747116858644565,"score_spread":0.355722910506945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199123346","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0120520145,0.00084772485,0.6688059,0.052035928,0.002462473,0.22245727,0.0023426667,0.0032172126,0.035778802],"genre_scores_gemma":[0.021022672,0.00058336597,0.863449,0.004455002,0.00022288132,0.10463183,0.0015103861,0.0001422148,0.003982654],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8157153,0.12269542,0.035671968,0.004624822,0.017138071,0.0041544344],"domain_scores_gemma":[0.85944915,0.061966486,0.010733313,0.013228617,0.04476045,0.009861961],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.23619369,0.0016439125,0.0012631261,0.0065532755,0.0050705983,0.011764142,0.0071469834,0.010427565,0.00759108],"category_scores_gemma":[0.1536227,0.0017110825,0.0027226927,0.0035530073,0.007875052,0.0145647805,0.012556988,0.010095823,0.004955424],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010174327,0.005674497,0.01710339,0.0052481173,0.00013795853,0.0018086028,0.021749869,0.0065361634,0.004105808,0.30167675,0.12514758,0.5097939],"study_design_scores_gemma":[0.0019271405,0.0072441897,0.018620199,0.022810992,0.00035451926,0.0039402675,0.030592775,0.028472586,0.013828086,0.11100037,0.7597659,0.0014430531],"about_ca_topic_score_codex":0.0043881573,"about_ca_topic_score_gemma":0.005167513,"teacher_disagreement_score":0.23619369,"about_ca_system_score_codex":0.011034735,"about_ca_system_score_gemma":0.06259229,"threshold_uncertainty_score":0.9419092},"labels":[],"label_agreement":null},{"id":"W3200208683","doi":"10.1089/cap.2021.0010","title":"Neurocognitive Outcomes from Memantine: A Pilot, Double-Blind, Placebo-Controlled Trial in Children with Autism Spectrum Disorder","year":2021,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Autism Spectrum Disorder Research","field":"Neuroscience","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Holland Bloorview Kids Rehabilitation Hospital","funders":"","keywords":"Memantine; Neurocognitive; Autism; Autism spectrum disorder; Psychology; Randomized controlled trial; Placebo; Clinical psychology; Verbal memory; Cognition; Psychiatry; Medicine; Dementia; Internal medicine","score_opus":0.025761143035182853,"score_gpt":0.32390630812403787,"score_spread":0.298145165088855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200208683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98566544,0.006098435,0.0006624184,0.0004975058,0.0004122352,0.004725356,0.00072268397,0.00020773192,0.0010083235],"genre_scores_gemma":[0.97809225,0.0038889085,0.0029370536,0.00071707845,0.000407907,0.011493109,0.0005543621,0.00002740401,0.0018820559],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995221,0.00022563487,0.000056196357,0.00008982679,0.00004221334,0.00006406806],"domain_scores_gemma":[0.9991868,0.000260893,0.00021997635,0.00006183452,0.00006804465,0.00020243286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013136663,0.0015074513,0.002170076,0.00055495946,0.00046370973,0.00069138996,0.0010181536,0.0019911097,0.0051959893],"category_scores_gemma":[0.0016285876,0.0005248927,0.0014022279,0.00034069477,0.0010805983,0.0007810039,0.00031286778,0.0019540659,0.00074774004],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92009324,0.02221838,0.0006257987,0.0027377096,0.0006878582,0.00018498945,0.0001686735,0.00031382305,0.011517519,0.000103891376,0.00084371027,0.040504325],"study_design_scores_gemma":[0.9053883,0.091799945,0.0013032205,0.00005471748,0.00013787443,0.000049595754,0.00002058126,0.00015870384,0.0006862848,0.000051323015,0.00034059398,0.000008887873],"about_ca_topic_score_codex":0.000671385,"about_ca_topic_score_gemma":0.0016161798,"teacher_disagreement_score":0.0051959893,"about_ca_system_score_codex":0.00049852877,"about_ca_system_score_gemma":0.0010021228,"threshold_uncertainty_score":0.017382264},"labels":[],"label_agreement":null},{"id":"W3203492688","doi":"10.1089/cap.2021.0064","title":"The Efficacy and Cognitive Effects of Acute Course Electroconvulsive Therapy Are Equal in Adolescents, Transitional Age Youth, and Young Adults","year":2021,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Electroconvulsive Therapy Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Mental Health","keywords":"Montreal Cognitive Assessment; Electroconvulsive therapy; Depression (economics); Tolerability; Medicine; Young adult; Psychiatry; Psychology; Cognition; Pediatrics; Internal medicine; Clinical psychology; Adverse effect; Cognitive impairment","score_opus":0.006836158399218081,"score_gpt":0.29343144511801056,"score_spread":0.2865952867187925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203492688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99789363,0.0013948433,0.00002219042,0.000043224183,0.000007810562,0.000010405856,0.00009608772,0.0000014179124,0.00053038215],"genre_scores_gemma":[0.99910885,0.0005286131,0.000044752884,0.000060807237,0.000012813934,0.000008063825,0.00012858609,7.1561703e-7,0.00010671779],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993807,0.00018590098,0.00008928691,0.000065460394,0.00019919116,0.0000794381],"domain_scores_gemma":[0.9984415,0.000409636,0.00071008864,0.0000583453,0.000120559576,0.00025990428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012116255,0.00016636937,0.00048496973,0.00058621477,0.0002209124,0.0006035005,0.00016201088,0.00029716894,0.00091908197],"category_scores_gemma":[0.003818983,0.0001431939,0.0006891297,0.00034080635,0.00024488615,0.00034265636,0.00026470155,0.00030810092,0.00015337524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011357499,0.00018194481,0.98333824,0.00004352153,0.00029074363,0.000116189854,0.00014621488,0.00003051793,0.0003021523,0.000025232324,0.00011692516,0.01427257],"study_design_scores_gemma":[0.000045938512,0.0005123321,0.99886405,0.000025215451,0.0000597432,0.00018390623,0.000096676005,0.000039720577,0.000047427184,0.000013302063,0.00010989682,0.0000017691957],"about_ca_topic_score_codex":0.0016434337,"about_ca_topic_score_gemma":0.003434185,"teacher_disagreement_score":0.0016434337,"about_ca_system_score_codex":0.00031512944,"about_ca_system_score_gemma":0.00026041252,"threshold_uncertainty_score":0.0064077973},"labels":[],"label_agreement":null},{"id":"W3205414166","doi":"10.1089/cap.2021.0034","title":"Efficacy and Safety of a Long-Acting Multilayer-Release Methylphenidate Formulation (PRC-063) in the Treatment of Adolescent Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Clinical Trial with a 6-Month Open-Label Extension","year":2021,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"Placebo; Methylphenidate; Attention deficit hyperactivity disorder; Randomized controlled trial; Adverse effect; Psychology; Clinical Global Impression; Clinical endpoint; Clinical trial; Psychiatry; Medicine; Physical therapy; Internal medicine","score_opus":0.08747277992799993,"score_gpt":0.42726832909305684,"score_spread":0.33979554916505694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205414166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932654,0.002157391,0.000435061,0.00018025805,0.00016156917,0.0026910843,0.00052983314,0.000080424026,0.00049900264],"genre_scores_gemma":[0.9881864,0.002663824,0.0025213955,0.00038894857,0.0003783922,0.0035124337,0.00089504,0.00002734131,0.0014262721],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991159,0.00038812327,0.000109387736,0.00015866433,0.00013726015,0.00009074576],"domain_scores_gemma":[0.99848723,0.0003141347,0.00042211887,0.00014788746,0.00013200357,0.00049660425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022275152,0.0013281616,0.0023587528,0.00046424576,0.00044305265,0.00077415025,0.0015599048,0.0019685838,0.0052843834],"category_scores_gemma":[0.00181953,0.0008687439,0.001407079,0.00040110538,0.001249616,0.0011266785,0.00051230646,0.0029325192,0.0010019104],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95349663,0.018826233,0.0004977716,0.0005304191,0.00039097955,0.00002528317,0.000050141854,0.00016137653,0.006818265,0.00003700294,0.00021892459,0.018946996],"study_design_scores_gemma":[0.8156976,0.18010515,0.0022753964,0.000022739581,0.0002601082,0.000033552544,0.000013999365,0.00025686392,0.001059865,0.000026539967,0.00023393903,0.000014181808],"about_ca_topic_score_codex":0.00080281036,"about_ca_topic_score_gemma":0.0016020973,"teacher_disagreement_score":0.0052843834,"about_ca_system_score_codex":0.00061637355,"about_ca_system_score_gemma":0.0014488002,"threshold_uncertainty_score":0.017677963},"labels":[],"label_agreement":null},{"id":"W3211117991","doi":"10.1089/cap.2021.0087","title":"Effect of a Multilayer, Extended-Release Methylphenidate Formulation (PRC-063) on Sleep in Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Fixed-Dose, Placebo-Controlled Trial Followed by a 6-Month Open-Label Follow-Up","year":2021,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada); University of Alberta","funders":"","keywords":"Pittsburgh Sleep Quality Index; Placebo; Tolerability; Double blind; Methylphenidate; Dosing; Medicine; Attention deficit hyperactivity disorder; Randomized controlled trial; Placebo-controlled study; Anesthesia; Psychology; Adverse effect; Internal medicine; Psychiatry; Sleep quality; Insomnia","score_opus":0.019082212162764157,"score_gpt":0.34936893452590645,"score_spread":0.33028672236314227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211117991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945437,0.0029995833,0.0002491917,0.000116663556,0.00011595952,0.0010949712,0.00038292326,0.000057278463,0.00043975492],"genre_scores_gemma":[0.99299,0.0027167953,0.0013958648,0.0002646718,0.00013897764,0.0011498524,0.0004820096,0.0000123967875,0.00084939005],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997118,0.00010445192,0.000037152346,0.00006343994,0.000047963393,0.000035229587],"domain_scores_gemma":[0.9995498,0.000096694595,0.00012298001,0.000040577324,0.000045640332,0.0001442783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009270705,0.0008492202,0.0019111653,0.00032734455,0.00028585733,0.0004632527,0.0009200905,0.0010434595,0.0031326816],"category_scores_gemma":[0.000817918,0.0004567317,0.001096237,0.00029091263,0.0005462913,0.0005888217,0.0003038183,0.0018307902,0.00048013887],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8956293,0.02063497,0.0015777962,0.0016193152,0.001218188,0.000069008034,0.000095701325,0.00036675046,0.01931573,0.00006143529,0.0005538432,0.058857955],"study_design_scores_gemma":[0.7271951,0.25807574,0.010042154,0.000072199015,0.00061576517,0.00009067114,0.000047271304,0.000674831,0.0025717686,0.000042602984,0.000547803,0.000024143957],"about_ca_topic_score_codex":0.0010568012,"about_ca_topic_score_gemma":0.0031246406,"teacher_disagreement_score":0.0031326816,"about_ca_system_score_codex":0.0004049906,"about_ca_system_score_gemma":0.0007841121,"threshold_uncertainty_score":0.010479808},"labels":[],"label_agreement":null},{"id":"W4210609640","doi":"10.1089/cap.2021.0092","title":"Clozapine for Management of Childhood and Adolescent-Onset Schizophrenia: A Systematic Review and Meta-Analysis","year":2022,"lang":"en","type":"review","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Clozapine; Observational study; Medicine; Olanzapine; Psychiatry; Pediatrics; Schizophrenia (object-oriented programming); Randomized controlled trial; Hypersalivation; Internal medicine; Anesthesia","score_opus":0.0618477965550992,"score_gpt":0.3903609249306816,"score_spread":0.3285131283755824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210609640","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023342096,0.99664646,0.00020151844,0.000103173305,0.00007805731,0.0002449944,0.00022756594,0.000014382225,0.00014969711],"genre_scores_gemma":[0.056013215,0.9409993,0.0012055327,0.00040867654,0.00011504122,0.00072205794,0.00036841692,0.0000114018185,0.00015636493],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99532473,0.0019504029,0.0014888102,0.0004217193,0.0006182997,0.00019599187],"domain_scores_gemma":[0.9917355,0.0053382483,0.0017114272,0.00020203674,0.00083182106,0.0001808912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007816137,0.0024618183,0.016846785,0.006798932,0.0005799236,0.0025506092,0.0021119758,0.0018150173,0.00390202],"category_scores_gemma":[0.01733286,0.0011427592,0.03041036,0.0067481757,0.0005552195,0.0014981391,0.0014075434,0.0016142351,0.0002364643],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023624604,0.00005628065,0.0014521532,0.6451945,0.3258155,0.00012656058,0.00008216384,0.00043251304,0.00021858679,0.00011958725,0.00062019815,0.02351961],"study_design_scores_gemma":[0.0009268036,0.000322162,0.0028022113,0.051656667,0.94148195,0.00010582881,0.00006254508,0.00017850295,0.00012311623,0.00014161514,0.0021713926,0.000027156675],"about_ca_topic_score_codex":0.008881339,"about_ca_topic_score_gemma":0.022743894,"teacher_disagreement_score":0.016846785,"about_ca_system_score_codex":0.0030910552,"about_ca_system_score_gemma":0.0049975854,"threshold_uncertainty_score":0.04133618},"labels":[],"label_agreement":null},{"id":"W4210780556","doi":"10.1089/cap.2021.0093","title":"Association of Lithium and Second-Generation Antipsychotics with Neurocognition in Youth with Bipolar Disorder","year":2022,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Centre of Excellence for Child and Youth Mental Health; University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Neurocognitive; Bipolar disorder; Psychology; Cognitive flexibility; Lithium (medication); Psychiatry; Neuropsychology; Clinical psychology; Cognition","score_opus":0.009462268448817895,"score_gpt":0.25204502252641925,"score_spread":0.24258275407760135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210780556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990823,0.0005044195,0.000015676831,0.000039172704,0.000004325217,0.000004898403,0.00015550287,0.0000019735285,0.00019172052],"genre_scores_gemma":[0.99942005,0.0002071488,0.00004672123,0.00002617359,0.0000070249766,0.0000058560063,0.00019403621,0.0000012904093,0.000091736765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996147,0.00007895876,0.000063501684,0.00007253158,0.00010463549,0.00006561311],"domain_scores_gemma":[0.998331,0.00020123304,0.001097577,0.000043321426,0.0001515232,0.00017535877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004790287,0.0002620049,0.0003698642,0.0007121758,0.00038413747,0.0005256828,0.00022505534,0.00037124084,0.0014589311],"category_scores_gemma":[0.0019582077,0.00019252098,0.0004607677,0.0008374243,0.0002386575,0.00026108575,0.00036317523,0.0005762239,0.00012416247],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005116938,0.000018153763,0.999084,0.000005868856,0.000017726095,0.000033965378,0.000019854746,0.000006524749,0.000046494777,0.0000037033833,0.00003064966,0.0006818564],"study_design_scores_gemma":[0.0000041495778,0.000057743888,0.9995461,0.000007684609,0.000018575387,0.00018906662,0.00006231884,0.000041470485,0.000024565108,0.0000050009094,0.000042163338,0.0000010548714],"about_ca_topic_score_codex":0.009638785,"about_ca_topic_score_gemma":0.023830635,"teacher_disagreement_score":0.009638785,"about_ca_system_score_codex":0.0004616813,"about_ca_system_score_gemma":0.0004579581,"threshold_uncertainty_score":0.019165337},"labels":[],"label_agreement":null},{"id":"W4223527802","doi":"10.1089/cap.2021.0059","title":"Bowel and Bladder Dysfunction Is Associated with Psychiatric Comorbidities and Functional Impairment in Pediatric Obsessive-Compulsive Disorder","year":2022,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Obsessive-Compulsive Spectrum Disorders","field":"Psychology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Children's Hospital; BC Mental Health & Substance Use Services; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Psychiatry; Urinary urgency; Constipation; Comorbidity; Major depressive disorder; Internal medicine; Obsessive compulsive; Interstitial cystitis; Urinary system; Overactive bladder; Mood","score_opus":0.00709254372975001,"score_gpt":0.2545289704306952,"score_spread":0.2474364267009452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223527802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99918705,0.00038119633,0.000024084604,0.00003087082,0.0000027209012,0.000004736375,0.00013408203,0.0000023817372,0.00023282714],"genre_scores_gemma":[0.999458,0.00021351941,0.00007611708,0.000014264967,0.0000049767855,0.0000057801963,0.00018122316,0.0000011556413,0.000044966037],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994987,0.00009750239,0.00007794562,0.00009526882,0.00013892539,0.00009162114],"domain_scores_gemma":[0.9981616,0.00022279054,0.0012377229,0.000040968524,0.00013615744,0.00020077682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004707946,0.00026899812,0.00029143758,0.0007829723,0.00028433517,0.00049864635,0.00026678725,0.0002830655,0.0017536401],"category_scores_gemma":[0.002407339,0.00022899783,0.0003989816,0.0010693514,0.000327426,0.00033613466,0.00055802765,0.00043718185,0.00013082693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016530252,0.000007927732,0.99886155,0.000008546603,0.000010257752,0.000098056415,0.00002578673,0.000006777219,0.00006466489,0.000003094111,0.000028053553,0.00086863845],"study_design_scores_gemma":[0.0000014200377,0.000020038973,0.99907494,0.000008947773,0.0000073209358,0.0007204099,0.00009018359,0.000022907365,0.000014514543,0.0000034847094,0.000035180663,7.763161e-7],"about_ca_topic_score_codex":0.005378782,"about_ca_topic_score_gemma":0.009297025,"teacher_disagreement_score":0.005378782,"about_ca_system_score_codex":0.0003318878,"about_ca_system_score_gemma":0.00043319995,"threshold_uncertainty_score":0.010694921},"labels":[],"label_agreement":null},{"id":"W4225392379","doi":"10.1089/cap.2021.0137","title":"Citalopram Did Not Significantly Improve Anxiety in Children with Autism Spectrum Disorder Undergoing Treatment for Core Symptoms: Secondary Analysis of a Trial to Reduce Repetitive Behaviors","year":2022,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Autism Spectrum Disorder Research","field":"Neuroscience","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Holland Bloorview Kids Rehabilitation Hospital; University of Toronto","funders":"National Institute of Mental Health; King's College London; Department of Health and Social Care; National Institute for Health and Care Research","keywords":"Anxiety; Citalopram; Placebo; Autism spectrum disorder; Randomized controlled trial; Psychology; Autism; Clinical psychology; Psychiatry; Population; Anxiety disorder; Adverse effect; Confidence interval; Medicine; Internal medicine; Antidepressant","score_opus":0.01786633686041778,"score_gpt":0.32432764032597194,"score_spread":0.30646130346555417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225392379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793372,0.0075489962,0.00055643136,0.0005205142,0.00042317892,0.0054002386,0.0039541842,0.00012718313,0.0021320719],"genre_scores_gemma":[0.98798966,0.002677918,0.0009614241,0.0004919215,0.00037970176,0.0042430134,0.0019265163,0.000029522467,0.0013003899],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9972785,0.0014249894,0.0003505913,0.00037490999,0.0002950026,0.00027604995],"domain_scores_gemma":[0.9953127,0.002000836,0.001270041,0.0005048303,0.00045520274,0.00045630021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030534952,0.0014989738,0.0042664353,0.0008900448,0.00046144178,0.0010839899,0.0007708681,0.0015451168,0.0069383457],"category_scores_gemma":[0.007060909,0.00042207775,0.007426024,0.0006988931,0.0007319859,0.00059265207,0.00056956225,0.0021426894,0.0005632366],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93066853,0.0055437475,0.004263774,0.005045587,0.020082178,0.0002889899,0.00014824474,0.0005286194,0.0032347962,0.00016730653,0.0018300327,0.028198132],"study_design_scores_gemma":[0.825826,0.1325237,0.024362266,0.00027744658,0.013293581,0.0001879274,0.000059232363,0.00053243135,0.0012976418,0.00021789611,0.0013810981,0.000040762057],"about_ca_topic_score_codex":0.0028211973,"about_ca_topic_score_gemma":0.005675769,"teacher_disagreement_score":0.0069383457,"about_ca_system_score_codex":0.0011766439,"about_ca_system_score_gemma":0.0021335334,"threshold_uncertainty_score":0.023211062},"labels":[],"label_agreement":null},{"id":"W4281568244","doi":"10.1089/cap.2021.0124","title":"Efficacy, Tolerability, and Acceptance of Long-Lasting Antipsychotics in Children and Adolescents: A Systematic Review","year":2022,"lang":"en","type":"review","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Risperidone; PsycINFO; Tolerability; Medicine; Psychiatry; Pediatrics; MEDLINE; Clinical psychology; Schizophrenia (object-oriented programming); Internal medicine; Adverse effect","score_opus":0.028615258347554445,"score_gpt":0.374454337196046,"score_spread":0.3458390788484915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281568244","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029342915,0.9965642,0.000031833788,0.000062291816,0.000024389825,0.00006789453,0.00018621002,0.000002495582,0.00012641847],"genre_scores_gemma":[0.03295445,0.96618015,0.00024418012,0.0002124142,0.000051478804,0.00014944379,0.00016067525,0.0000023309185,0.000044878438],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99667966,0.00081340707,0.0014864594,0.00029167117,0.0006359575,0.0000928198],"domain_scores_gemma":[0.97810715,0.015798664,0.0045666406,0.00017326145,0.001151542,0.00020275662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044483924,0.00069511915,0.0046481974,0.0046794144,0.00029090402,0.0015264548,0.0011214141,0.00124255,0.0020793928],"category_scores_gemma":[0.016493967,0.000607905,0.0042558657,0.0057963873,0.0006412939,0.0012342705,0.00068310543,0.0006637508,0.00010830662],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003658207,0.000031557014,0.003803433,0.93476474,0.008548108,0.00014510594,0.00030294634,0.0000706315,0.00013683278,0.000134664,0.0008339395,0.05086219],"study_design_scores_gemma":[0.0005100491,0.00066135125,0.034070536,0.84709096,0.09580426,0.0016737658,0.00089685596,0.00014137264,0.00026750096,0.00017796598,0.018648213,0.000057129517],"about_ca_topic_score_codex":0.00549254,"about_ca_topic_score_gemma":0.014451587,"teacher_disagreement_score":0.00549254,"about_ca_system_score_codex":0.0017263086,"about_ca_system_score_gemma":0.0046778778,"threshold_uncertainty_score":0.023525655},"labels":[],"label_agreement":null},{"id":"W4283017130","doi":"10.1089/cap.2022.0013","title":"<i>Letter to the Editor:</i> Antidepressant and Antisuicidal Effects of Esketamine in Adolescents with Major Depressive Disorder and Suicidal Ideation: A Case Series","year":2022,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Humanities; Medicine; Psychiatry; Library science; Art","score_opus":0.00420618564527537,"score_gpt":0.2592069677436826,"score_spread":0.25500078209840726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283017130","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19855787,0.027787855,0.0018201009,0.6764057,0.071822606,0.00018525305,0.00084821664,0.0005134661,0.022059],"genre_scores_gemma":[0.5599014,0.010632204,0.0018474454,0.23294158,0.18249783,0.000105330786,0.00044655128,0.00018126518,0.01144644],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99932325,0.00014112014,0.00013661002,0.00012524282,0.00012191912,0.00015191757],"domain_scores_gemma":[0.9971136,0.0010859612,0.00058170815,0.00013287131,0.0004352455,0.0006505041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006244986,0.0008392508,0.0011456618,0.0011710554,0.001166348,0.0014318083,0.0019329396,0.0122101735,0.0036033238],"category_scores_gemma":[0.0074363193,0.000626264,0.0011194369,0.00077315426,0.0011170768,0.0022223028,0.0006323897,0.0075570485,0.0016737338],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000099255616,0.00006859046,0.011121064,0.00014464238,0.00006387136,0.88400006,0.00019551738,0.00013388158,0.00039709345,0.0004883148,0.09860347,0.0046841726],"study_design_scores_gemma":[0.00008807941,0.000095023985,0.010700041,0.00018202,0.0000812037,0.95152414,0.00047110862,0.00084337866,0.00036630942,0.0006788374,0.034913667,0.000056300596],"about_ca_topic_score_codex":0.0023182847,"about_ca_topic_score_gemma":0.002995122,"teacher_disagreement_score":0.0122101735,"about_ca_system_score_codex":0.0015762007,"about_ca_system_score_gemma":0.0008914274,"threshold_uncertainty_score":0.012054265},"labels":[],"label_agreement":null},{"id":"W4312098090","doi":"10.1089/cap.2022.0036","title":"Preliminary Observations of Resting-State Magnetoencephalography in Nonmedicated Children with Obsessive-Compulsive Disorder","year":2022,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Obsessive-Compulsive Spectrum Disorders","field":"Psychology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Hospital for Sick Children; Ontario Centre of Excellence for Child and Youth Mental Health; University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of Mental Health; Canadian Institutes of Health Research","keywords":"Magnetoencephalography; Resting state fMRI; Psychology; Neuroscience; Neuroimaging; Default mode network; Audiology; Functional connectivity; Medicine; Electroencephalography","score_opus":0.009211650512343761,"score_gpt":0.27473678581560407,"score_spread":0.26552513530326033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312098090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992654,0.00006002184,0.000090782,0.000029241572,0.0000020582386,0.000006073692,0.0001644226,0.000008912539,0.00037316213],"genre_scores_gemma":[0.9994117,0.00006286736,0.00017642553,0.000031399984,0.0000036596055,0.00001079873,0.00019413345,0.0000026996283,0.00010625621],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99986637,0.000015506172,0.000017610218,0.0000406783,0.000029388051,0.000030293526],"domain_scores_gemma":[0.99940264,0.00014303975,0.0002532561,0.000026571284,0.00008047735,0.0000940054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002010446,0.00034385404,0.00026616835,0.00054333033,0.00023829895,0.00032591462,0.00020170973,0.00039209874,0.0011388145],"category_scores_gemma":[0.001468475,0.0001470712,0.00014697431,0.0003320134,0.00035666264,0.00021639091,0.0002654147,0.00031766077,0.00014023787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026589129,0.000081413535,0.968919,0.000058904126,0.000034485318,0.005250361,0.0012667858,0.00007724931,0.01715792,0.00004264583,0.00030345854,0.006541887],"study_design_scores_gemma":[0.000004840842,0.00007983479,0.99620926,0.0000034399754,0.000009410673,0.002967981,0.00021940889,0.000038974697,0.0003657415,0.0000095510695,0.00008912264,0.0000024469805],"about_ca_topic_score_codex":0.008015603,"about_ca_topic_score_gemma":0.013990596,"teacher_disagreement_score":0.008015603,"about_ca_system_score_codex":0.00033546076,"about_ca_system_score_gemma":0.0002362072,"threshold_uncertainty_score":0.015937865},"labels":[],"label_agreement":null},{"id":"W4366351805","doi":"10.1089/cap.2022.0078","title":"Multivariable Prediction Modeling of Antidepressant Initiation in Unipolar Depressed Adolescents: A Secondary Analysis of the IMPACT Trial","year":2023,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Suicide and Self-Harm Studies","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"","keywords":"Suicidal ideation; Depression (economics); Randomized controlled trial; Clinical psychology; Medicine; Psychiatry; Antidepressant; Major depressive disorder; Psychology; Poison control; Injury prevention; Internal medicine; Mood; Emergency medicine; Anxiety","score_opus":0.026676750175611077,"score_gpt":0.3445614349544911,"score_spread":0.31788468477888004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366351805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9260036,0.008778519,0.03551617,0.0018322169,0.0008777037,0.010597892,0.011177006,0.00058079796,0.004636079],"genre_scores_gemma":[0.97810286,0.00069553696,0.008975957,0.00029160257,0.00026484387,0.0066550313,0.004153582,0.000049856077,0.00081082346],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.96268654,0.03269103,0.0014857206,0.0014306203,0.0011469285,0.0005591587],"domain_scores_gemma":[0.94866055,0.036522422,0.0060879043,0.005655641,0.0023782603,0.00069517165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04234369,0.0013687811,0.0032334463,0.00065126043,0.0004563518,0.0015007384,0.0016194985,0.0010133316,0.0055873757],"category_scores_gemma":[0.07226005,0.0006652815,0.009443357,0.0009814163,0.00043208234,0.0010990844,0.0011336084,0.0023646476,0.0005133007],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5363814,0.004307213,0.22735286,0.01050359,0.12065525,0.00023403385,0.00046680903,0.018907404,0.00090829976,0.0037828125,0.010098701,0.06640157],"study_design_scores_gemma":[0.30324188,0.08529366,0.25382,0.0022002838,0.1708713,0.00043556,0.00036631463,0.15771215,0.0026091305,0.012411792,0.010725142,0.00031279598],"about_ca_topic_score_codex":0.0017082877,"about_ca_topic_score_gemma":0.0014354249,"teacher_disagreement_score":0.04234369,"about_ca_system_score_codex":0.00070675946,"about_ca_system_score_gemma":0.0018761264,"threshold_uncertainty_score":0.22393751},"labels":[],"label_agreement":null},{"id":"W4384522844","doi":"10.1089/cap.2022.0083","title":"Vascular Endothelial Growth Factor Polymorphism rs699947 Is Associated with Neurostructural Phenotypes in Youth with Bipolar Disorder","year":2023,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Centre for Addiction and Mental Health","funders":"","keywords":"Vascular endothelial growth factor; Anterior cingulate cortex; Internal medicine; Postcentral gyrus; Medicine; Neuroimaging; Magnetic resonance imaging; Psychology; Pathology; Neuroscience; Cognition; VEGF receptors; Radiology","score_opus":0.009960288662271924,"score_gpt":0.2516264045336726,"score_spread":0.24166611587140066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384522844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999446,0.0001198754,0.000066452034,0.000029965906,0.000005499673,0.0000025683546,0.00016902867,0.0000035338633,0.00015712412],"genre_scores_gemma":[0.9995289,0.00006695228,0.000112753405,0.000018875573,0.0000056698536,0.0000046634896,0.00017104724,0.0000037629939,0.00008736821],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983144,0.00003313365,0.000025246349,0.000055146986,0.000027609765,0.000027338816],"domain_scores_gemma":[0.9994721,0.00009356231,0.0003061483,0.000024851977,0.00004524878,0.000057992584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026641894,0.00038187194,0.0003125908,0.00057075126,0.00042191884,0.00041099367,0.00015593387,0.00042501788,0.002648403],"category_scores_gemma":[0.0010393541,0.00023898951,0.00029737075,0.0006744832,0.0002051119,0.00013763166,0.0002218058,0.00028981527,0.00020266362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085501286,0.00004526472,0.98923653,0.000023644781,0.000110159286,0.00058790937,0.00022345273,0.00007389999,0.0051992713,0.00006455298,0.0002921193,0.0032881247],"study_design_scores_gemma":[0.000016369673,0.000049964765,0.99858534,0.00001548604,0.00004872316,0.00074291433,0.00010701409,0.00012403604,0.00016106505,0.00005108101,0.00009563178,0.0000024584608],"about_ca_topic_score_codex":0.0050242287,"about_ca_topic_score_gemma":0.0075496486,"teacher_disagreement_score":0.0050242287,"about_ca_system_score_codex":0.00020426311,"about_ca_system_score_gemma":0.00012811637,"threshold_uncertainty_score":0.009989977},"labels":[],"label_agreement":null},{"id":"W4391984652","doi":"10.1089/cap.2023.0039","title":"Impact of Cytochrome P450 Genetic Variation on Patient-Reported Symptom Improvement and Side Effects Among Children and Adolescents Treated with Fluoxetine","year":2024,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital; University of Manitoba; University of Calgary","funders":"","keywords":"Fluoxetine; Genetic variation; Psychology; Cytochrome P450; Psychiatry; Variation (astronomy); Medicine; Clinical psychology; Pediatrics; Internal medicine; Environmental health","score_opus":0.0035104538718488286,"score_gpt":0.26584031507600214,"score_spread":0.2623298612041533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391984652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999433,0.00020814598,0.000026059506,0.000031746265,0.0000018350205,0.000004120347,0.00015296768,0.0000013311054,0.00014077764],"genre_scores_gemma":[0.9997236,0.00007027677,0.000051329058,0.000011624915,0.000002033669,0.0000029839766,0.000111998204,9.924014e-7,0.000025187572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991997,0.0002922447,0.00007394497,0.00014375526,0.00019334367,0.00009701379],"domain_scores_gemma":[0.99728286,0.0008435974,0.0013723719,0.00008530854,0.00019935772,0.00021648541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007349219,0.00023997591,0.00034615886,0.00044415696,0.0002832051,0.00042071193,0.00022155745,0.0003592318,0.0012079236],"category_scores_gemma":[0.0033236248,0.00017925652,0.00060599163,0.0006795041,0.00037314979,0.00018626111,0.00021051963,0.0006227998,0.00009439724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006259977,0.000012752298,0.99910516,0.0000041948274,0.00004270652,0.00004192905,0.000044604356,0.00001534309,0.00007120568,0.0000042740153,0.000020426132,0.00057465414],"study_design_scores_gemma":[0.0000025470242,0.000029744053,0.99971956,0.000002480408,0.000019093628,0.00011473366,0.00003536316,0.0000347163,0.000017073586,0.0000024950461,0.000021314321,8.393429e-7],"about_ca_topic_score_codex":0.018183196,"about_ca_topic_score_gemma":0.020351391,"teacher_disagreement_score":0.018183196,"about_ca_system_score_codex":0.00054511137,"about_ca_system_score_gemma":0.00035547014,"threshold_uncertainty_score":0.036154747},"labels":[],"label_agreement":null},{"id":"W4394564982","doi":"10.1089/cap.2023.0090","title":"Comparing Symptoms of Major Depression in Youth with Confirmed Versus Suspected Bipolar Disorder","year":2024,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research","keywords":"Bipolar disorder; Depression (economics); Psychiatry; Major depressive disorder; Psychology; Major depressive episode; Depressive symptoms; Clinical psychology; Medicine; Mood; Anxiety","score_opus":0.013242591042896604,"score_gpt":0.29313334708842353,"score_spread":0.27989075604552693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394564982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99972266,0.00007793267,0.0000144716905,0.000007661567,0.0000026016755,0.0000064926153,0.000071165276,6.5526143e-7,0.00009627256],"genre_scores_gemma":[0.9995839,0.00008222665,0.000056080764,0.00001017222,0.000004138696,0.000012144056,0.0002092756,5.399677e-7,0.000041432755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972683,0.00008385026,0.000052063064,0.000038796654,0.000048697464,0.00004968167],"domain_scores_gemma":[0.99901915,0.00018786044,0.00049297017,0.000020047219,0.0000939025,0.00018621514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006493243,0.00019463174,0.00027415052,0.0005619617,0.00027948286,0.00037021397,0.00015732597,0.00021057705,0.0008076675],"category_scores_gemma":[0.0018667768,0.00014507458,0.00036039227,0.00036308938,0.00021152587,0.0002298067,0.0004043504,0.00040260996,0.0000923555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014568162,0.000030193982,0.9982035,0.000012964899,0.000021695354,0.000042417407,0.00019582995,0.000008834146,0.00013566542,0.000006312299,0.00005159474,0.0011451603],"study_design_scores_gemma":[0.000004795007,0.00011049234,0.9993717,0.0000037847,0.000008779975,0.00012451051,0.0002921877,0.000016650378,0.000032461336,0.000003648569,0.000030399162,6.66566e-7],"about_ca_topic_score_codex":0.0032542371,"about_ca_topic_score_gemma":0.009278895,"teacher_disagreement_score":0.0032542371,"about_ca_system_score_codex":0.00036187147,"about_ca_system_score_gemma":0.00023378873,"threshold_uncertainty_score":0.006470561},"labels":[],"label_agreement":null},{"id":"W4400278031","doi":"10.1089/cap.2024.0017","title":"Comparative Efficacy of Omega-3 Fatty Acid with Other Interventions for Depression in Children and Adolescents: A Systematic Review and Network Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Child and Adolescent Psychosocial and Emotional Development","field":"Psychology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brain and Cognition Discovery Foundation; University of Toronto","funders":"","keywords":"Meta-analysis; Depression (economics); Psychological intervention; Psychology; Omega 3 fatty acid; Omega; Systematic review; Psychiatry; Psychotherapist; Medicine; Clinical psychology; Fatty acid; MEDLINE; Internal medicine; Docosahexaenoic acid; Chemistry; Biochemistry; Polyunsaturated fatty acid; Philosophy","score_opus":0.07356180117465333,"score_gpt":0.41098414316163806,"score_spread":0.33742234198698473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400278031","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0056289206,0.99226683,0.000493643,0.00015411721,0.00014068911,0.00062273256,0.00043000627,0.000025270616,0.00023763342],"genre_scores_gemma":[0.18842377,0.80301964,0.0036746773,0.00079541217,0.0002661106,0.0026451696,0.00082883606,0.000029222869,0.0003172905],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98921764,0.005613133,0.0027547912,0.0010174519,0.0011193765,0.00027761393],"domain_scores_gemma":[0.9773117,0.017518455,0.0031569325,0.00047134812,0.0012661911,0.00027542622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014660355,0.0025739048,0.022131559,0.007911363,0.00074224896,0.00302161,0.0023779427,0.002391311,0.0039838385],"category_scores_gemma":[0.036301807,0.0012205533,0.032514043,0.00750392,0.0008490575,0.00191237,0.00164702,0.0020073864,0.00022303326],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027480228,0.000049140475,0.0021210029,0.42532653,0.5567481,0.000083807965,0.00007916063,0.00032774644,0.0001452647,0.00013461903,0.000339925,0.011896647],"study_design_scores_gemma":[0.0011525862,0.00030482968,0.0025024833,0.034216587,0.96022356,0.000058370937,0.00004854092,0.0001786994,0.000092919756,0.0001532356,0.0010495273,0.000018597904],"about_ca_topic_score_codex":0.0072762123,"about_ca_topic_score_gemma":0.016254654,"teacher_disagreement_score":0.022131559,"about_ca_system_score_codex":0.0038099668,"about_ca_system_score_gemma":0.004155735,"threshold_uncertainty_score":0.07753229},"labels":[],"label_agreement":null},{"id":"W4402731719","doi":"10.1089/cap.2024.0023","title":"Description, Implementation, and Efficacy of the Comprehensive Behavioral Intervention for Tics as First-Line Treatment for Tourette and Other Tic Disorders","year":2024,"lang":"en","type":"review","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Obsessive-Compulsive Spectrum Disorders","field":"Psychology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tics; Tourette syndrome; Intervention (counseling); Psychology; Psychiatry; Psychotherapist; Clinical psychology; Medicine","score_opus":0.050057636361879196,"score_gpt":0.43731769509003005,"score_spread":0.38726005872815084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402731719","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004731905,0.9889909,0.00073620345,0.0011674521,0.00029757892,0.0011837103,0.00044734025,0.000028495266,0.002416384],"genre_scores_gemma":[0.04399428,0.9449882,0.0059107533,0.0016089719,0.00030844097,0.002052342,0.00050779607,0.000013767174,0.00061543024],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967147,0.0013199368,0.0007222146,0.0003111433,0.00084194366,0.000090121255],"domain_scores_gemma":[0.99635905,0.0021001599,0.0008052905,0.00006879247,0.0005503364,0.00011646082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004217568,0.0006220422,0.0017987868,0.0021749684,0.0003285401,0.001364486,0.001227529,0.0010042461,0.0031225663],"category_scores_gemma":[0.00974632,0.00031897635,0.0021026013,0.0016492152,0.00030116196,0.0007385746,0.0005551745,0.0016022391,0.00031353216],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012417719,0.0005217281,0.00096743094,0.2368146,0.0024817206,0.000078445315,0.0001863564,0.00040065008,0.0006040899,0.0010348182,0.0039185234,0.7517498],"study_design_scores_gemma":[0.009049975,0.01100374,0.05062355,0.6702817,0.029010782,0.0011812064,0.00061290344,0.0018128842,0.0024755383,0.0010399633,0.22274178,0.00016607894],"about_ca_topic_score_codex":0.009602167,"about_ca_topic_score_gemma":0.025908558,"teacher_disagreement_score":0.009602167,"about_ca_system_score_codex":0.002027912,"about_ca_system_score_gemma":0.005318652,"threshold_uncertainty_score":0.022304893},"labels":[],"label_agreement":null},{"id":"W4403187354","doi":"10.1089/cap.2024.0061","title":"Quality of Life and Outcomes Associated with Adverse Effects in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder and Their Parents/Caregivers","year":2024,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Otsuka Pharmaceutical","keywords":"Attention deficit hyperactivity disorder; Psychology; Attention deficit; Quality of life (healthcare); Adverse effect; Attention deficit disorder; Psychiatry; Clinical psychology; Medicine; Psychotherapist; Internal medicine","score_opus":0.01100998585346165,"score_gpt":0.2997030117782035,"score_spread":0.2886930259247419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403187354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979438,0.0008409204,0.0000459257,0.00014586863,0.000006815903,0.000018350187,0.00045962507,0.0000023348832,0.0005363273],"genre_scores_gemma":[0.9987393,0.0004627149,0.0001437759,0.0000622214,0.000007740238,0.000021497197,0.00048389827,9.531788e-7,0.00007789159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891925,0.00038695117,0.00018566225,0.000102163875,0.00026479337,0.0001411445],"domain_scores_gemma":[0.9953791,0.00052108685,0.0030153478,0.000070721464,0.00046774288,0.00054597243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015705252,0.00026303486,0.00042301993,0.00082729716,0.00042291306,0.00060204015,0.0002653846,0.0003047414,0.0012154904],"category_scores_gemma":[0.005669153,0.0001852706,0.00069021154,0.00094579515,0.00027050366,0.0005695747,0.0006943051,0.0007317261,0.00013294176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054311826,0.000045691675,0.9971154,0.000026296566,0.000065216715,0.00005785413,0.0001798131,0.000046192905,0.000020877342,0.0000065822596,0.00016612906,0.00221556],"study_design_scores_gemma":[0.000010016323,0.00018426239,0.9983486,0.000038760427,0.000032367083,0.00028461762,0.0006253295,0.0001427784,0.000036719623,0.000013257658,0.00027818067,0.0000051850534],"about_ca_topic_score_codex":0.0046111937,"about_ca_topic_score_gemma":0.0069486434,"teacher_disagreement_score":0.0046111937,"about_ca_system_score_codex":0.00069906533,"about_ca_system_score_gemma":0.0005126995,"threshold_uncertainty_score":0.0091686845},"labels":[],"label_agreement":null},{"id":"W4408297644","doi":"10.1089/cap.2024.0130","title":"Psychiatric Polygenic Risk Scores and Week-by-Week Symptomatic Status in Youth with Bipolar Disorder: An Exploratory Study","year":2025,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Polygenic risk score; Bipolar disorder; Psychiatry; Psychology; Clinical psychology; Exploratory research; Medicine; Mood; Genotype; Single-nucleotide polymorphism","score_opus":0.007927719452705841,"score_gpt":0.2752045516119025,"score_spread":0.2672768321591967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408297644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994986,0.00005764937,0.000054767836,0.000008140069,0.0000011668872,0.000016027838,0.00025330164,0.0000016537601,0.000108506734],"genre_scores_gemma":[0.9992768,0.00004199141,0.00015091173,0.000011997925,0.0000041339263,0.000031157044,0.00038231316,0.0000018649565,0.00009882],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99950564,0.0002016126,0.000037805192,0.0001150597,0.00005915879,0.00008067523],"domain_scores_gemma":[0.9990736,0.00015575546,0.00036139297,0.00011343702,0.000088557324,0.00020721093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009782694,0.00046268626,0.00035563213,0.00079454604,0.000742614,0.0006488848,0.00039528453,0.0004961331,0.0015760943],"category_scores_gemma":[0.0017745468,0.0003792851,0.0008473724,0.00095688447,0.00032048125,0.0004659149,0.00078649586,0.0006023731,0.00033949869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014165563,0.000067895926,0.99876356,0.0000052943524,0.00005161773,0.00006290681,0.00018502938,0.000016030981,0.00009677466,0.000012021637,0.000057407397,0.00053985603],"study_design_scores_gemma":[0.0000107705155,0.00022313355,0.9991055,0.0000042608995,0.000030787272,0.00014303581,0.0002862595,0.0000947335,0.000016463156,0.000015003919,0.00006731059,0.0000028253864],"about_ca_topic_score_codex":0.008469747,"about_ca_topic_score_gemma":0.010027321,"teacher_disagreement_score":0.008469747,"about_ca_system_score_codex":0.00038212232,"about_ca_system_score_gemma":0.00038617622,"threshold_uncertainty_score":0.016840935},"labels":[],"label_agreement":null},{"id":"W4412708002","doi":"10.1177/10445463251360685","title":"Placebo Response on Attention-Deficit/Hyperactivity Disorder Ratings: Application to Multimodal Treatment Study of Attention-Deficit/Hyperactivity Disorder 3-Month Outcomes","year":2025,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Attention deficit hyperactivity disorder; Placebo; Attention deficit disorder; Attention deficit; Psychology; Psychiatry; Clinical psychology; Medicine; Alternative medicine","score_opus":0.014918368643088301,"score_gpt":0.3527060155380382,"score_spread":0.3377876468949499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412708002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879049,0.0025155402,0.0034325419,0.00015151953,0.000103864004,0.0034498533,0.00070509745,0.00012662503,0.0016100347],"genre_scores_gemma":[0.9906816,0.00039370352,0.0041745654,0.00006499328,0.00011053905,0.0037221126,0.00028566812,0.000017833803,0.00054909097],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99031353,0.0075024846,0.0005495398,0.000451357,0.0010518442,0.00013124087],"domain_scores_gemma":[0.9893197,0.0049016173,0.0042032064,0.0006364062,0.00052975415,0.0004092735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010951605,0.0008456168,0.0018700359,0.00054143765,0.00027006946,0.00039091308,0.00053215754,0.00094334106,0.0027874836],"category_scores_gemma":[0.014374179,0.00032673345,0.0013405259,0.00054829393,0.00052430516,0.0005341188,0.00058484246,0.0010766566,0.000201128],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7766337,0.008448206,0.04792583,0.0019383277,0.0027401096,0.00007835844,0.0004349999,0.0021044964,0.01959937,0.000179937,0.0007036835,0.13921295],"study_design_scores_gemma":[0.11161891,0.3406677,0.5279157,0.00016514435,0.002009408,0.00021215928,0.00011009686,0.0064756353,0.008450405,0.00034884026,0.0019470038,0.00007908146],"about_ca_topic_score_codex":0.00035096434,"about_ca_topic_score_gemma":0.0006988981,"teacher_disagreement_score":0.010951605,"about_ca_system_score_codex":0.00036288385,"about_ca_system_score_gemma":0.00040345773,"threshold_uncertainty_score":0.05791831},"labels":[],"label_agreement":null},{"id":"W68616365","doi":"10.1089/cap.2014.0011","title":"Child, Parent, and Service Predictors of Psychotropic Polypharmacy Among Adolescents and Young Adults with an Autism Spectrum Disorder","year":2014,"lang":"en","type":"article","venue":"Journal of Child and Adolescent Psychopharmacology","topic":"Autism Spectrum Disorder Research","field":"Neuroscience","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Polypharmacy; Autism spectrum disorder; Psychiatry; Autism; Comorbidity; Medicine; Logistic regression; Psychological intervention; Population; Clinical psychology; Psychology; Environmental health; Internal medicine","score_opus":0.008645951997678546,"score_gpt":0.2775594231401138,"score_spread":0.26891347114243525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W68616365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994406,0.00017358457,0.000016377118,0.00006651463,0.000002984253,0.000004807568,0.00014017866,0.0000012210473,0.00015371115],"genre_scores_gemma":[0.9994159,0.00019712804,0.000067494984,0.000029036015,0.0000048536685,0.000006952566,0.00018579744,9.414076e-7,0.00009187007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967146,0.000074764175,0.000056715955,0.000041400835,0.000097454154,0.00005823645],"domain_scores_gemma":[0.9978382,0.0004046205,0.0012505628,0.000044740107,0.00016658007,0.0002953613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047701827,0.00018164935,0.0002360084,0.0005427987,0.00034030195,0.000475294,0.00019792454,0.0003361944,0.0020589228],"category_scores_gemma":[0.0033996322,0.00019296535,0.00036744628,0.0005346539,0.00017104835,0.00035480573,0.0004724618,0.00065541675,0.00017258013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008494853,0.000013991681,0.9993957,0.000003022781,0.000006593916,0.000037895934,0.000052894622,0.0000067569845,0.000018836485,0.000003131535,0.000035989255,0.00041659395],"study_design_scores_gemma":[0.0000016718928,0.000032681968,0.9991866,0.0000095728465,0.000007439495,0.00026192956,0.0003276128,0.000072287316,0.000017784983,0.0000043934315,0.00007714196,8.88704e-7],"about_ca_topic_score_codex":0.013230819,"about_ca_topic_score_gemma":0.019966202,"teacher_disagreement_score":0.013230819,"about_ca_system_score_codex":0.00037667237,"about_ca_system_score_gemma":0.00049360265,"threshold_uncertainty_score":0.026307642},"labels":[],"label_agreement":null}]}